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Abstract
GLUT4 is the main insulin-regulated glucose transporter, which is present in 
insulin-responsive tissues. In the un-stimulated cells, GLUT4s are localized 
in intra-cellular GLUT4 storage vesicles (GSV). In response to insulin 
stimulation, GSVs rapidly translocate, dock and fuse with the plasma 
membrane in order to expose GLUT4 to the extra-cellular glucose. The 
insulin-stimulated GLUT4 vesicle translocation is a multi-step exocytotic 
process but the crucial regulated and rate determining step along this 
process has been previously difficult to resolve.
The work described in this thesis investigates the fusion process in the 
exocytotic limb of the GLUT4 translocation pathway using two in vitro 
systems. The first of these assays used plasma membrane reconstituted 
into liposomes and studied their fusion with immuno-isolated GLUT4 
vesicles. To aid the isolation of biologically active GLUT4 vesicles in the first 
fusion system, the maltose-binding protein-protein A fusion protein were 
cloned and expressed.
In this system, fusion is SNARE proteins and cytoplasm dependent but not 
cytoskeleton dependent. The rate of the fusion activity is stimulated 8-fold by 
the insulin activated plasma membrane fraction. Both the magnitude and 
time course of stimulated fusion recapitulate the insulin response of intact 
cells. Akt from the cytoplasm fraction is required for fusion. However the 
participation of Akt in the stimulation of fusion is dependent on its in vitro 
recruitment onto the insulin-activated plasma membrane. These data reveal 
that insulin activation of the plasma membrane fraction of the fusion reaction 
is an essential step in regulation. Inhibition of fusion was found using a Ca2+ 
chelator and a V-ATPase inhibitor, suggesting roles of Ca2+ and the 
V-ATPase in the fusion mechanism.
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The second fusion assay system used only recombinant SNAREs 
reconstituted into liposomes. Experiments using the second fusion system 
show that fusion is cytoplasm and Ca2+ dependent. The kinetics and 
characteristics of this fusion system have been studied and have been 
compared with the more complex system utilizing components obtained 
from insulin sensitive cells.
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Glucose is one of the main sources of energy in eukaryotic organisms. It 
plays a central role in metabolism and cellular homeostasis. Therefore the 
level of glucose in the blood is very tightly regulated. Most mammalian cells 
are dependent on a continuous supply of glucose, which acts as one of the 
primary sources for the generation of adenosine-5’-triphosphate (ATP) 
(Gould and Holman, 1993). In normal individuals, the blood glucose level is 
normally in a range of 3.5 - 5.5 mM (0.63 -1 mg/ml) (Tuch et al., 2000).
Glucose homeostasis is maintained by the coordinated regulation of 3 
processes: glucose absorption via the small intestine, glucose production in 
the liver, and consumption of glucose by nearly all tissues. These three 
processes are regulated by two hormones: insulin and glucagon. In 
response to elevated circulating glucose (e.g. after a meal), insulin is 
secreted into the bloodstream by the pancreatic p cells and promotes 
glucose uptake in insulin responsive tissues. By contrast, when blood 
glucose concentration is low (e.g. periods between meals), glucagon is 
secreted and stimulates the breakdown of glycogen from liver and the 
release of glucose into the blood.
Abnormal levels of blood glucose cause severe problems to health. Low 
blood glucose concentrations (hypoglycemia) can cause seizures, loss of 
consciousness, and irreversible cell damage. Excessive blood glucose 
concentrations (hyperglycemia) have a detrimental effect referred to as 
“glucotoxicity”, which can result in blindness, renal failure, cardiac and 
peripheral vascular disease, and neuropathy (Scheepers et al., 2004). In
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addition, as glucose is the main regulator of insulin secretion and production, 
excessive amounts of glucose over a prolonged period have negative 
effects on pancreatic (3 cell function, resulting in increased basal insulin 
release, reduced maximal secretory response, and a gradual depletion of 
insulin stores (Kaiser et al., 2003). Thus, blood glucose concentrations need 
to be maintained within narrow limits and kept at a steady level.
1.1.1 Diabetes
The disease diabetes mellitus constitutes a vast majority of pathological 
cases of abnormality in glucose homeostasis. The International Diabetes 
Federation estimated that the global number of people with diabetes will rise 
from 194 million in 2003 to 333 million by 2025 (Zimmet et al., 2003). This 
will be an overall increase of 72 %, while in Africa, Asia and Middle East the 
expected increase is 90 - 100 % (Jenkins and Campbell, 2004). Diabetes 
results from a deficiency of insulin or a loss of response to insulin. The 
resulting elevated blood glucose causes the kidneys to excrete glucose in 
the urine. When the cells, which normally use glucose as energy supply, are 
lacking in glucose, fat becomes the main source of energy for cellular 
respiration. However, breakdown of fat causes the accumulation of acidic 
metabolites in the blood which is harmful to eyes, brains and can be life 
threatening.
There are mainly two classifications of diabetes mellitus. Type 1, insulin 
dependent diabetes mellitus, is a type of organ-specific autoimmune 
disorder characterized by the destruction of pancreatic p cells which 
consequently impairs insulin secretion. Type 2, non insulin dependent 
diabetes mellitus, which makes up about 90 % of the patients suffering from 
diabetes mellitus (Bennett, 1994), is mostly a result of faulty insulin action 
rather than the consequence of alterations in the levels of insulin in the
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blood (as is the case for type 1). In other words, in type 2 diabetes mellitus, 
insulin is present in the blood, but the body's cells no longer react properly to 
insulin and therefore cannot use it. This phenomenon is generally referred to 
as "insulin resistance". This is usually due to abnormalities on the cell 
surface of insulin responsive cells or within the cell, or both.
1.2 The glucose transporter families
Since glucose plays a central role in cellular metabolism, the transport of 
glucose across the plasma membrane of mammalian cells is one of the 
most important cellular nutrient transport events. Because the lipid bilayer of 
the eukaryotic plasma membrane is impermeable for hydrophilic molecules, 
glucose is transported across the plasma membrane by membrane 
associated carrier proteins, glucose transporters. The three processes to 
maintain glucose homeostasis mentioned earlier (section 1.1) are 
accomplished with the help of the glucose transporter proteins. They are 
divided into two main groups: the facilitative glucose transporters (GLUT) 
and the sodium/glucose co-transporters (SGLT) (Bell et al., 1990; 
Carruthers, 1990). The plasma membranes of virtually all mammalian cells 
contain GLUT proteins. The GLUT transport system for glucose is the 
facilitative diffusion type: these transporters allow the movement of glucose 
across the plasma membrane down a chemical gradient either into or out of 
cells. These transporters are specific for the D-enantiomer of glucose and 
are not coupled to any energy-requiring components, such as ATP 
hydrolysis or a H+ gradient (Gould and Holman, 1993). In contrast, the 
sodium/glucose co-transporters (SGLT), mainly expressed in intestine and 
kidney, actively accumulate glucose into the cells against its concentration 
gradient and across the luminal surface. The glucose concentrated inside 
the cells by them moves outward via GLUT proteins which are located 
mainly at the basolateral surface (Scheepers et al., 2004).
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1.2.1 The tissue expression and function of glucose transporters
The human GLUT family consists of 14 members, 11 of which have been 
shown to catalyze sugar transport (Fig 1.1). Their genes appear to belong to 
the family of solute carriers 2A (SLC2A). The individual isoforms exhibit 
different substrate specificities, kinetic characteristics, and expression 
profiles, thereby allowing a tissue-specific adaptation of glucose uptake 



























Fig 1.1 Dendrogram of the family of human sugar transporters.
The alignment was performed with the CLUSTAL program. Numbers 
at the branches of the tree indicate percentage of identity (Scheepers et 
al., 2004).
According to sequence similarities and characteristic elements, they are 
divided into three subfamilies (Joost and Thorens, 2001).
The class I GLUTs comprise GLUT1 to 4 and the recently identified GLUT14. 
GLUT1 to 4 are thoroughly characterized isoforms. GLUT1 is ubiquitously 
expressed and responsible for the basic supply of cells with glucose. It 
exhibits highest expression levels in erythrocytes and endothelial cells of the
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brain (Mueckler et al., 1985). GLUT2 is predominantly expressed in 
pancreatic p cells, liver, kidney, and small intestine (basolateral membrane). 
It transports fructose, glucosamine and glucose (Fukumoto et al., 1988; 
Uldry et al., 2002; Wood and Trayhurn, 2003). GLUT3 is a high-affinity 
glucose transporter with predominant expression in tissues with a high 
glucose requirement such as brain (Kayano et al., 1988). GLUT4 is a 
high-affinity glucose transporter expressed in insulin-sensitive tissues (heart, 
skeletal muscle, adipose tissue) (Fukumoto et al., 1989). Insulin stimulates 
the translocation of GLUT4 from intracellular compartments to the plasma 
membrane, resulting in an approximate 20-30-fold increase in glucose 
transport in rat adipocytes (Holman et al., 1990b; Taylor and Holman, 1981), 
2-4-fold in human adipocytes (Pedersen and Gliemann, 1981), 7-fold in rat 
muscle (Ploug et al., 1987) and 2-fold in human muscle (Dohm et al., 1988). 
The values for the fold changes are approximate and can vary depending on 
the tissue preparation for experiment. In addition, in skeletal muscle 
translocation of GLUT4 can be induced by muscle contraction and hypoxia 
(Cartee et al., 1991; Lund et al., 1995). GLUT14 is exclusively expressed in 
testis. The amino acid sequence of GLUT14 is 95 % identical with GLUT3 
(Wu and Freeze, 2002).
The class II GLUTs include the fructose-specific transporter GLUT5 and 
three related isoforms, GLUT7, GLUT9, and GLUT11. GLUT5 exhibits 
virtually no glucose transport activity and is responsible for the uptake of 
fructose in small intestine, testis, and kidney (Kayano et al., 1990). GLUT7 is 
a high-affinity transporter for glucose and fructose in small intestine, colon, 
testis, and prostate (Li et al., 2004). GLUT9, which is suggested to be critical 
for early pre-implantation development (Carayannopoulos et al., 2004), is a 
glucose transporter highly expressed in kidney and liver, lowly expressed in 
small intestine, placenta, lung, and leukocytes (Phay et al., 2000). GLUT11 
is a fructose transporter with low affinity for glucose, expressed
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predominantly in pancreas, kidney but also moderately in heart and skeletal 
muscle (Doege et al., 2001).
Class III GLUTs comprise the transporter isoforms GLUT6, GLUT8, 
GLUT10, GLUT12, and HMIT. GLUT6 is a low-affinity glucose transporter, 
predominantly expressed in brain, spleen, and peripheral leukocytes (Doege 
et al., 2000a). GLUT8 and GLUT12 are glucose transporters whose activity 
can be inhibited by D-fructose and D-galactose, indicating that they might be 
multifunctional transporters (Ibberson et al., 2000; Rogers et al., 2003). 
GLUT8 is predominantly expressed in testis (Doege et al., 2000b) and 
GLUT12 in heart and prostate (Rogers et al., 2003). GLUT10 is 
predominantly expressed in the liver and pancreas but its substrate 
specificity is not clear (Andersen et al., 2003; McVie-Wylie et al., 2001). The 
H+-coupled m yo inositol transporter (HMIT) is expressed predominantly in 
the brain. It specifically transports myoinositol and related stereoisomers 
but lacks any glucose transport activity (Uldry et al., 2001).
These different characteristics allow a complex and specific regulation of 
glucose uptake according to the cellular requirements and the physiologic 
conditions of substrate supply (Joost and Thorens, 2001). Table 1.1 
summaries the characteristics of all the GLUT isoforms.
20
Table 1.1 Summary of tissue distribution, substrate specificity and other characteristics 
for GLUT isoforms. (N/A: data not available)
Class Name Tissue distribution Substratespecificity Characteristics
GLUT1
Erythrocytes, 
Brain endothelial cells 
(blood-brain barrier)
Glucose
























GLUT14 Testis N/A N/A
GLUT5













Kidney, liver (high), small 




pancreas, kidney, and 







brain, spleen, and 
peripheral leukocytes
Glucose (low) N/A
GLUT8 Testis Glucose (high) N/A
II I
GLUT10 liver and pancreas N/A N/A
111







1.2.2 The structure of glucose transporters
Although the overall sequence homology between the members of GLUTs 
family is less than 30 % (Fig 1.1) (Scheepers et al., 2004), there is a much
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higher degree of structural similarity. The common features revealed by 
sequence alignment and analysis of all the above-mentioned transporters 
include (Joost and Thorens, 2001): (1) 12 transmembrane hydrophobic 
helices as secondary structure with both the N- and C-termini at the 
cytoplasmic surface, (2) seven conserved glycine residues in the helices (1, 
2, 4, 5, 7, 8 and 10) as Sugar/polyol transporter signatures, (3) several basic 
and acidic residues at the intracellular surface of the proteins, whose 
interaction mediates the conformational alteration of the transporter during 
the translocation of the substrate (Schurmann et al., 1997) and provide the 
proper membrane topology (Sato and Mueckler, 1999), (4) two conserved 
tryptophan residues in helices 6 and 11 which have been shown to be 
essential for both transport activity and ligand (cytochalasin B, forskolin) 
binding (Garcia et al., 1992; Schurmann et al., 1993), and (5) two conserved 
tyrosine residues in helices 4 and 7 which have also been shown to be 
important for the function of GLUT1 and GLUT4 (Mori et al., 1994; Wandel 
et al., 1994).
The three classes of GLUTs also have their specific features. Residues that 
appear specific for the class I transporters are a glutamine in helix 5 (QL 
motif corresponding with Q161 in GLUT1; (Mueckler et al., 1994)) and the 
STSIF-motif in the extracellular loop 7 (Doege et al., 1998). The specific 
characteristic of class II transporters is the lack of the tryptophan following 
the conserved GPXXXP motif in helix 10 (corresponding with tryptophan 
388 in GLUT1, which is shown to be important for cytochalasin B and 
forskolin binding, but not for glucose transport activity) (Garcia et al., 1992; 
Schurmann et al., 1993). Class III GLUTs are characterized by a shorter 
extracellular loop 1 that lacks a glycosylation site, and by the presence of 
such a site in the larger loop 9 (Joost and Thorens, 2001).
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1.3 GLUT4: the insulin-regulated glucose transporter
Glucose transporter 4 (GLUT4) is the major glucose transporter of muscle, 
adipose cells and cardiac cells. It is unique amongst other members of the 
GLUT family because it is mainly present on insulin-sensitive cells and is 
delicately regulated by insulin through posttranslational events. Insulin 
maintains glucose homeostasis largely by enhancing glucose uptake into 
insulin-sensitive fat and muscle tissues. GLUT4 is responsible for 
insulin-stimulated glucose transport into the cells of these targeted tissues.
Observations have indicated that GLUT4 plays a crucial role in whole-body 
glucose homeostasis. Firstly, insulin-stimulated glucose transport is an 
important rate-limiting step for glucose metabolism in both muscle and fat 
tissue, and is severely disrupted in type 2 diabetes (Bryant et al., 2002). 
Secondly, GLUT4 knock-out mice show mild or strong insulin resistance 
(Watson et al., 2004b). In contrast, over expression of the human GLUT4 in 
muscle and fat tissue in the diabetic DB/DB mouse model protect these 
animals from insulin resistance or diabetes (Watson et al., 2004b). 
Accordingly, understanding the molecular and cellular characteristics and 
mechanisms of GLUT4 and its regulation could possibly yield new targets 
for therapeutic interventions for diabetes, one of the most prevalent 
diseases that we will have to confront in the near future.
1.3.1 GLUT4 in insulin-sensitive cells
In 1980, Cushman’s group and Kono’s group independently found insulin 
caused the redistribution of “glucose transport activity” from intracellular 
membrane compartments to the cell surface (Cushman and Wardzala, 1980; 
Suzuki and Kono, 1980). By measuring glucose binding and transport 
activity in membrane fractions isolated from rat adipocytes, they found that 
insulin resulted to a decrease of this activity in the intracellular membrane
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fraction but at the same time caused a simultaneous increase in the plasma 
membrane fraction. This specific “glucose transport activity” was confirmed 
to be one isoform of the GLUTs family in 1989, when five independent 
groups reported the cloning of the cDNA encoding this isoform - GLUT4 
(Birnbaum, 1989; Charron et al., 1989; Fukumoto et al., 1989; James et al., 
1989; Kaestner et al., 1989). This allowed the generation of the GLUT4 
antibodies which provided an important tool for further study of this protein.
Like all the GLUTs proteins, the structure of GLUT4 also contains 12 
transmembrane domains with the N- and C- terminus facing the cytoplasm 
(Fig 1.2). A number of sorting signals are present in the structure. These 
include a FQQI motif at the N-terminus and a dileucine motif with an acidic 
cluster downstream at the C-terminus. The FQQI motif functions in the 
GLUT4 endocytosis from the plasma membrane and the trafficking from 
endosomal compartments into the insulin responsive perinuclear storage 
compartment (Al Hasani et al., 2002; Garippa et al., 1994; Melvin DR et al., 
1999). The dileucine motif acts during the endocytosis of GLUT4 from the 
plasma membrane and exit of GLUT4 from the trans-Golgi network (TGN) 
(Garippa et al., 1996; Palacios et al., 2001; Subtil et al., 2000). The 
C-terminal acidic cluster appears to function in the targeting of GLUT4 from 
endosomes to a subdomain of the TGN enriched in the t-SNARE (SNARE 
stands for soluble /V-ethylmaleimide sensitive factor attachment protein 




Fig 1.2 Schematic diagram of the predicted transmembrane 
topology of GLUT4. See text for details (Watson et al., 2004b).
Muscle and adipose cells are the major tissues displaying insulin-dependent 
glucose uptake. Although GLUT1 expresses at low level in those tissues 
and is insulin-sensitive to some extent (Rudich A et al., 2003), it is not the 
major player in this event. Insulin increases glucose uptake primarily via 
GLUT4 rather than GLUT1. In the basal state, approximately 5 -10 % of the 
GLUT4 is located at the cell surface and > 90 % in intracellular 
compartments. This steady-state distribution is resulted from the fast 
endocytosis and slow exocytosis of the GLUT4 (Patel et al., 2005; Yang and 
Holman, 1993). When cells are stimulated with insulin, GLUT4 proteins 
rapidly translocate from the intracellular compartments to the plasma 
membrane and become exposed to the outside of the cells so as to be able 
to transport glucose into the cells. It can be readily visualized by using a 
fluorescent tag (Fig 1.3), or by photo-labeling and protein pull-down 
techniques. GLUT4 vesicle movement can also be recorded under 
microscopy once GLUT4 is labeled (Lizunov et al., 2005; Oatey et al., 1997).
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Fig 1.3 Insulin stimulation results in the translocation of GLUT4 
from intracellular storage sites to the plasma membrane.
Differentiated 3T3-L1 adipocytes were transfected with a 
GLUT4-enhanced green fluorescent protein fusion construct and then 
incubated in the absence (A) or presence (B) of insulin for 30 min. The 
cells were fixed and subjected to confocal fluorescent microscopy 
(Watson et al., 2004b).
1.3.2 Intracellular GLUT4 compartments
In basal state GLUT4s sequester in the intracellular compartments. The 
understanding of these compartments helps in figuring out the whole picture 
of GLUT4 translocation. There are three classifications for intracellular 
GLUT4 compartments. One is by Klip’s group (Dugani and Klip, 2005), 
namely “ERC pool” and “non-ERC pool” respectively where ERC stands for 
endosomal recycling compartment. This denomination comes from the 
study using chemical ablation of transferrin receptor (TfR) - containing 
compartments. TfR, an ERC marker, identifies two populations of GLUT4 
pools: one overlapping with TfR (ERC pool), and one separating away from 
it (non-ERC pool) (Martin et al., 1996). The non-ERC pool is thought to be 
the compartment that insulin stimulates to translocate, therefore recognized 
as the “GLUT4 storage vesicle (GSV)” compartment. The second 
classification is by James’ group (Larance et al., 2005). They claim in the
basal state GLUT4 is localized in three kinds of compartments: the 
endosomal system, the trans-Golgi network (TGN) and the highly 
insulin-responsive GLUT4 storage vesicle (GSV). The third classification is 
by Kandror’s group (Xu et al., 2006). They indicate that there are at least two 
GLUT4 vesicular populations: ubiquitous cellugyrin-positive transport 
vesicles and specialized cellugyrin-negative insulin-responsive GLUT4 
storage vesicles (GSV). Cellugyrin is a four transmembrane domain 
containing protein, representing a ubiquitous analogue of the major synaptic 
vesicle protein - synaptogyrin. Cellugyrin-positive vesicles are not enriched 
in GLUT4 and do not translocate to plasma membrane. It is suggested that 
they may represent intracellular transport vesicles en route to GSVs.
The characteristics of GSV have been studied extensively. James’ group 
concludes that the major membrane proteins in GSVs are GLUT4, IRAP and 
VAMP2 (Larance et al., 2005). IRAP is an insulin-responsive 
aminopeptidase. It co-segregates with GLUT4 and undergoes the same 
insulin-stimulated redistribution. It is thought to move with GLUT4 across the 
different compartments in parallel (Dugani and Klip, 2005). VAMP2 is the 
vesicle-associated protein 2, a vesicular soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor (v-SNARE). It is recognized to be the 
protein that is more likely to mark the GSV. It is required for the GLUT4 
fusion with the plasma membrane in insulin stimulated state (Koumanov et 
al., 2005). However, stimuli apart from insulin such as hypertonic shock and 
platelet-derived growth factor do not require VAMP2 to increase GLUT4 
levels on plasma membrane, but depends on another v-SNARE VAMP7 
(Bryant et al., 2002; Watson et al., 2004b). This raises the question of 
whether GSV includes a sub-class of VAMP2 positive vesicles or whether 
VAMP2 joins the GSVs when cells are stimulated by insulin. The remaining 
proteins are probably endosomal or TGN-derived. They include the Rab 
proteins which are associated with insulin signalling cascade, assistant
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proteins for SNARE-mediated membrane fusion and so on. By using protein 
mass spectrometry, a full screen of the proteins on GSV has been analysed 
(Larance et al., 2005).
Recently it has been found that GSVs are formed in a series of sorting 
events of GLUT4. The GLUT4 sorting from the TGN to the GSVs requires a 
Golgi-localized y-ear-containing Arf-binding protein (GGA) (Watson et al., 
2004a). GGA interacts with sortilin, a TGN and endosomal membrane 
protein which is thought to be necessary for the formation of small GLUT4 
enriched vesicles (Shi and Kandror, 2005). Whether these vesicles bear 
other characteristics of the GSVs is still under investigation.
1.3.3 Regulation of GLUT4 trafficking
Kinetic studies identify that it is the exocytosis process that is stimulated by 
insulin (Satoh et al., 1993; Yang and Holman, 1993). Recently McGraw’s 
group indicates that GLUT4 distribution between the plasma membrane and 
the intracellular compartments is maintained by an insulin-modulated 
bipartite dynamic mechanism (Martin et al., 2006). In other words, in basal 
state the GLUT4s undergo slow efflux and rapid internalization dynamically 
and attain equilibrium; insulin stimulates this exchange rate to break the 
equilibrium and realize the GLUT4 translocation.
Apart from the insulin signalling cascade, in skeletal and cardiac myocytes, 
muscle contraction also induces an increase in glucose transport. The acute 
effect of muscle contractions on glucose transport is independent of insulin 
and reverses rapidly after cessation of exercise.




A complicated signalling cascade is involved in insulin-stimulated glucose 
transport, the full extent of which has not been identified. The translocation 
of GLUT4 to the plasma membrane following stimulation with insulin may 
require regulation at various steps. There has been at least two pathways 
identified or postulated: the phosphatidylinositol (Ptdlns) 3-kinase (PI 
3-kinase) pathway (Kanzaki and Pessin, 2003) (Fig 1.4) and the Rho-family 
GTPase TC10 pathway (Baumann et al., 2000). The former is well 
established and the latter remains controversial.
The PI 3-kinase pathway involves a series of activation cascades. The 
interaction of insulin with the insulin receptor (IR) on the outer surface of the 
plasma membrane activates the protein tyrosine-kinase activity that is 
associated with the (3-subunit of the receptor. The receptor then 
phosphorylates itself and IR substrate-1 (IRS1). Phosphorylated IRS1 binds 
to phosphatidylinositol (Ptdlns) 3-kinase (PI 3-kinase), which is recruited to 
the plasma membrane and converts the inositol phospholipid 
Ptdlns-4,5-bisphosphate (Ptdlns(4,5)P2) to Ptdlns-3,4,5-trisphosphate 
(PIP3). The increased amount of PIP3 results in its interaction with 
Akt/protein kinase B (PKB) at the pleckstrin homology (PH) domain, thereby 
recruiting Akt/PKB to the plasma membrane. At the plasma membrane, 
phosphorylation of Akt/PKB at Thr308 by PIP3-bound 
3-phosphoinositide-dependent protein kinase-1 (PDK1) results in Akt/PKB 
activation. PIP3 also triggers the activation of the mammalian target of 
rapamycin complex-2 (mTORC2) by an unknown mechanism, allowing 
mTORC2 to phosphorylate Akt/PKB at Ser473 for maximal activation. These 
phosphorylated upstream molecules are directly or indirectly inducing 
GLUT4 translocation from the GSV compartment to the plasma membrane. 
The cascade until Akt/PKB activation is well established.
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Akt/PKB then phosphorylates downstream proteins. The cascade 
downstream of Akt/PKB activation is still under investigation. Of many of 
Akt/PKB substrates, three have been identified as being involved in 
insulin-stimulated glucose transport (Watson and Pessin, 2006): AS160 (Akt 
substrate of 160 kDa) (Kane et al., 2002), PIKfyve (phosphoinositide kinase 
for five position containing a fyve finger) and synip.
AS160 consists of two phosphotyrosine binding (PTB) domains, a Rab-GAP 
domain (GAP stands for GTPase-activating protein) and five PKB 
phosphorylation sites (Sano et al., 2003). Rab proteins are small G-proteins 
involved in vesicle trafficking (section 1.4.1). In their GTP-bound form, the 
Rab protein is involved in vesicle movement and fusion. The Rab-GAP 
stimulates the intrinsic GTPase activity of the Rab to generate the inactive 
GDP-bound form of the Rab. AS160 is specific for Rabs 2A, 8A, 10 and 14 
which are present on the GLUT4 vesicles (Kessler et al., 2000; Larance et 
al., 2005; Miinea et al., 2005). It is shown to be associated with GLUT4 
vesicles in the basal state but not with insulin-stimulated GLUT4 vesicles 
(Larance et al., 2005). A mechanism involving AS160 and GLUT4 
translocation to the plasma membrane has been addressed. It suggests that 
the insulin-stimulated translocation of GLUT4 requires a Rab to be in its 
active GTP form. In basal cells, the Rab involved in translocation is 
maintained in its inactive GDP form by the GAP domain of AS160. When 
AS160 is phosphorylated by insulin-activated Akt, the GAP activity of AS160 
is inhibited. This increases the level of the active GTP form of a Rab and 
thus GLUT4 vesicle translocation is triggered (Sano et al., 2003). This 
theory has further been confirmed by the use of short-hairpin RNA (shRNA) 
to knockdown the AS160 protein (Eguez et al., 2005). Results confirmed 
that the AS160 GAP activity was required for the basal retention of GLUT4.
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PIKfyve is the second protein identified as being downstream of Akt/PKB 
and involved in insulin-stimulated GLUT4 translocation. It co-localizes with a 
highly motile subpopulation of GLUT4 vesicles. Akt/PKB phosphorylates 
PIKfyve at serine 318 and this phosphorylation stimulates the PI(3)P 
5-kinase activity of the enzyme. It then catalyses the synthesis of PI(5)P and 
PI(3,5)P2. PIKfyve was first reported to have a role in insulin-stimulated 
glucose transport by the use of dominant-negative kinase-dead PIKfyve 
(Ikonomov et al., 2002). Expression of a PIKfyve construct mutated at the 
Akt/PKB phosphorylation site enhances insulin-stimulated GLUT4 
translocation (Berwick et al., 2004). This gives evidence for the role of 
PIKfyve in GLUT4 trafficking. However, further experiments are needed to 
determine if PIKfyve is an important signalling molecule in this process.
Another recently identified Akt substrate involved in GLUT4 translocation is 
the SNARE (soluble A/-ethylmaleimide sensitive factor-attachment 
receptor)-associated protein synip (Yamada et al., 2005). Synip was 
originally identified to interact with syntaxin4 (Min et al., 1999). Syntaxin4 is 
a t-SNARE localized to the cell surface, whereas another SNARE molecule, 
VAMP2, is localized to GLUT4 vesicles (sections 1.4.2, 1.4.3). Interactions 
between syntaxin4 and VAMP2, together with other fusogenic molecules, 
are thought to drive the fusion of GLUT4 vesicle with the plasma membrane. 
As a working model, synip binds to syntaxin4 in the basal state and blocks 
the ability of VAMP2 to interact productively with syntaxin4 (Min et al., 1999). 
Although several other syntaxin-binding proteins including tomosyn and 
Munc18c have also been reported to prevent the translocation of GLUT4 by 
interfering with the SNARE-dependent fusion mechanism (Tamori et al., 
1998; Tellam et al., 1997; Thurmond and Pessin, 2000; Widberg et al., 
2003), synip is the only one that is observed to be under regulation by 
insulin. Insulin induces the dissociation of synip from syntaxin4, thus 
enabling productive SNARE pairing between syntaxin4 and VAMP2 (Min et
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al., 1999). Insulin stimulation results in the Akt phosphorylation of synip at 
Ser99, leading to the dissociation of the synip-syntaxin4 complex (Yamada 
et al., 2005). Mutation of Ser99 prevents the dissociation of synip from 
syntaxin4 and inhibits GLUT4 translocation in a dominant interfering manner. 
Thus, the insulin-stimulated phosphorylation of synip by Akt might provide a 
mechanism for insulin to regulate the docking or fusion of GLUT4 vesicles 
with the cel! surface. However, this hypothesis is still controversial, because 
other results suggest that phosphorylation of synip at Ser99 is not necessary 














Fig 1.4 Schematic diagram  showing the relation between 
insulin-signaling and GLUT4 vesicles translocation through 
PI3-kinase pathway. See text for details (Watson RT and 
Pessin JE., 2006).
The TC10 pathway is known as a PI 3K-independent signalling pathway. It 
was only identified in adipose cells but not muscle cells (Baumann et al., 
2000). This pathway originates in caveolae or in lipid rafts, involves tyrosine 
phosphorylation of the proto-oncogene c-Cbl and results in the activation of 
a small GTP-binding protein, TC10, a member of the Rho family GTPases. 
To date this pathway remains controversial as some groups found that this
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pathway has no effect on insulin signalling to GLUT4 (Zhou et al., 2004).
B) Contraction and exercise
Independent of insulin, the contraction-stimulated GLUT4 translocation in 
muscle cells is believed to be the result of the activation of a different 
pathway. It involves the AMP-activated protein kinase (AMPK), which is 
activated by a contraction-induced rise in AMP (Adenosine 
5’-monophosphate) and a concomitant drop in ATP. The downstream 
targets of AMPK that are involved in GLUT4 translocation await their 
identifications. Some chemical inhibitors suggest one or more protein kinase 
C (PKC) isoforms are involved (Luiken et al., 2004). It also has been found 
that contraction increases the insulin sensitivity in those cells. However, the 
basic mechanism underlying this phenomenon still remains a mystery 
(Holloszy, 2005).
1.4 Membrane fusion
The fusion of GLUT4 vesicles with the plasma membrane is an important 
step in exposing GLUT4 to the exterior of the cell, thus enabling it to 
transport its hexose substrate into and out of the cell. There is evidence that 
insulin, as well as stimulating translocation of GLUT4 vesicles to the plasma 
membrane, also directly promotes the docking and fusion of vesicles to the 
plasma membrane (Inoue et al., 1999; Timmers et al., 1996). This 
up-regulation by insulin occurs both on the plasma membrane and on 
GLUT4 vesicles. Insulin treatment affects intracellular pH (Yang et al., 
2002b; Yang et al., 2002a), interaction of SNAREs with proteins such as 
synip (Min et al., 1999; Tellam et al., 1997; Watson and Pessin, 2006), and 
calcium ion concentration (Whitehead et al., 2001), all of which affect 
membrane fusion.
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In general, membrane fusion is a universal reaction with great diversities. It 
occurs in all life forms, from the extra- and intra-cellular fusion of viral 
pathogens with host cells, the extra-cellular fusion of eukaryotic cells, to the 
intra-cellular fusion of organelles. Despite the diversity, all fusion reactions 
embody a fundamental process which includes membrane contact, 
membrane merger and the opening of an aqueous fusion pore (Jahn et al., 
2003) (Fig 1.5).
Two models are widely involved to describe the fusion: the “proximity” model 
and the “protein-pore” model. The “proximity” model shows a fusion pore 
lined by lipids. According to the stalk hypothesis (Chernomordik et al., 1987; 
Kozlov and Markin, 1983), counteracting electrostatic forces are overcome, 
lipids of the proximal leaflets interact, thus membranes are brought to close 
proximity, which is termed as “tethering” or “docking”. Then the boundary 
between the hydrophilic and hydrophobic portion of the bilayer is 
destabilized, the proximal monolayers merge to form a stalk, then the fusion 
pore open. The “protein-pore” model shows a fusion pore formed from 
transmembrane segments of proteins. When the fusion pore dilates, the 
transmembrane segments separate laterally, lipids are incorporated into the 
pore, and the bilayers merge. Normally the opening of the fusion pore is 
followed by an irreversible gradual expansion of the fusion pore, and it 
causes full fusion (Lindau and Aimers, 1995). In some cases, the initial 
fusion pore is followed by its rapid closure in a kiss-and-run event (Fisher et 
al., 2001; Lindau and de Toledo, 2003).
Although fusion can be demonstrated in pure lipid vesicles free of protein 
(Chanturiya et al., 1997), in most of the cases fusion is strongly influenced 
by certain proteins, which include Rab proteins, SNARE proteins, and a 
variety of assisting proteins.
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hemifusion fusion pore
Fig 1.5 Hypothetical formation of a fusion pore (Jahn et al., 2003).
1.4.1 Rab proteins
When an intracellular transport vesicle (“donor”) is destined to fuse with an 
“acceptor” membrane, it first needs to recognize its partner membrane by 
physical contact in a specific location, which is termed as “tethering” or 
“docking”. This provides specificity to the fusion reactions. Tethering or 
docking is thought to be mediated by the Rab family of small GTPase 
proteins. They shuttle between a soluble GDP bound form that is inactive 
and a membrane bound GTP bound form that is active. In most fusion 
reactions, active Rabs on the donor membrane recruit effectors (often by 
assembly of multimeric complexes) that are present in the acceptor 
membrane, thereby tethering the two membranes together (Jahn et al., 
2003). During or after fusion, Rab proteins are inactivated by 
GTPase-activating proteins (GAPs), and dissociated from the respective 
membrane to initiate a new cycle of fusion. As mentioned earlier, several 
isoforms of Rab proteins have been identified on GLUT4 vesicles and a 
mechanism has been raised to bridge insulin signalling and GLUT4 
translocation through AS160 and Rab (section 1.3.3.A).
1.4.2 SNARE hypothesis
SNARE proteins (soluble /V-ethylmaleimide-sensitive factor attachment 
protein receptor) are thought to act following the tethering of transport 
vesicles and target membrane. Since the late 1980s, when SNARE proteins 
were first characterized, rapid progress has identified SNAREs as key 
elements in membrane fusion.
SNAREs were originally identified in synaptic vesicles, and are a super 
family of small proteins with 25 members in yeast, 36 members in human 
and 54 members in plant (Jahn and Scheller, 2006). They have a simple 
domain structure. A characteristic of SNAREs is the SNARE motif: an 
evolutionarily conserved stretch of 60 - 70 amino acids that are arranged in 
heptad repeats. At their C-terminal ends, most SNAREs have a single 
transmembrane domain that is connected to the SNARE motif by a short 
linker. Many SNAREs have independently folded domains that are 
positioned N-terminal to the SNARE motif and that vary between the 
subgroups of SNAREs (Fasshauer, 2003; Hong, 2005).
SNARE proteins can be functionally classified as vesicular (v-SNARE) and 
target (t-SNARE) SNAREs according to the membrane on which they are 
present. The best characterized SNARE proteins are those involved in 
synaptic transmission. They are the t-SNAREs syntaxinl and SNAP25, 
which reside on the plasma membrane, and the v-SNARE VAMP2 
(vesicle-associated membrane protein, also known as synaptobrevin), which 
is present on synaptic vesicles. Following the tethering, SNAREs engage in 
trans-complexes that bridge the fusion membrane. When the membranes 
fuse, the SNAREs align with each other to form cis-complexes (Fig 1.6). 
After fusion SNARE complexes are dissociated so that the individual 
SNARE proteins can be recycled with their resident membranes.
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Fig 1.6 Hypothetical transition states in SNARE-mediated fusion 
according to the stalk hypothesis. The SNAREs form trans-complex to 
tether the vesicle in close proximity. Then by either bent (possibly strained), 
or the C-terminal ends pulled into the hydrophobic core of the bilayer, the 
SNAREs form cis complexes before fusion is complete. In this case, the 
assembly of at least some SNARE complexes might therefore be complete 
before fusion-pore opening (Jahn and Scheller, 2006).
1.4.3 SNARE in GLUT4 exocytosis
Membrane fusion displays selectivity among different pairs of v- and 
t-SNARE proteins (McNew et al., 2000; Whyte and Munro, 2002). Earlier it 
has been mentioned that GLUT4 traffics through a series of intracellular 
compartments (section 1.3.2). The v-SNARE VAMP2 is a selective marker 
for GLUT4 Storage Vesicles (GSV), a subset of GLUT4 vesicles that largely 
segregate from TfR and which are the most competent for insulin-stimulated 
GLUT4 vesicle fusion with plasma membrane (Bryant et al., 2002; Watson 
et al., 2004b). The t-SNAREs in the target plasma membrane are syntaxin4 
and SNAP23. The insulin signalling can target components of the 
vesicle-PM fusion machinery through the mechanism described earlier on 
(section 1.3.3). Other proteins like tomosyn and munc18c can bind 
syntaxin4 to modulate the insulin-dependent gain in surface GLUT4 
(Hodgkinson et al., 2005; Widberg et al., 2003). Although Rab-mediated 
tethering typically occurs via an intermediate tethering complex rather than 
directly to SNARE proteins, Rab4 is found to interact with the SNARE 
protein syntaxin4 in an insulin dependent manner (Li et al., 2001). This
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finding suggests that Rab4 may directly link long and short range transport 
of GLUT4 vesicles in the exocytic pathway under insulin regulation.
1.4.4 Methods to study membrane fusion
There are various methods to study membrane fusion. In living cells, 
organelles are stained with fluorescent or luminescent markers and the 
process is monitored under microscopy (Lizunov et al., 2005). The living-cell 
fusion assays exactly represent the event happening in cells in real time. 
The drawbacks are that the assays are normally hard to manipulate. There 
are enormous interference factors in living cells, which would affect the 
event that is studied. Hence, many groups have set up cell-free fusion 
assays to study versatile fusion events in organisms. In the yeast system, 
yeast vacuoles are isolated by density gradient centrifugation and are 
applied directly in fusion reactions (Mayer et al., 1996; Rothman and Orci,
1992). In various cells, endosomes are harvested, labeled and mixed 
together in vitro to check the endocytic fusion events (Luzio et al., 2005; 
Rizzoli et al., 2006). In 1990s, fusion of lysosomes and late endosomes has 
been shown in a cell-free system and proved to be ATP, cytosol and 
temperature dependent (Mullock et al., 1994; Mullock et al., 1998). This 
fusion requires the presence of NSF (A/-ethylmaleimide sensitive factor) and 
SNAPs (soluble NSF attachment proteins) and is inhibited by Rab-GDI 
(GDP dissociation inhibitor), which implies a need for a Rab GTPase. These 
characteristics are consistent with the action of the fusion machinery used at 
many other sites on the secretory and endocytic pathways and are in 
accordance to the tenets of the SNARE hypothesis (Rothman, 1994). An In 
vitro assay has also been set up to reconstitute mitochondria inner and outer 
membrane fusion (Meeusen et al., 2004). Not only vesicles directly purified 
from cells, but also artificial liposomes are used in numerous studies to 
investigate the functions of proteins of interest. Using the reconstituted
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liposomes fusion assay, SNARE proteins have been confirmed as the 
minimal machinery to drive membrane fusion (Weber et al., 1998).
In the reconstituted liposome fusion assay, fluorometric methods exploit 
processes, such as non radioactive energy transfer, fluorescence quenching 
and pyrene excimer formation, which are dependent on probe concentration 
(Blumenthal et al., 2002; Duzgunes and Wilschut, 1993; Hoekstra D., 1990; 
Hoekstra, 1990; Stegmann et al., 1989). Assays of membrane fusion report 
either the mixing of membrane lipids (lipid mixing) or the mixing of the 
aqueous contents of the fused entities (content mixing). There are also 
additional methods for detecting membrane fusion based on image analysis 
(Yates and Rampersaud, 1998) or carbon-fiber amperometry (Graham et al., 
2002).
A) Lipid Mixing
Struck, Hoekstra and Pagano introduced lipid-mixing assays based on 
NBD-rhodamine energy transfer (Struck et al., 1981). In this method, 
membranes labeled with a combination of fluorescence energy transfer 
donor and acceptor lipid probes - typically NBD-PE and A/-Rhodamin-PE, 
respectively - are mixed with unlabeled membranes. Fluorescence 
resonance energy transfer (FRET) is detected as rhodamine emission at 
-585 nm resulting from NBD excitation at -470 nm. The fluorescence 
decreases when the average spatial separation of the probes is increased 
upon fusion of labeled membranes with unlabeled membranes (Fig 1.7). 
This assay has been successfully used in the study of membrane fusion 
(Wilschut et al., 1992). The reverse detection scheme has also proven to be 
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Fig 1.7 Pictorial representation of a lipid-mixing assay based on 
fluorescence resonance energy transfer (FRET). The average spatial 
separation of the donor (D) and acceptor (A) lipid probes increases upon 
fusion of labeled membranes with unlabeled membranes. This results in 
decreased efficiency of proximity-dependent FRET (represented by yellow 
arrows). Decreased FRET efficiency is registered by increased donor 
fluorescence intensity and decreased acceptor fluorescence intensity.
Lipid mixing assays can also be based on self-quenching of octadecyl 
rhodamine B fluorescence (Hoekstra et al., 1984). Fusion increases the 
space between octadecyl rhodamine B so as to decrease self-quenching 
and increase fluorescence. This assay is extensively used for detecting 
virus fusion with cells (Cheetham et al., 1994; Srinivasakumar et al., 1991). 
Another lipid mixing assay, based on pyrene excimer formation (Bron et al.,
1993), has also been applied to study membrane fusion (Bron et al., 1994).
A drawback of the lipid mixing assay is that incomplete fusion can produce a 
positive signal. In the hemi-fusion step (Fig 1.6, Fig 1.5), the fluorescent 
probe can move through the phospholipid bilayer bridge. In this case a 
positive signal can be detected although fusion is not complete.
B) Content Mixing
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Leakage of aqueous contents from cells or vesicles as a result of lysis, 
fusion or a change in physiological permeability can be detected 
fluorometrically using low molecular weight soluble tracers. Assays 
designed to detect solution mixing often rely on a fluorophore and quencher 
pair, and this provide a technique to monitor content mixing.
Wilschut and Papahadjopoulos originally described a content mixing assay 
of fluorescent enhancement with Tb3+/dipicolinic acid (DPA) (Wilschut et al., 
1980). In this assay, separate vesicle populations are loaded with TbCh or 
DPA. Vesicle fusion results in formation of Tb3+/DPA chelates that are 
-10,000 times more fluorescent than free Tb3+ (Wilschut et al., 1980). 
Fluorescence of the chelates is detected at 490 nm or 545 nm, following 
excitation at 276 nm. Including Ca2+ and EDTA in the external medium 
inhibits formation of the complex outside the fused vesicles. The Tb3+/DPA 
fluorescence enhancement assay has been used to investigate the role of 
phospholipid conformation in vesicle fusion (Glaser and Gross, 1994) and 
the interaction of cardiotoxin with phospholipid vesicles (Chien et al., 1994).
There are also other assays for content mixing. Fluorescence quenching 
assays with ANTS/DPX were originally developed by Smolarsky and 
co-workers to follow complement-mediated immune lysis (Smolarsky et al., 
1977). This assay is based on the collisional quenching of the polyanionic 
fluorophore ANTS by the cationic quencher DPX. The ANTS/DPX 
fluorescence quenching assay has since been widely used to detect 
membrane fusion (Bailey and Cullis, 1994; Epand et al., 1995).
1.4.5 Role of Ca2+ in membrane fusion and insulin-stimulated GLUT4 
exocytosis
The hypothesis that SNAREs form the basic molecular apparatus that forces 
lipid bilayers to fuse is widely supported (Jahn, 2004; Sorensen, 2004).
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However, this does not imply that SNAREs alone are required to induce 
vesicle exocytosis in organisms. SNAREs alone are sufficient to induce 
fusion of liposomes, but the kinetics of these events does not mimic the 
kinetics that has been observed in synaptic vesicle fusion in vivo (Hu et al., 
2003; Weber et al., 1998). Additional accessory proteins must serve to 
regulate the fusion reaction. In the most extensively studied vesicle 
exocytosis and membrane fusion event, the neuronal transmitter release, 
Ca2+ triggers exocytosis from neurons and neuroendocrine cells. The delay 
between a rapid rise in Ca2+ and a postsynaptic response can be as short as 
60 to 200 psec, placing strong kinetics constraints on the transduction 
pathway that culminates in secretion (Llinas et al., 1981; Sabatini and 
Regehr, 1996). Therefore one particularly important accessory protein is 
needed to sense Ca2+.
A protein has been found to work in this process. Strong evidences support 
that synaptotagmin functions as the Ca2+ sensor which regulates 
SNARE-mediated exocytosis in neurotransmitter release (Augustine, 2001; 
Chapman, 2002; Tucker et al., 2004). Upon binding Ca2+, the loop domains 
of the synaptotagmin partially penetrate into lipid bilayers that contain 
anionic phospholipids (Bai et al., 2004a; Chapman and Davis, 1998; Davis 
et al., 1999), which has been proved essential for the action of 
Ca2+-synaptotagmin during fusion (Bhalla et al., 2005). Some isoforms of 
synaptotagmin oligomerize in the presence of Ca2+, providing another route 
through which Ca2+ could regulate exocytosis (Tucker and Chapman, 2002). 
In addition, synaptotagmin binds to the t-SNAREs syntaxin and SNAP25 
(Davis et al., 1999; Tucker et al., 2004). Mutations that selectively disrupt 
this binding reduce the rate of secretion and destabilize fusion pores in 
PC12 cells (Bai et al., 2004b). Together these findings suggest that 
synaptotagmin acts on a state of vesicles in which SNARE complexes have 
fully assembled. The SNARE complex assembly creates a metastable
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fusion intermediate. The Ca2+-triggered synaptotagmin insertion and its 
interaction with the t-SNAREs destabilize the intermediate and regulate the 
opening and closing of fusion pores.
The role of Ca2+ in membrane fusion has also been studied from another 
perspective. In yeast vacuole fusion, Ca2+ efflux from vacuole has been 
found critical (Peters and Mayer, 1998). Ca2+ concentration inside of yeast 
vacuole is > 2 mM, accumulated by active transport through an ATP-driven 
Ca2+ pump and a Ca2+/H+ exchanger. In the studies, the Ca2+ ionophore 
ionomycin and Ca2+-ATPase inhibitors strongly inhibited fusion. Strong Ca2+ 
chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) 
was also found inhibiting if present in the whole fusion process, but not if 
removed before the fusion initiated. All these facts suggest that the process 
relevant to fusion is the Ca2+ efflux from the vacuole lumen. The inhibitors 
were added to ongoing fusion at different time points, from the beginning of 
fusion to the time point of full resistance, ie, when fusion was not inhibited 
any more. The inhibitory time course of ionomycin and BAPTA was much 
longer than the one of GDP dissociation inhibitor 1 (GDI1). GDI1 is a 
docking marker (Mayer and Wickner, 1997). The longer inhibitory effect 
means that when docking is completed, fusion is still inhibited by ionomycin 
and BAPTA. This finding indicates that Ca2+ is required in the post-docking 
phase. The conclusion is remarkably similar with the finding in synaptic 
vesicle fusion. In synaptic vesicle fusion calmodulin was required as the 
receptor for the Ca2+ signal. But unlike synaptotagmin, which interferes with 
fusion at low Ca2+ concentrations, calmodulin exerts an active, promoting 
effect on the post-docking events (Peters and Mayer, 1998).
Ca2+ has already found to be involved in insulin action and glucose transport 
(Youn et al., 1994). Although insulin treatment does not elevate the 
intracellular concentration of free Ca2+ (Kelly et al., 1989; Klip and Ramlal,
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1987), the treatment of 3T3-L1 adipocytes with the Ca2+ chelator 
BAPTA-AM markedly inhibits insulin-stimulated GLUT4 translocation 
(Whitehead et al., 2001; Worrall and Olefsky, 2002). In addition it has been 
reported that elevated concentrations of cytosolic Ca2+ that are induced by 
exercise lead to an increase in glucose transport (Holloszy, 2003; Pereira 
and Lancha, 2004). So far there has not been a clear suggested mechanism 
for how Ca2+ affects glucose transport. It has been suggested that Ca2+ 
plays a minimal or permissive role on this event (Whitehead et al., 2001).
1.4.6 Role of pH in membrane fusion and insulin-stimulated GLUT4 
exocytosis
Apart from the commonly accepted model for the general membrane fusion 
machinery in which membranes are forced into close proximity by the action 
of SNAREs, various studies have shown that membrane protein exocytosis 
and membrane fusion are related to certain pH conditions. Analysis of 
transferrin receptor (TfR) recycling (Johnson et al., 1993; Presley et al., 
1997) has revealed that reduced endosome acidification results in a 
reduced rate of exit of TfRs from the recycling compartment to the plasma 
membrane. The vesicle coating and budding of secretory vesicles which 
requires the redistribution of ADP ribosylation factor (ARF) to the 
cytoplasmic face of the trans-Golgi network, is a pH-dependent process 
(Zeuzem et al., 1992). In adrenal chromaffin cells, the intragranular pH 
rapidly modulates exocytosis and it has been suggested that the gradient of 
pH is the main driving force that maintains secretory vesicles accumulation 
and membrane fusion (Camacho et al., 2006). In addition, pH-dependent 
fusion steps are known to be involved in virus-induced fusion involving 
hemagluttinin (Stegmann, 2000).
In GLUT4 translocation, cytosol pH has been found to be important in
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glucose transport activity in rat adipocytes (Yang et al., 2002b). 
Insulin-stimulated cytosol alkalinization has also been revealed to facilitate 
the optimal activation of glucose transport in cardiomyocytes (Yang et al., 
2002a). The intra-cellular or intra-vesicular pH is normally created by H+ 
pumps including the Na+/H+ exchanger and the vacuolar H+-ATPase. 
Inhibition of these proteins has blocked the glucose transport and GLUT4 
exocytosis.
There are two hypotheses raised to explain the pH effects on membrane 
fusion and protein exocytosis: 1) the electrochemical gradient of pH is 
utilized as a driving force, 2) the V-ATPase acts as a fusion pore.
For various organelles in vivo (lysosomes, endosomes, trans-Golgi 
cisternae, secretory granules, etc), acidification of the organelles is required 
for many cellular processes including receptor-ligand dissociation, 
degradation pathways. The generation of intercompartment proton motive 
forces by gradient of H+ is utilized as driving forces for numerous secondary 
transport processes including exocytosis and membrane fusion (Nelson, 
2003; Nishi and Forgac, 2002). V-ATPases translocate protons across the 
membrane of these organelles to realize acidification and electrochemical 
gradient of pH (Nelson and Harvey, 1999; Nishi and Forgac, 2002).
V-ATPases are large multimeric enzymes made up of several different 
subunits. These subunits are organized in two complexes: a cytoplasmic 
complex V1 that hydrolyzes ATP and a membrane complex V0 involved in 
proton translocation. V1 is composed of eight different subunits (A-H). V0 
contains four to five proteolipid subunits c and single copies of subunits a, d, 
and c” (Nelson and Harvey, 1999; Nishi and Forgac, 2002). The a subunit of 
V0 is a 110-kDa integral membrane protein, with nine transmembrane 
domains located in its C-terminal half and a large N-terminal sector in the 
cytoplasm (Leng et al., 1999). Several isoforms of the a subunit have been
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identified. In yeast there are two isoforms associated to vacuolar and 
Golgi/endosomal membranes, respectively (Kawasaki-Nishi et al., 2001) 
and in mice, four (a1-a4) (Nishi and Forgac, 2000; Oka et al., 2001; 
Toyomura et al., 2000). Except a4, which is specifically expressed in kidney, 
all the others are expressed to various extents in all tissues. In neurons, the 
V1 and V0 complexes are transported independently in the axon and 
assemble once arrived in nerve terminals (Morel et al., 1998). V-ATPase is 
present both in the presynaptic plasma membrane and in the membrane of 
synaptic vesicles. The large electrochemical H+ gradient generated by this 
enzyme, pH 5.2 - 5.5 inside the synaptic vesicles (Fuldner and Stadler, 
1982; Michaelson and Angel, 1980), is used by specific vesicular 
transporters to accumulate the neurotransmitter.
Although “pore models” for membrane fusion have been suggested 
repeatedly in the past, it has been difficult to gather compelling data to verify 
the presence of a proteolipid pore during membrane fusion (Jahn, 2004; 
Jena, 2004; Lindau and Aimers, 1995; Mayer, 2002; Morel, 2003; Weimer 
and Jorgensen, 2003). The existence of a proteinaceous pore capable of 
releasing neurotransmitter has first been proposed for vesicles isolated from 
electroplaques of the electric organ of Torpedo marmorata. Israel et al. 
reported the isolation of a proteolipid pore complex from synaptosomes from 
electroplaques of Torpedo, named the “mediatophore” (Israel et al., 1986). 
This pore complex was later shown to contain a subunit of the V0 complex 
of V-ATPase and transfection of this component in some cells allowed 
quantal release of neurotransmitter (Falk-Vairant et al., 1996). But these 
studies failed to demonstrate the role of V0 proteins at the synapse in vivo 
because it was difficult to mimic a complex event such as synaptic vesicle 
exocytosis by transfecting a single protein in cells (Falk-Vairant et al., 1996). 
The Torpedo V0 subunit a1 was only shown to localize specifically to nerve 
terminals and interact with SNAREs (Morel et al., 2003). A direct
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requirement of VO proteolipids for membrane fusion was demonstrated for a 
yeast vacuolar fusion assay (Peters et al., 2001). The proteolipid 
pore-forming VO complex from V-ATPase was shown to be required 
downstream of SNARE action (Bayer et al., 2003; Peters et al., 2001).
Although so far the yeast vacuolar fusion assay is the only system in which 
evidence for an additional component downstream of SNARE function has 
been identified (Bayer et al., 2003; Peters et al., 2001), the new studies in 
Drosophila nerve terminals largely showed coincident observations. The V0 
subunit a1 was shown to be required for evoked synaptic vesicle exocytotic 
fusion, independently of proton translocation (Hiesinger et al., 2005). The 
earlier mentioned fact that subunit a1 was shown to localize to synaptic 
terminals and interact with the v-SNARE n-Syb (Morel et al., 2003) is in 
agreement with the findings in Drosophila synapses. The selective 
interactions of the 100 KDa subunit of V0 complex with the t-SNAREs 
Syntaxin and SNAP-25 are in agreement with the observations made in 
yeast (Hiesinger et al., 2005; Peters et al., 2001).
Larance et al. identified the V-ATPase subunit a is present on GLUT4 
vesicles from 3T3-L1 adipocytes using Mass Spectrometry (Larance et al., 
2005). This finding leads to the questions as to whether there is acidification 
in the lumen of GLUT4 vesicles and whether the gradient of H+ affects the 
vesicle fusion with plasma membrane and GLUT4 exocytosis. The presence 
of subunit a also suggests the possibility that it functions as a fusion pore. 
These findings provide a basis for elucidating whether pH is involved in the 
mechanism of GLUT4 vesicles fusion with plasma membrane.
1.5 Experimental aims
The work described in this thesis is mainly aimed at elucidating the 
mechanism involved in insulin-stimulated GLUT4 vesicle fusion with plasma
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membrane. Two strategies were tried to reconstitute this event in vitro: 1) to 
immuno-isolate GLUT4 vesicles and reconstitute plasma membrane 
liposomes for a fusion assay, 2) to use recombinant SNARE proteins in a 
reconstituted liposome fusion assay.
Investigations were undertaken to determine the factors necessary for 
immuno-isolation of GLUT4 vesicles and for reconstitution of plasma 
membrane liposomes for fusion assay. The kinetics of the fusion were 
determined and compared with those in insulin-stimulated glucose uptake. 
The relation of insulin signalling to this event was explored by use of PI 
3-kinase inhibitors, by immuno-depletion of cytosolic components and by 
determining factors recruited to the plasma membrane liposomes.
Studies were also undertaken to investigate the roles of Ca2+ ions and the 
V-ATPase protein in GLUT4 vesicles fusion with plasma membrane. To 
address this aim, specific chelators, ionophores and inhibitors were applied 
to the membrane and cytosol fractions of the fusion assay. Fusion assays 
were also carried out at different pH levels to address the question of 
whether a pH gradient is required.
Recombinant SNARE proteins were reconstituted and used in liposome 
fusion assays. The aim was to assess the ability of SNARE proteins to drive 
fusion. In these studies, membrane fusion was observed in the presence of 
cytosol and Ca2+. Studies which aimed to determine whether this assay 
measured SNARE-specific fusion were carried out.
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Chapter 2 Materials and methods
2.1 Materials
2.1.1 Laboratory chemicals
Unless otherwise stated, all chemical reagents were purchased from Fisher 
Scientific or Sigma.
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Table 2.1 Laboratory chemicals
Reagent Resource
Enhanced chemiluminescent reagent (ECL) Amersham Pharmacia Biotech
ECL Advance Western Blotting Detection Kit Amersham Pharmacia Biotech
SuperSignal West Dura Extended Duration Substrate Kit Pierce
Monocomponent porcine insulin
gift from Dr. G. 
Daniellson (Novo 
Nordisk)




Intergen Co.Bovine Serum Albumin
Biotinylated-Europium(TMT) in house
Dylight647 conjugated Streptavidin Pierce
n-octyl glucoside Melford Laboratories
Protein molecular markers Sigma or New England Biolabs
1 -Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC 
or PC)
1, 2-Dioleoyl-sn-Glycero-3-[Phospho-L-Serine] (Sodium Salt) 
(DOPS or PS)
Avanti Polar Lipids 
Avanti Polar Lipids
L-a-Phosphatidylethanolamine (PE; from porcine brain) Avanti Polar Lipids
Amylose resin New England Biolabs
Ni-NTA His-Bind Resin Novagen
1,2-b/s(o-Aminophenoxy)ethane-N,N,N\N’-tetraacetic Acid, 
Sodium (BAPTA) Calbiochem
1 ^ -b/sfa-AminophenoxyJethane-N.N.N’.N’-tetraacetic Acid 
Tetra(acetoxymethyl) Ester (BAPTA-AM) Calbiochem
4-Bromo-A23187 Calbiochem
Concanamycin A Calbiochem
Acrylamide stock (30 % acrylamide, 0.8 % bis-acrylamide) Flowgen
Molecular biology grade agarose Invitrogen




The buffer compositions are stated in the context of their use. For a 
compiled full description, the buffers are summarised in appendix 1), 2) and 
3).
2.1.3 Antibodies
The source of antibodies and their appropriate dilutions for western blotting 
(section 2.2.4) and immunoprecipitations (section 2.2.1) are shown in the 
tables below. All antibodies were diluted in Tris-buffered saline (TBS) (10 
mM Tris, pH 7.4, 154 mM NaCI).
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In House production 











Rabbit anti-syntaxin4 Polyclonalserum In House production 1:4000
Rabbit anti-SNAP23 PolyclonalPurified In House production 1 pg/ml
Rabbit anti-VAMP2 PolyclonalPurified In House production 1 pg/ml




Purified Santa Cruz 1:1000
Rabbit












Monoclonal Cell signalling 1:1000 (5 % BSA)
Goat anti-V-ATPase 
subunit a Polyclonal Santa Cruz 1:400
52
Table 2.3 Sources and dilutions of secondary antibodies used for Western Blot analysis
Antibody Source Dilutions
Goat anti-rabbit IgG HRP conjugate Sigma 1:4000
Goat anti-mouse IgG HRP conjugate Sigma 1:1000
Goat anti-sheep IgG HRP conjugate Sigma 1:4000
Rabbit anti-goat IgG 
HRP conjugate Sigma 1:4000
Table 2.4 Sources and concentrations of antibodies used for immuno-precipitations
Antibody Source Concentration Required for Immuno-precipitation
Rabbit anti-GLUT4 FPLC purified against GLUT4 
peptide
100 pg for pHDM of basal
C-terminus adipocytes from 2 rats
Mouse anti-Aktl Cell signalling 15 pi for 150 pi of concentrated cytosol from rat adipocytes
Rabbit anti-Akt2 Upstate 15 pi for 150 pi of concentrated cytosol from rat adipocytes
2.1.4 Preparation of Bovine Serum Albumin for rat adipocytes
10 g of BSA (Fraction V) per 60 ml of double-distilled water was dissolved 
overnight at 4 °C. The BSA was filtered through a Millipore type A 
membrane filter (0.8 pm pore size) under vacuum and the pH of the solution 
was adjusted to 7.6 with 10 M NaOH. Double distilled water was added to 
give a final BSA concentration of 10 % (w/v). The BSA was divided in to 40 
ml aliquots and stored at -20 °C until required.
2.1.5 Preparation of insulin
Monocomponent porcine insulin was a gift from Dr. G. Daniallson, Novo 
Nordisk. 1 mg of insulin was dissolved in 1 ml of 0.03 M HCI and the solution 
made up to 3 ml with double-distilled water. 1 ml of this solution was then 
diluted to 50 ml with 1 % (w/v) BSA in Krebs-Ringer-HEPES (KRH) buffer
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(140 mM NaCI, 4.7 mM KCI, 2.5 mM CaCI2, 1.25 mM MgS04, 0.2 mM 
NaH2P04 , 10 mM HEPES, pH 7.4). The resulting insulin solution (1 pM) was 
divided into 500 pi aliquots and stored at -20 °C until required. The solution 
was not frozen again once it had been thawed.
2.1.6 Protease inhibitors
Unless otherwise stated, the protease inhibitors and the concentrations at 
which they were used are shown in table 2.5 below.









Ser and Cys proteases
1 pg/ml 
1 pg/ml (1.46 pM)
Leupeptin Acid proteases 1 pg/ml (2.1 pM)
AEBSF Ser proteases 100 pM
2.1.7 Molecular biology reagents
1) Oligonucleotide primers
DNA primers were made to order through Sigma-Aldrich. Primer sequences 
are shown below:
Table 2.6 Sequences of oligonucleotides
Primer name Sequence
BamH\ for 
(section 3.3.1) 5’ - GGG GGA TCC CCA AGC TTA AAA GAT GAC CC - 3’
His for 1st 
(section 3.3.3) 5’ - GGC CGC CAC CAC CAC CAC CAC CAC TGA C - 3’
His for 2nd 
(section 3.3.3) 5’ - GGC CGC CAC CAC CAC CAC CAC CAC TGA G - 3’
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2) Vectors and constructs
The plasmid pMBP-Parallel2 was a gift from Dr. Stephan Bagby from 
University of Bath. The plasmid pAX11 was a gift from Dr. J. Zueco. Plasmid 
pT7 blue was from Novagen. Thrombin cleavable His-tagged, 
Nuclease-A-fused full length rat VAMP2 (His-NucA-VAMP2) 
pDRSN1-VAMP2 and glutathione S-transferase (GST)-fused full length 
mouse SNAP23 and rat syntaxin4 co-expression construct 
(GST-SNAP23-syntaxin4) pGEX-tSNAREs were from former PhD student 
Dr. David Ribe in our laboratory at the University of Bath.
3) Restriction enzymes and ligase
Table 2.7 Restriction enzymes and ligase
Enzyme Resource
BamH\ (section 3.3.1, 3.3.3) Boehringer-Mannheim
SpeI (section 3.3.1, 3.3.3) Sigma
No1\ (section 3.3.3) and Xho\ (section 
3.3.3) New England Biolabs (NEB)
Xba\ (section 3.3.3) Promega
T4 DNA ligase (section 3.3.1, 3.3.3) Promega
2.2 Methods
2.2.1 Preparation of rat adipocytes
1) Isolation of rat adipocytes
Isolated adipose cells were prepared from the whole epididymal fat pads of 
male Wistar rats (180 - 200 g) as described (Simpson et al., 1983; Taylor 
and Holman, 1981). The rats were stunned and the necks dislocated. The 
epididymal fat tissue was quickly removed and rinsed in KRH buffer (140 
mM NaCI, 4.7 mM KCI, 2.5 mM CaCfe, 1.25 mM MgSO.*, 0.2 mM NaH2P 04,
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10 mM HEPES, pH 7.4) with 1 % (w/v) BSA at 37 °C. The washed tissue 
was placed in adipocyte digestion buffer (3.5 % (w/v) BSA in KRH 
supplemented with 5 mM glucose and 500 pg/ml Collagenase type 1 from 
Clostridium histolyticum) in a 23 ml polystyrene flat-bottomed tube 
(Sarstedt), and minced finely with scissors. Both buffers were supplemented 
with adenosine at a final concentration of 200 nM. The tissue suspension 
was shaken rapidly in a shaking water bath at 37 °C for approximately 25 - 
26 min until most of the tissue lumps were digested. The resulting cell 
suspension was filtered through a nylon mesh (250 pm mesh size, 
Lockertex), into a 23 ml polystyrene flat-bottomed tube (Sarstedt), washed 
with 1 % BSA/KRH, and returned to 37 °C. The cells were allowed to float. 
The infranatant buffer was removed using a needle (2 mm diameter X 100 
mm) attached to a 20 ml plastic syringe, and 15 - 20 ml 1 % (w/v) BSA/KRH 
buffer was added. The cells were gently resuspended and then allowed to 
float. This washing procedure was repeated 3 - 4 times. The cell suspension 
was adjusted to a cytocrit of 40 % (using a capillary tube which was 
centrifuged at 1000 g for 1 min and expressed as the ratio of the length of 
the packed cell fraction in the tube to the total length of the suspension in the 
tube) and ready for further use.
2) Stimulation of rat adipocytes with insulin
Insulin at a final concentration of 20 nM was used to stimulate the isolated 
rat adipocytes (40 % cytocrit) for 20 min at 37 °C. Basal cells were also 
maintained at 37 °C during this time.
3) Sub cellular fractionation (subfractionation) of rat adipocytes
Basal or insulin-treated cells were washed once in HEPES-EGTA-Sucrose I 
(HESI) buffer (250 mM Sucrose, 0.5 mM EGTA, 20 mM HEPES, pH 7.0) 
(with protease inhibitor cocktail and AEBSF) at 15 - 18 °C. When the cells
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floated to the top the excess HESI buffer was removed. The cells were 
rapidly homogenized (basal first) with 10 strokes of a 55 ml Potter-Elvehjem 
homogenizer (Thomas Scientific), with a specific clearance of 150 pm. 
Homogenized cells were transferred to disposable centrifuge tubes and 
rapidly centrifuged at 1000 g for 1 min at 4 °C in a refrigerated Ole Dich 
centrifuge (Camlab). After that the centrifuge tubes were kept on ice for 10 
min to solidify the fat. The homogenizer was washed, cooled and the same 
procedure was repeated with the insulin stimulated cells. The homogenate 
(infranatant between top fat layer and bottom pellet) was collected with a 
21G needle (TERUMO) and a 2 ml syringe (TERUMO). The following spins 
were all carried out in a TL-100 bench-top ultracentrifuge (Beckman) using 
TLA-100.3 rotor at 4 °C unless otherwise stated. The procedure is 
represented on Fig 2.1. The collected infranatant was centrifuged at 17,500 
g (18,000 rpm) for 20 min to obtain a crude plasma membrane (PM) pellet 
containing mitochondria and nuclei, as well as a supernatant containing the 
microsomal and cytosolic fractions. The PM pellet and the supernatant were 
prepared separately afterwards. 1) The pellet containing plasma membrane 
was resuspended in 1 ml HESI buffer and homogenized once again with 5 
strokes in a 2 ml homogenizer (Thomas Scientific). The homogenizer was 
washed out with a further 1 ml HESI which was added to the homogenate 
and centrifuged at 17,500 g (18,000 rpm) for 20 min. The pellet was 
resuspended in 300 pi HESI, loaded on top of a 600 pi sucrose cushion 
(1.12 M Sucrose, 1 mM EDTA, 20 mM HEPES, pH 7.0) and centrifuged at
105,000 g (35,000 rpm) for 20 min in the TLS-55 swing out rotor. The 
mitochondria and nuclei were pellet down and purified plasma membrane 
was recovered at the cushion interface. 700 pi of the interface was 
harvested, resuspended in 2 ml HESI and centrifuged at 74,000 g (37,000 
rpm) for 9 min. The plasma membrane pellet was washed with another 2 ml 
of HESI and re-pelleted at 74,000 g (37,000 rpm) for 9 min. The plasma 
membrane was then resuspended in 150 pi HESI. 2) The supernatant
containing microsomal and cytosolic fractions was centrifuged at 49,000 g 
(30,000 rpm) for 9 min to pellet the high density microsomes (HDM), leaving 
the low density microsomes (LDM) and cytosol in the supernatant (post 
HDM supernatant, or pHDM supernatant). The HDM pellet was washed in 2 
ml HESI and pelleted again at 49,000 g (30,000 rpm) for 9 min. Then the 
HDM was resuspended in 50 pi HESI. The low density microsomes (LDM) 
were pelleted by centrifugation at 541,000 g (100,000 rpm) for 17 min 
leaving the cytosol in the supernatant. Then the pellet was washed with 2 ml 
HESI and pelleted again at 541,000 g (100,000 rpm) for 17 min. The low 
density microsomes were resuspended in 100 pi HESI. All the fractions were 







1, 000 rpm 1 min
Supernatant
Pellet (HDM)
Resuspend in 2 ml HESI
30, 000 rpm 9 min
18, 000 rpm 20 min
100, 000 rpm 17 min
18, 000 rpm 20 min
Pellet (HDM) 
Resuspend in 50 pi HESI.
30, 000 rpm 9 min
Pellet (LDM) 
Resuspend in 100 pi HESI.
Post HDM Supernatant 
(LDM + Cytosol)
Pellet (purified PM)
Resuspend in100 pi HESI
Pellet (PM)
Resuspend in 2 ml HESI. 
37, 000 rpm 9 min
Pellet (LDM) 
Resuspend in 2  ml HESI. 
100, 000 rpm 17min
Interface (PM)
Collect 700 pi, resuspend in 2 
ml HESI.
37, 000 rpm 9 min
Pellet (PM)
Add 1ml HESI, resuspend with 
pipette, homogenise 5 strokes, 
transfer to tube. Add 1ml HESI 
and Homogenise 2 strokes to 
clean. Pool to same tube.
Discard supernatant. 
Resuspend pellet in 300 pi 
HESI, load onto 600 pi 
sucrose cushion.
35, 000 rpm 20 min in 
Swing out rotor (TLS- 
55)
Fig 2.1 Diagram representation of the rat adipocytes sub-cellular 
fractionation. See texts for details.
4) Concentrated cytoplasm from rat adipocytes
Basal or insulin-stimulated rat adipocytes were washed with KRH without 
BSA at 37 °C, then with intra-cellular (1C) buffer (20 mM HEPES pH 7.4, 140 
mM K-glutamate, 5 mM NaCI, 1 mM EGTA) containing 1 pg/ml of protease
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inhibitor cocktail and 100 |jM AEBSF (section 2.1.6) at 15 -1 8  °C, and then 
spun briefly to concentrate the cells. The infranatant buffer was discarded 
with a syringe. The cells were then vortexed vigorously for about 5 - 1 0  sec, 
repeated 5 times. The suspension was transferred to a polycarbonate 
centrifuge tube (Beckman) and spun at 250, 802 g using MLA-80 rotor in 
Beckman Optima MAX Ultracentrifuge for 70 min at 4 °C. After 
centrifugation, the tubes were left on ice for 10 -1 5  min to solidify the fat at 
the top. The cytoplasm in the middle layer was harvested with a 2 ml syringe 
and a 21G needle. The protein concentration of cytoplasm was determined. 
The cytoplasm was aliquoted, snap frozen in liquid nitrogen and then kept at 
-80 °C.
5) Immuno-precipitations
•  Immuno-precipitation of GLUT4 vesicles from rat adipocytes with 
MBP-Spa and Amylose resin
1 ml of amylose resin slurry (NEB) was loaded on a disposable Talon gravity 
column (Clontech) resulting in 0.7 ml of bed volume. Resin was washed 3 
times with column buffer (20 mM HEPES pH 7.4, 150 mM NaCI) by filling the 
column with the buffer. One aliquot (500 pi) of recombinant MBP-Spa 
bacterial lysate was thawed on ice and diluted to 3 ml with high salt column 
buffer 1 (20 mM HEPES pH 7.4, 500 mM NaCI) with 100 units of a-Amylase 
inhibitor from Triticum aestivum (wheat seed). This was added to column and 
rotated for 2 h or overnight at 4 °C. The next day (or after 2 h) the column 
was drained, washed 1 time with high salt column buffer 2 (20 mM HEPES 
pH 7.4, 1 M NaCI), and 2 times with normal column buffer. 100 pg of rabbit 
affinity purified anti C-terminal GLUT4 antibody was diluted in 3 ml column 
buffer with 100 units of a-Amylase inhibitor (for basal GLUT4 vesicles, 100 
pg Ab/rat; for fusion assay with 4 rats, 100 pg Ab/fusion assay). This was
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rotated in the column for 2 h at 4 °C. After incubation the column was 
washed 3 times with column buffer. Freshly prepared post HDM supernatant 
(section 2.2.1.3) and 100 unites of a-Amylase inhibitor were added to the 
column, and rotated for 2 h at 4 °C. At the end of the incubation the 
supernatant was drained from the column, and the column was washed with 
at least 8 ml of the desired buffer (IC buffer for fusion assay in Chapters 4, 5,
6). The efficiency of the washes was monitored by either measuring the 
absorbance at 280 nm in the UV spectrometer or the fluorescence contained 
it the vesicles with the FARCyte fluorescent plate reader (Tecan). 40 mM 
maltose was freshly prepared in 5 ml of the desired buffer (IC buffer for 
fusion assay in Chapters 4, 5, 6) to be the elution buffer. When the washes 
finished the column was plugged, 1 ml elution buffer was added to the 
column and the column was rotated for 10 min at room temperature. This 
eluate was collected in a tube as elution fraction 1. The rest elution buffer 
was added to the column and 4 to 6 additional 500 pi fractions were 
collected. The efficiency of the elutions was monitored by either measuring 
the absorbance at 280 nm in the UV spectrometer or fluorescence. The 
ultimate confirmation was to run all the fractions on a gel to confirm the 
presence of GLUT4.
•  Immuno-precipitation of Akt from concentrated cytosol
To immuno-deplete Akt from concentrated cytosol, freshly-made 
concentrated cytosol from rat adipocytes was incubated overnight with 
anti-Aktl antibody clone 5G3 (Cell Signalling Technology) alone or in 
combination with anti-Akt2 antibody clone AW114 (Upstate). 150 pi of 
cytosol from insulin-stimulated adipocytes were incubated with 15 pi Akt1 
antibody and 15 pi Akt2 antibody. The controls were cytosols with and 
without 10 pg mouse IgG and 10 pg rabbit IgG. For depletion of Akt1 only, 
cytosol was incubated with Akt1 antibody only and the controls were with
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and without mouse IgG. The antibodies were removed with immobilised 
ProteinA/G by incubating the cytosol-antibody mixture with 15 |jl ProteinA/G 
beads (Peirce). The cytosol was analysed to assess the amount of depletion 
by western blot prior to use in the fusion assay.
2.2.2 Rat adipocytes GLUT4 surface photolabeling
Rat adipocytes at 40 % cytocrit were stimulated with 5 nM insulin for 20 min 
at 37 °C. In a typical experiment 10 ml of cells were used. After cooling the 
cells to 18 °C the surface GLUT4 was labeled with 500 pM biotinylated 
photolabel GP15 (Hashimoto et al., 2001). 1 ml cells were transferred to a 
35 mm polystyrene dish at 18 °C. 500 pM biotinylated photolabel GP15 was 
added to the cells and mixed well. The dishes were irradiated for 1 min in a 
Rayonet RPR-100 photochemical reactor with 300 and 350 nm lamps. Cells 
were then transferred to 5 polystyrene tubes and washed 5 times with 25 ml 
KRH buffer at 18 °C.
2.2.3 Rat adipocytes GLUT4 surface DyLight tagging and GLUT4 
internalization
Photolabeled rat adipocytes (section 2.2.2) were incubated with 10 pg/ml of 
cells DyLight647 streptavidin (Pierce) for a further 15 min. Insulin was 
removed and GLUT4 was internalized (Yang et al., 2002b). Briefly, the cells 
were washed three times with pH 6.0 KRH buffer at room temperature to 
remove insulin and 1 time with KRH buffer containing 2 mM glucose. The 
cells were then kept in KRH buffer containing 2 mM glucose at 37 °C for 45 
min to allow GLUT4 internalization and reversal of the cells to basal state.
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2.2.4 Protein Biochemistry techniques
1) SDS-polyacrylamide gel electrophoresis
Three-time concentrated SDS sample buffer was prepared and stored at 
room temperature. At the time of use, reducing agent dithiothreatol (DTT) 
was added freshly. Protein samples were solubilised in one-time 
concentrated sample buffer (2 % (w/v) SDS, 62.5 mM Tris HCI pH 6.8, 0.01 
% (w/v) bromophenol blue, and 10 % (v/v) glycerol) with 20 mM DTT and 
heated at 95 - 100 °C for 5 -1 0  min in a heating block.
Electrophoresis was carried out using the Laemmli discontinuous buffer 
system. Slab gels were prepared using either the mini-Protean 3 system 
(Bio-Rad), mini-Atto system (Atto Corporation), or the CBS system (C.B.S. 
Scientific Company Inc). 10 or 15 % resolving gels and 6 % stacking gels 
were prepared. All gels were made to a thickness of 1.5 mm. Gels were 
prepared according to the manufacturers’ instructions, using the following 
buffer system: acrylamide/bis-acrylamide (30 % (w/v) acrylamide) (National 
Diagnostics, Flowgen), Resolving gel buffer (1.5 M Tris HCI, 0.4 % (w/v) 
SDS, pH 8.8), Stacking gel buffer (0.5 M Tris HCI, 0.4 % (w/v) SDS, pH 6.1), 
10 % (w/v) ammonium persulphate (APS) and
N,N,N,N’-tetramethylethylenediamine (TEMED). The stock solutions were 
stored up to 1 month at room temperature. Composition of the resolving and 
stacking gels can be seen in Appendix table 4). Polymerisation was initiated 
by the addition of TEMED and APS, both to 0.05 % (v/v) final concentration. 
Gels were run at a constant 200 Volts in electrophoresis running buffer (25 
mM Tris HCI, pH 6.3, 0.1 % (w/v) SDS, 0.2 M Glycine) for approximately 1 h 
until the bromophenol blue dye had just run off the gel.
Molecular weight markers were either High Molecular Weight markers 
(HMW markers) consisting of myosin (205 kDa), p-galactosidase (116 kDa),
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phosphorylase b (97.4 kDa), bovine albumin (66 kDa), ovalbumin (45 kDa) 
and carbonic anhydrase (29 kDa), or Broad range Protein markers (BMW 
markers) (New England Biolabs) consisting of myosin (212 kDa), 
MBP-p-galactosidase (158 kDa), p-galactosidase (116 kDa), phosphorylase 
b (97 kDa), serum albumin (66 kDa), glutamic dehydrogenase (55.6 kDa), 
maltose binding protein 2 (42.7 kDa), lactate dehydrogenase (36.4 kDa), 
triose phosphate isomerase (26.6 kDa), trypsin inhibitor (20 kDa), lysozyme 
(14 kDa), aprotonin (6.5 kDa) and insulin A, B chain (2.3 - 3.4 kDa).
2) Electrophoretic transfer of proteins to nitrocellulose membrane
Following SDS-PAGE, proteins on the gels were transferred onto 
nitrocellulose membranes using the Multiphor II Novablot electrophoretic 
transfer apparatus (Pharmacia) by the semi-dry transfer method. The 
stacking gel was removed and the resolving gel briefly incubated in 
SDS-transfer buffer to remove the electrophoresis running buffer. The filter 
paper and nitrocellulose cut to the size of the gel were also briefly immersed 
in transfer buffer (39 mM Glycine, 48 mM Tris, 0.0375 % SDS (w/v), 20 % 
methanol (v/v), pH 8.8 without adjusting). Nine pieces of Whatman paper 
(3mm) (Munktell, Pharmacia Biotech) were placed on the anode of the 
transfer apparatus. A piece of nitrocellulose membrane (Gelman Sciences, 
45 pm pore size) was placed on the stack, followed by the gel. The final nine 
pieces of filter paper were placed on the gel and the cathode on top of the 
stack. All trapped bubbles were removed. The transfer was run at a constant 
current calculated as follows: (area of the gel cm2) x 0.8 mili Amps for 1 h 50 
min. Following transfer, the nitrocellulose membrane was washed briefly in 
distilled water, and stained with Ponceau S stain (0.1 % (w/v) Ponceau S in 
3 % (v/v) trichloroacetic acid) for 2 - 3 min. Excess stain was washed off with 
distilled water and the protein bands could be visualised. The nitrocellulose
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was left to air dry and the positions of the molecular weight markers were 
recorded.
3) Western Blotting
The nitrocellulose membrane was washed in Tris-buffered Saline with 0.1 % 
(v/v) Tween-20 (TBS-T) to re-hydrate and remove the Ponceau S stain. The 
nitrocellulose was then blocked in 5 % Marvel (dried skimmed milk powder) 
in TBS-T with gentle rocking for 30 - 60 min at room temperature or 
overnight at 4 °C, to block non-specific protein binding sites. The membrane 
was washed 4 times for 15 min in TBS-T followed by incubation with the 
primary antibody, at the required dilution (section 2.1.3), in TBS-T containing 
1 % (w/v) BSA, for 2 h at room temperature. For sheep C-terminal GLUT4, 
Akt, phosphorylated-Akt and V-ATPase, the incubation was overnight at 4 
°C. The nitrocellulose was washed for 6 times for 5 min with TBS-T followed 
by incubation for 45 min at room temperature with the secondary antibody at 
the required dilution (section 2.1.3) in blocking solution. Once again the 
nitrocellulose was washed for 6 times for 15 min in TBS-T.
The nitrocellulose membrane was developed using ECL or ECL Advance 
(Amersham Pharmacia Biotech) following the manufacturer’s guidelines. In 
brief the two reagents were mixed in a 1:1 ratio and the membrane was 
incubated for 1 min in ECL or 5 min in ECL Advance. The chemiluminescent 
signals were detected with an EPI Chemi II darkroom imaging system 
(UVP). In experiments where protein bands were quantified by densitometry, 
multiple exposures of the blots were performed to ensure that the analysis 
was performed in the linear range of signal densities.
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4) Coomassie blue staining
Protein bands on the gels were visualised by staining with Coomassie 
brilliant blue reagent (0.2 % (w/v) Coomassie blue R-250 in 10 % (v/v) 
glacial acetic acid, 30 % (v/v) MeOH, 60 % (v/v) dH20 ) for 1 h, followed by 
incubation with destain (30 % (v/v) MeOH, 10 % (v/v) glacial acetic acid, 60 
% (v/v) dH20). The gels were dried at room temperature between two layers 
of Biotrace membrane presoaked in destaining solution containing 8.7 % 
(v/v) glycerol.
5) BCA protein determination
The bicinchoninic acid (BCA) protein assay (Pierce) was used to determine 
protein concentrations. A standard curve of BSA using a 1 mg/ml BSA stock 
(in 0.1 M NaOH) was prepared. 10 pi of 1 - 10 pg BSA was added to 
Microtitre plate (Sterilin) in duplicate. 10 pi of sample was also added to the 
plate, either undiluted or diluted with 0.1 M NaOH. The BCA working 
solution was prepared by adding Reagent A (1 % BCA-N02, 2 % 
Na2C03 .H20 , 0.16 % Na2tartarate, 0.4 % NaOH, 0.95 % NaHCOa) and 
Reagent B (4 % (w/v) CuS04.5H20 ) together in a ratio of 50:1. 200 pi of this 
working solution was added to each of the wells containing standard and 
samples. The plate was incubated at 37 °C for 30 min with the lid in place, 
allowed to cool and then read on a microplate spectrophotometer (Tecan) at 
565 nm.
2.2.5 Molecular Biology and protein expression
Standard molecular biology techniques were used for all DNA manipulation 
and protein expression (Sambrook et al., 1989).
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1) Plasmid miniprep extraction
Plasmid DNA was purified from cultures of E.coli cells in 10 ml Luria Broth 
(LB) medium (1 % (w/v) Bacto™ Tryptone, 0.5 % (w/v) Bacto™ Yeast 
Extract, 0.5 % NaCI, pH 7.5, autoclaved) using the Wizard Plus SV miniprep 
DNA purification system (Promega), according to the protocol provided by 
the manufacturer.
2) Polymerase chain reaction (PCR) for Spa sequence from pAX11
2 pi of pAX11 DNA was amplified in 60 pi of Pfx amplification buffer 
(Invitrogen) containing 10 mM of dNTP, 50 mM MgS04, 0.4 pi Platinum Pfx 
DNA polymerase (Invitrogen) and 10 pM of two primers, M13 Uni 5’ GGG 
TTT TCC CAG TCA and M13 R 5’ ATG ACC ATG ATT ACG (Eurogentec). 
The polymerase chain reaction (PCR) involved 30 cycles of denaturation (92 
°C 10 sec), annealing (55 °C 30 sec) and extension (68 °C 1 min) after an 
initial denaturation step at 92 °C for 2 min. A final extension of 10 min was 
carried out at 68 °C. Annealing temperature for the subsequent PCR with 
the new primer (MNG-Biotech AG) was 60 °C.
3) DNA Gel extraction
The DNA gel slices were collected and gel extraction was performed using a 
commercial kit (Qiagen), according to the protocol provided by the 
manufacturer.
4) DNA digestion
BamH\-Spe\ double digestion of both the Spa PCR product and 
pMBP-Parallel2 involved the incubation of 1 pi of DNA, 1.5 pi buffer 2 
(Sigma), 1 pi of each of the restriction enzymes BamH\ and Spel and 1.5 pi
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of 10 times concentrated BSA (1 mg/ml) for 1 h at 37 °C. Single digestion of 
pMBP-Spa with Xho\ involved the incubation of 26 pi of DNA, 4 pi NEBuffer 
3 (New England Biolabs), 4 pi of Xho\ and 4 pi of 10 times concentrated 
BSA (1 mg/ml) for 2 h at 37 °C. 20 pi of the Xho\ single digested pMBP-Spa 
was then incubated with 3 pi NEBuffer 3 (New England Biolabs), 3 pi of A/ofl 
and 3 pi of 10 times concentrated BSA for 2 h at 37 °C. Then the A/ofl was 
heat inactivated by keeping the digest product at 70 °C heating block for 20 
min. The digestions were loaded onto a gel and the bands excised quickly 
under UV light with a razor blade.
5) Cloning
The cohesive ends of the Spa PCR product and pMBP-Parallel2 digestion 
products were ligated using the LigaFast Rapid DNA ligation system 
(Promega). The following equation was used to calculate the amount of 
insert DNA required for the ligation reaction:
100 ng plasmid x insert kbx ratio of (insert! plasmid)
------------------------------------------------------------------------------- — ng of insert
plasmid kb
100x0 47x2In the case of pMBP-Spa (section 3.3), the insert was ------= 13.9 ng .
100 ng of the digested pMBP-Parallel2 plasmid was mixed with 13.9 ng of 
the Spa insert and 10 pi of 2 times concentrated rapid ligation buffer. This 
was heated at 65 °C for 5 min and cooled for a few minutes on ice before the 
addition of 0.66 pi of ligase. As a control, a perfectly blunt ended cloning kit 
(Novagen) was also used to ligate the digested insert into a PT7 blue vector 
(Novagen). Briefly, 5 pi of end conversion mix was added to 13.9 ng of the 
Spa insert and incubated at 22 °C for 15 min followed by 75 °C for 5 min and 
cooled on ice for 2 min. 100 ng of the PT7 vector was added with 1 pi of T4 
DNA ligase and incubated for 60 min on ice. 2 pi of this or the
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pMBP-Parallel2 ligation mixture was added to 50 pi of XL1 blue cells which 
were placed on ice for 5 min. cells were heat shocked at 42 °C for 1 min, 
cooled on ice for 2 min and added to 250 pi of SOC medium (0.5 % Yeast 
extract, 2.0 % tryptone, 10 mM NaCI, 2.5 mM KCI, 10 mM MgCl2 , 20 mM 
MgS04 , 20 mM glucose) with 35 pi of 2 %
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal) and 20 pi of 100 
nm Isopropyl-B-D-thiogalactopyranoside (IPTG). These two reagents allow 
colonies containing the plasmid with the Spa insert to be easily identified via 
the blue-white screening method because the pMBP-Parallel2 plasmid 
contains the lacZ operon. When the Spa gene is inserted into the plasmid, 
the lacZ operon is disrupted inhibiting the transcription of p-galactosidase, a 
product of the lacZ-a gene. X-gal is a substrate which turns blue when 
incubated in the presence of p-glactosidase. Therefore, the blue colonies 
have an intact lacZ operon and do not contain the insert. IPTG binds to the 
lacZ repressor thus activating the operon and causing expression of the 
intact gene, if present. The cells were applied to plates containing 10 pg of 
ampicillin and incubated overnight at 37 °C. White colonies were used to 
transform 50 ml of LB medium containing 20 pg/ml of ampicillin. The 
plasmids were harvested as earlier described (section 2.2.5.1).




100 ng of the digested pMBP-Spa plasmid was mixed with 0.833 ng of the 
Poly-His insert and 1.5 pi of T4 ligase buffer. This was heated at 65 °C for 5 
min and cooled down to room temperature before the addition of 1.5 pi of T4 
ligase, 1.5 pi of Promega buffer E, 1.5 pi of BSA, 1 pi of Xba\ and 0.6 pi of 
H20 . As a control, 0.833 ng of the Poly-His insert was replaced with H20  of 
the same volume. This mixture was incubated at 37 °C for 2 h and then 
transfected to TB1 competent cells. The transfected cells were grown
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overnight in selective LB-Agar (1 % (w/v) Bacto™ Tryptone, 0.5 % (w/v) 
Bacto™ Yeast Extract, 0.5 % NaCI, 1.5 % (w/v) Agar, pH 7.5, autoclaved) 
plate and single colony was cultured in a 10 ml mini-culture overnight. The 
plasmid was extracted with a mini-prep kit (Promega).
6) DNA analysis
DNA products were run on 0.6 % (w/v) agarose Tris-acetate EDTA (TAE) 
(40 mM Tris-acetate, pH 8, 1 mM EDTA) gels containing 0.1 % (v/v) SYBR 
Safe™ DNA gel stain (New England Biolabs) at 160 Volts for 20 - 40 min. 
The DNA bands were visualized by SYBR staining under UV 
transillumination.
DNA sequencing was carried out using service by MWG Biotech.
7) Preparation of competent cells
A glycerol stock of E. Coli bacterial cells (Rosetta (DE3) pLysS; Novagen) 
was scraped with a sterile pipette tip and inoculated to 200 pi LB and 
incubated at 37 °C for 30 min. This culture was plated onto a pre-warmed LB 
plate containing 34 pg/ml of chloramphenicol and was left overnight at 37 
°C. The next day, a single colony from the LB plate was inoculated into a 2.5 
ml LB medium and then incubated overnight at 37 °C with shaking 
(approximately 225 rpm). The next day, the entire overnight culture was 
used to inoculate 250 ml of LB medium containing 20 mM MgS04 in a 1 L 
flask. The culture was let grow at 37 °C with shaking until the OD6oo reached 
0.4 - 0.6. The cells were pelleted by centrifugation at 4,500 g for 5 min 
(Beckman Avanti J-25) at 4 °C. The cell pellets were then gently 
resuspended in 0.4 volume (based on the original culture volume, for a 250 
ml culture, 100 ml was used) of ice-cold TFB1 medium (30 mM potassium 
acetate, 10 mM CaCl2, 50 mM MnCfe, 100 mM RbCI, 15 % (v/v) glycerol, pH
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5.8 with 1 M acetic acid, 0.2 pm filter-sterilized). The resuspended cells were 
maintained on ice for 5 min and then pelleted again at 4,500 gfor 5 min at 4 
°C. The pellet was gently resuspended in 1/25 of the original culture volume 
(for a 250 ml culture, 10 ml was used) of ice-cold TFB2 medium (10 mM 
MOPS, 75 mM CaCfe, 10 mM RbCI, 15 % (v/v) glycerol, pH 6.5 with 1 M 
KOH, 0.2 pm filter-sterilized). The cells were maintained on ice for 15 - 60 
min and then aliquoted to 100 pi per tube, snap frozen in liquid nitrogen and 
stored at -70 °C.
8) Transformation of cDNA constructs to competent cells
An aliquot of competent cells was thawed on ice. 0.5 pi of mini-prep of the
desired construct was then added to the competent cells and mixed by
gently swirling. The sample was then incubated on ice for 30 min. The tube
#
was heated at 42 °C for 45 - 60 sec then placed on ice to cool for 30 min. 
200 pi LB medium was added to the tube which was then left in 37 °C 
incubator for 45 min. The mixture was plated onto the selection plate (LB 
supplemented with 20 g/L Agar + selective antibiotics) which was kept 
(up-side-down) in a 37 °C incubator for overnight culture.
9) Protein expression
A single colony of the transformation was inoculated into 10 ml of LB 
containing selective antibiotics (200 pg/ml ampicillin for MBP-Spa and 
MBP-Spa-His; 200 pg/ml ampicillin and 34 pg/ml chloramphenicol for 
recombinant SNARE proteins). This culture was incubated overnight in a 
shaking incubator at a speed of 200 rpm at 37 °C. The following morning, 5 
ml of the overnight culture was transferred to a 2 L conical flask containing 1 
L LB supplemented with selective antibiotics. This was incubated at 37 °C 
with shaking at 200 rpm until the UV absorbance at 600 nm reached 0.5 - 
0.6 (approximately 3 h). IPTG at 0.5 mM final concentration was added to
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the culture to induce recombinant protein expression. Then the culture was 
incubated for a further 3 h. The cells were harvested by centrifugation for 5 
min at 5000 g (Beckman Avanti J-25) in 250 ml bottles. The supernatant was 
discarded and the cell pellet was stored at -80 °C.
10) Protein extraction
•  MBP-Spa and MBP-Spa-His extraction
The cell pellet from section 2.2.5.9 was resuspended in 50 ml of column 
buffer containing AEBSF and 1 mM EDTA. Cells were frozen overnight at 
-20 °C and defrosted on ice. To release the protein, the cell suspension was 
sonicated for 2 min on ice with a tip sonicator. The suspension was 
sonicated at amplitude of 15 microns for 8 times 15 sec with intervals of 45 - 
60 sec on ice. Then the suspension was centrifuged at 9,000 g for 30 min at 
4 °C in 50 ml tubes. The supernatant containing MBP-Spa or MBP-Spa-His 
was collected, aliquoted in 500 pi, snap frozen in liquid N2 and stored at -80 
°C.
•  MBP-Spa-His purification
Ni-NTA His-Bind Resin (Novagen) was used for purification of MBP-Spa-His 
protein. 1 ml of the 50 % Ni-NTA His-Bind slurry was loaded on to a gravity 
column, washed 3 times with column buffer containing 10 mM imidazole and 
AEBSF, before 4 ml of cleared MBP-Spa-His lysate was added to the resin. 
The mixture was rotated at 4 °C for 60 min. The flow through was collected 
for analysis. The resin was washed with 10 ml Ni-NTA wash buffer (300 mM 
NaCI, 50 mM sodium phosphate buffer, 20 mM imidazole, pH 8.0). The 
protein was eluted with 4 times 0.5 ml Ni-NTA Elution Buffer (300 mM NaCI, 
50 mM sodium phosphate buffer, 250 mM imidazole, pH 8.0). The fractions 
were collected and put in a dialysis tubing with a molecular weight cut off of
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1 2 - 1 4  kDa (Medicell International Ltd) to dialyse against 4 L of column 
buffer at 4 °C overnight. The next day, the dialysate was collected and the 
protein concentration was determined and then AEBSF was added to the 
solution.
•  t-SNARE purification
The cell pellet from section 2.2.5.9 was thawed on ice and then fully 
resuspended in a total of 50 ml ice-cold IB wash buffer (50 mM Tris HCI pH
7.5,1 mM EDTA, and 1 % (w/v) octyl-p-D-glucoside) and then decanted into 
a 50 ml tube. The tube was put into a beaker of wet ice and the bacterial 
cells were sheared by tip sonicating at amplitude of 24 microns with 2 pulses 
of 45 sec and a pause of 45 sec in between each pulse). The sonicated 
suspension was transferred to two 30 ml centrifuge tubes and centrifuged at 
16,000 g for 10 min. The pellets were resuspended in a total of 50 ml IB 
wash buffer and centrifuged at 16,000 g for a further 10 min. The wash was 
repeated twice. Then the purified inclusion bodies were resuspended in a 2 
ml solubilisation buffer (6 M guanidine HCI, 10 mM DTT, 1 % (w/v) 
octyl-p-D-glucoside). This solution was incubated at room temperature for 
20 min. The insoluble material was spun down at 20,000 g for 30 min. The 
solubilised material was buffer exchanged with reconstitution buffer (25 mM 
HEPES pH 7.4, 100 mM NaCI, 1 mM DTT, 1 % (w/v) octyl-glucoside) using 
Bio-Spin 6 (Bio-Rad) columns for a total of 400 pi of the solubilised protein. 
The proteins, in reconstitution buffer, were incubated at room temperature 
with rotation for 1 h prior to the reconstitution into vesicles.
•  V-SNARE purification
The cell pellet from v-SNARE expression (from section 2.2.5.9) was taken 
out from -80 °C and thawed on ice, and then resuspended in 25 ml of 50 mM 
sodium phosphate buffer pH 7.9. This sample was then maintained on ice
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for 15 min to allow the nuclease to digest the DNA. 15 ml of 5 M NaCI 
containing 0.5 g octyl-glucoside (to have a final concentration of 1 % (w/v)) 
was added and the volume was made up to 50 ml. This mixture was rotated 
at 4 °C for 1 h and then centrifuged at 20,000 g for 30 min to remove 
insoluble material. The supernatant was transferred to a 50 ml tube 
containing 0.75 ml of His-Bind resin (Novagen). This sample was rotated at 
4 °C for 2 h or overnight. The resin was then spun down and resuspended 
twice at 500 for 2 min and washed with at least 20 ml reconstitution buffer. 
The resin was then resuspended in the reconstitution buffer and transferred 
to a 2 ml microfuge tube and allowed to settle. The buffer was removed until 
the amount remaining was just sufficient to keep the resin in suspension 
(about 1.2 ml in total). 20 units of thrombin were added to the resin 
suspension which was incubated at room temperature overnight with 
end-to-end rotation. The next day, the resin was transferred to a gravity 
column to recover the digested protein. The column was then placed 
carefully in a universal tube, transferred to a bench top centrifuge (Beckman 
Allegra X-22) and then spun at 500 g for 1 min to recover the VAMP2 
protein.
2.2.6 Preparation of liposomes
1) Plasma membrane protein -  reconstituted liposomes
Basal and insulin stimulated plasma membranes were prepared (Simpson et 
al., 1983) (section 2.2.1.3) and reconstituted in phospholipid liposomes 
using an adaptation of previously described methods (Kono, 1983; 
Schurmann et al., 1989). 270 jug of purified plasma membrane was 
solubilised in 1.25 % (w/v) n-octyl glucoside and applied to Sephadex G50 
column. 200 pi aliquots of solubilised eluted plasma membrane protein (300 
pg/ml) were gently vortex mixed with 40 pi of 150 mg/ml Soya bean
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phosphatidylcholine (Type IV-S Sigma) in 20 mM HEPES pH 7.4. A 
Biotin-Europium(TMT) ligand (section 4.2 for molecule structure) was added 
at 55 nM final concentration and the mixture was sonicated for 15 sec in 
Decon FS100 Frequency Sweep water bath sonicator (Decon Ultrasonics 
Ltd) and frozen to -70 °C for at least 2 h. The samples were then thawed, 
resonicated and purified on flotation Histodenz gradients (Weber et al., 
1998). Briefly the liposomes were mixed 1:1 with 80 % Histodenz in 
reconstitution buffer (25 mM HEPES pH 7.4, 100 mM KCI, 1 mM DTT) 
containing 10 % glycerol. This was overlayed with 30 % Histodenz in 
reconstitution buffer with glycerol, and then with buffer only. After an 11 h 40 
min spin at 151,263 g (35,000 rpm in a SW41Ti rotor), liposomes were 
collected at the 0 - 30 % Histodenz interface. The amount of encapsulated 
Biotin-Eu(TMT) was monitored by measuring the fluorescence against a 
standard curve. Typically 1 to 2 nM of Biotin-Eu(TMT) was encapsulated.
2) Recombinant SNARE protein -  reconstituted liposomes
A 150 pi mixture of 13 mM PC:PE:PS (102:30:18 volumn ratio) in chloroform 
was made up. The chloroform was evaporated under a gentle stream of 
nitrogen. The complete removal of chloroform was ensured by drying under 
vacuum for 30 min. The dry lipids were resuspended in 400 pi of 
reconstitution buffer (25 mM HEPES pH 7.4, 100 mM NaCI, 1 mM DTT, 1 % 
(w/v) octyl-glucoside) containing t/v-SNAREs. For protein-free/plain 
vesicles, reconstitution buffer without the SNAREs was used. These 
samples were incubated together for 30 min at room temperature on a 
rocking platform (with frequent gentle shaking by hand). The vial containing 
the mixture was vigorously vortexed with 800 pi of liposome buffer. For 
t-SNARE liposomes, the liposome buffer contains 25 mM HEPES pH 7.4, 
100 mM NaCI, 15 mM EuCh, 150 mM citrate, 1 mM DTT. For v-SNARE 
liposomes, the liposome buffer contains 25 mM HEPES pH 7.4, 100 mM
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NaCI, 150 mM 2,6-pyridinedicaroxylic acid (dipicolinic acid, DPA). The 
samples were quickly mixed in the vial with vortexing for a further 30 sec. 
These samples were dialysed against 4 L of dialysis buffer containing 4 g 
Biobeads SM2 beads (Bio-Rad) at 4 °C overnight. The next morning, an 
Optiprep gradient was made up in dialysis buffer (25 mM HEPES pH 7.4, 
100 mM NaCI, 1 mM DTT): 40 % of Optiprep in liposome dialysate followed 
on top with 30 % Optiprep in dialysis buffer, 20 % Optiprep in dialysis buffer 
and dialysis buffer alone. The gradient was spun at 200,620 g (50,000 rpm 
with MLS-50 rotor) for 5.5 h at 4 °C in the Beckman Optima Ultracentrifuge. 
The liposomes were visible as a white band near the top of the gradient. The 
liposomes were harvested in a volume of 1 ml.
2.2.7 Fusion assay
1) Plasma membrane protein -  reconstituted liposomes and GLUT4 
vesicles fusion assay
Fusion assays were performed in duplicate or triplicate. 50 pi of GLUT4 
vesicles, liposomes and cytosol were mixed with 25 pi of IC buffer 
containing 1 pM biocytin on ice. Fusion was initiated by adding 50 pi of ATP 
regenerating system (final concentration: 1 mM ATP, 5 mM MgCh, 8 mM 
phosphocreatine, and 31 U/ml creatine phosphokinase Type 1) at 37 °C. In 
some cases GLUT4 vesicles and PM liposomes were mixed with the ATP 
regenerating system on ice and the reaction was initiated by adding cytosol. 
Fusion was stopped by returning the samples on ice and addition of 1 % 
TritonX-100 containing excess biocytin. The extent to which fusion had 
occurred prior to this endpoint was detected by TR-FRET between 
Europium(TMT) and DyLight647 in a FARCyte microplate reader (Tecan). 
The TR-FRET signal was calculated from the ratio of the emission at 670 nm 
/  612 nm with excitation at 340 nm. The zero time point was used as a
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measure of the background and was subtracted from each value. Generally 
the extent of fusion at 5 min was compared with the maximal fusion obtained 
by incubation at 37 °C for 30 min. Both the 670 nm and the 612 nm 
emissions were with a lag time of 50 psec, an integration time of 400 psec 
and with 30 flashes. All attempts to monitor fusion activity in real time were 
unsuccessful.
2) Recombinant SNARE protein-reconstituted liposomes fusion assay
Standard assays were performed in white 96-well LIA-plate (flat-bottomed, 
medium binding; Greiner Bio-one). Typically 50 pi v-SNARE DPA 
encapsulated vesicles (VD) were mixed with 50 pi t-SNARE Europium (Eu) 
encapsulated vesicles (TE) in the presence of 25 pi of 2.3 mg/ml cytoplasm. 
The plates were then placed in the FARCyte fluorescence plate reader 
(Tecan). The FARCyte was equilibrated to 37 °C. Fluorescence was 
followed with filters set at 340 nm (excitation) and 612 nm (emission). The 
fluorescence was monitored at either 0.5 or 2 min intervals with a lag time of 
50 psec, an integration time of 400 psec and with 30 flashes.
3) Treatments
•  T rypsin treatment
50 pi of VD vesicles were mixed with freshly dissolved TPCK trypsin (final 
concentration 1 mg/ml) and left in a 37 °C incubator for 30 min.
•  Botulinum Neurotoxin B light chain (BoLC/B, BoNT/B) treatment
Recombinant Botulinum neurotoxin B light chain (BoNT/B, BoLC/B) was 
purchased from the Centre for Applied Microbiology and Research (Porton 
Down). BoNT/B stock (5 pM) was first diluted in ddH20  to 500 nM, and then 
incubated in a 37 °C incubator for 1 h to activate. Inactivated toxin was
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generated by heating at 9 5 - 100 °C in a heating block for 30 min. When the 
toxin samples were ready, they were added to either v-SNARE DPA 
encapsulated liposomes or GLUT4 vesicles to the desired final 
concentrations and incubated in 37 °C for a further 1 h. Then the samples 
were ready for either a western blot analysis or for the fusion assay.
2.2.8 Data analysis
Densitometric analysis of western blots and DNA gels was performed using 
Labworks version 4 (UVP). Graphical analysis was performed using 
GraphPad PRISM version 4.0 (Graphpad Software, Inc). Statistical analysis 
was carried out using the PRISM programme with unpaired and paired 
two-tailed t tests as indicated in the figure legends.
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Chapter 3 Cloning and characterization of 
Maltose-Binding Protein-Protein A and Maltose-Binding 
Protein-Protein A-Poly His fusion proteins for the isolation 
of GLUT4 vesicles
3.1 Introduction
The isolation of GLUT4 vesicles is important in understanding their 
biological properties. In most of the work in this thesis, it is essential to keep 
GLUT4 vesicles intact with preserved biological activity in order to carry out 
further experiments. Microsomal vesicles are normally obtained from tissues 
by a process of enzyme digestion, homogenization and the differential 
centrifugation (Chapter 2, section 2.2.1). The resulting supernatant contains 
a variety of vesicles and other cellular components of a similar density. A 
common method of isolating GLUT4 vesicles from this supernatant is by 
immunoprecipitation with a specific antibody to the GLUT4 molecule (Slot et 
al., 1991). The constant region (Fc) of the antibody can be bound by 
Staphylococal protein A (Spa), which is derived from the cell surface of a 
common bacterial pathogen, Staphylococcus aureus. Spa has extraordinary 
affinity for immunoglobulin G (IgG) from a number of mammalian species 
such as human, mouse, rabbit, pig and dog (Ey et al., 1978; Goding, 1978; 
Langone, 1982; Lindmark et al., 1983). This interesting and very useful 
property has been widely exploited as an immunological tool. However, 
using this tool to achieve GLUT4 vesicle isolation requires two more 
conditions: 1) to isolate GLUT4 vesicle from the supernatant, the Spa is 
required to attach to a solid matrix; 2) to keep the biological activities of the
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GLUT4 vesicles for further experiments, the eluting condition needs to be 
mild and have a minimal effect on intact GLUT4 vesicles.
To fulfill the first condition covalent bonding of Spa to a solid matrix is a 
frequently used technique, for example, protein A sepharose beads (Miller 
and Stone, 1978). However, it does not satisfy the latter requirement as the 
only way to elute the vesicles from these beads is by using a detergent or 
low pH conditions. Another approach that could be used is to prepare a 
bi-functional protein using genetic engineering. The structural genes of two 
proteins are fused in frame, and the resulting protein carries the active site 
of each protein. The most frequently used gene fusion affinity tags include 
glutathione S-transferase (GST), maltose binding protein (MBP), and the 
His6 peptide (Sheffield et al., 1999). Comparing within these three, MBP has 
the mildest eluting condition and the easiest operation procedure.
MBP is a periplasmic protein of E. Coli. The 40-kDa protein is encoded by 
the malE gene of E. coli K12 TB1 cells (Duplay et al., 1988). It has high 
affinity for maltose but will also bind other sugars (e.g. amylose) less 
strongly. Since 1988, MBP fusion plasmid has been shown to facilitate the 
expression and purification of foreign peptides in E. coli (Di Guan et al., 
1988). The fused proteins can be purified by one-step affinity 
chromatography on cross-linked amylose matrix. Bound fusion proteins can 
be eluted with 10 mM maltose in physiological buffer and maltose does not 
affect the native conformation of most proteins. The absence of detergent in 
the process would be expected to keep vesicles intact. In addition, MBP 
fusion protein can make the protein of interest considerably more soluble, 
preventing the formation of protein aggregates within the cells (Kapust and 
Waugh, 1999). Therefore, without chemical coupling, the fusion protein 
between MBP and Spa would be expected to be able to bind amylose resin 
at one end, and the GLUT4 antibody and then GLUT4 vesicles at the other
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end. The complex could be eluted from the amylose resin in 
maltose-containing buffer. Thus the eluted GLUT4 vesicles would be intact 
and biologically active (Fig 3.1).
G L U T 4  
A b  /
G L IT 4  vesicleAmylose
Maltose
f^Amylose^ ^
G L U T 4  
A b  /
G LU T4 vesicle
G L IJ T 4
Fig 3.1 Schematic representation of the proposed mechanism to isolate intact 
GLUT4 vesicles from post high-density microsome supernatant. A specific 
antibody binds to the GLUT4 molecules on the surface of the vesicle. The protein 
A component of the fusion protein binds to the constant region (Fc) of the antibody 
and the maltose-binding component (MBP) binds to the amylose resin. The 
complex can be eluted from the resin using excess maltose.
In 1995, Kobatake et al. produced a MBP-Spa fusion protein to immobilize 
antibodies for enzyme immunoassays (Kobatake et al., 1995). The Spa 
gene was excised from a plasmid using restriction enzymes and inserted 
into pMAL-C2 plasmid (New England Biolabs) which was designed for 
expression of an MBP fusion protein. The resulting fusion protein had a 
molecular weight of 65 kDa and demonstrated both efficient IgG binding 
activity and amylose binding activity. Protein A is a 58 kDa protein (Uhlen et 
al., 1984). Its gene sequence from N-terminus to C-terminus contains a 
signal sequence S, five highly homologous IgG-binding regions E, D, A, B
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and C, each binding to IgGs independently (Moks et al., 1986), and a 
C-terminal cell-wall-covalent-binding region X (Lindmark et al., 1977; Uhlen 
et al., 1984). Kobatake et al. excised the Spa gene from a plasmid and 
ensured three IgG binding domains were complete (Kobatake E et al., 
1990). They confirmed that the fusion protein had sufficient binding activity 
to the Fc region of IgG.
3.2 Cloning strategy
The aim of this chapter is to clone a maltose-binding protein-protein A fusion 
protein (MBP-Spa) using a modified version of the procedure described by 
Kobatake et al (1995). Two and a half IgG binding regions of Spa were 
cloned into the maltose-binding protein vector and the fusion protein was 
expressed in E.Coli. The differences from Kobatake et afs method are the 
proportion of the Spa gene used and the use of the pMBP-Parallel2 plasmid 
instead of pMAL-C2. The fragment of Spa used in the method described in 
this chapter was PCR-amplified from pAX11, a vector containing two and a 
half IgG binding regions in sequence (Zueco and Boyd, 1992). The plasmid 
pMBP-Parallel2 is based on pMAL-C2. They both contain the 
maltose-binding protein gene malEfollowed downstream by multiple cloning 
sites (MCS). The gene of interest can be inserted into the multiple cloning 
sites. Successful insertion inactivates the p-galactosidase activity of the 
malE-lacZa fusion. This leads to a blue to white color change on Xgal plates 
when the construction is transformed into an appropriate host. The fused 
gene is expressed using a strong Ptac promoter in the vector (Fig 3.2). In 
pMBP-Parallel2 there is a “Parallel” polylinker which replaces the original 
polylinker between malE and lacZa in pMAL-C2. This “Parallel” polylinker 
was mainly used for easy and direct comparisons of different affinity tags 















— [Maltose Binding Protein] eta I
G0G9GACTAATT0GAGCrCGAA(3lACAAiCAACAATAA(3lATAACAACAACCTCGGG !aTC GAT^  AOS ACC 
A Q T N S S E N N N N N N N N N N L G  l i e  A re  Thr Thr
Spacer Region
E%el Scol Ban HI Eco R1 Sfwl Safi
GAA AAC CTO TAT T IT  CAG (L c  GcJ ATG tlsA To!1 o k  ATT <kk AGG d r  Ack TOG us AGC JcA 
Glu A re  Leu T vr Phe Gin G lv A la  Met G ly Eer G ly  l i e  Gin Arg Pro Thr Ser Thr fie r Eer
rTEV Protease 
Cleavage Site J
Spel S o il Sip V Xbal Pstl Xho I Sph I Kpul Hind HI
<!ta gtc! i c o  GCC TC GAji IcT AgI  Oclr TOC A<Lt 'cTC GaI  Aci Lag c d  goc
Leu Val A la  A la  A la  Phe Glu Eer Arg A la  Cy» Ser Leu Glu A la  Cy* G ly Thr Lya Leu Gly
a c t  qgc cgt c g t t t t  aca acg tc g  *Non-umque sites
Thr G ly  Arg Arg Phe Thr Thr Eer
Fig 3.2 Characteristics of pMAL-C2 and pMBP-Parallel2. A: a schematic 
graph of pMAL-C2 (pMAL Protein Fusion and Purification System Instruction 
Manual, New England Biolabs). B: Multiple cloning sites of pMBP-Parallel2 
(Dr. S. Bagby, University of Bath).
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This fusion protein should be able to fulfill the requirements mentioned 
earlier and provides the foundation for the research carried out in Chapters 
4, 5, and 6. This method is a strong tool for intact intracellular vesicle 
isolation and can be widely used in other studies.
3.3 Results
3.3.1 Cloning of Maltose-Binding Protein-Protein A fusion protein
The preparation of MBP-Spa construct was done by a final year project 
student Katie Newens (University of Bath). The pAX11 plasmid was 
sequenced with M13 Uni primer which is located downstream of the Spa 
gene. The sequencing result confirmed the presence of two and half IgG 
binding regions by sequence alignment with the entire Staphylococcal 
protein A (Spa) gene obtained from the on-line EMBL nucleotide sequence 
database (http://www.ebi.ac.uk/embl/). To allow cloning of the Spa fragment 
into the MBP vector, the gene coding for a fragment of Spa was amplified 
from pAX11 (Fig 3.3). BamH\ and Spel were chosen as the restriction sites 
for insertion into pMBP-Parallel2. pAX11 did contain a Spel site in the MCS 
downstream of the Spa gene, but did not have a BamHI site upstream. 
Consequently the forward primer was designed to encompass the start of 
the Spa fragment together with a BamH\ site and reverse primer was M13 
Uni. The designed primer was:
5 '  -  GGG GGA TCC CCA AGC TTA AAA GAT GAC CC - 3 '








Tyr Arg Ala Arg lie Asn Ser... 
TAC CGA GCT CGA ATT AAT TCA..
Ala Asn Ser Arg Gly Thr Glu Phe Thr Ser Ala Cys Gly Ser Val Asp Leu Gin Pro 
GCC AAT TCCCGGGGT ACC GAA TTC ACT AGT GCA TGC GGA TCC GTC GAC CTG CAG CCG
Smal EcoRI Spel Sphl BamHI S a il  Ps t l
Fig 3.3 Structure of the pA X ll vector. The MCS is downstream of Spa gene.
Spel restriction site is in the MCS (Zueco and Boyd, 1992).
BamH\ and Spel were the chosen restriction enzymes for insertion of the 
fragment into pMBP-Parallel2 so that cohesive ends would be produced 
facilitating ligation. This choice of enzymes also allowed the Spa fragment to 
be kept in frame, and generated a stop codon shortly downstream of 
pMBP-Parallel2 by frame shift, ensuring that the transcription ceased soon 
after the fusion protein.
The Spel site in pMBP-Parallel2 is located downstream of maltose binding 
protein in the multiple cloning sites and cuts the DNA between two codons, 
thus maintaining the reading frame (Fig 3.4). However, the Spel site of 
pAX11 induced the enzyme to cut the DNA within a threonine codon, 
therefore when the Spa fragment is ligated into pMBP-Parallel2 it results in a
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frame shift mutation downstream of the Spel site in pMBP-Parallel2. This 
leads to the formation of stop codon shortly downstream (TAG) (Fig 3.4).
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pAXll multiple cloning sites:
5 ' -  AAT TCC CGG GGT ACC GAA TTC A [ CT AGT GCA TGC GGA TCC GTC GAC CTG
A s n  S e r  A r g  G ly  T h r  G lu  P h e  T h r  s e r  A la  C y s G ly  S e r  V a l  A sp  L eu
Smal Kpnl EcoRI S p e l SphI BamHl S a i l
CAG CCG
G in  P r o  
P s t l
p M B P - P a r a l l e 2 :
Maltose Binding protein
5 ' -ACT AAT TCG AGC TCG AAC AAC AAC AAC AAT AAC AAT AAC AAC AAC CTC
T N  S S  S N N  N N N  N N N  N N L
GGG ATC GAT ACG ACC GAA AAC CTG TAT TTT CAG GGC GCC ATG GGA TCC GGA
G ly  l i e  A s p  T h r  T h r  G lu  A s n  L eu  T v r  P h e  G in  G lv  A la  M et G ly  S e r  G ly
S p a c e r  R e g io n  EheI  Ncol BamHI EcoRI
ATT CAA AGG CCT ACG TCG ACG AGC T C A | CTA GTC GCG GCC GCT TTC GAA TCT
l i e  G in  A r g  P r o  T h r  S e r  T h r  S e r  S e r  L eu  V a l  A la  A la  A la  P h e  G lu  S e r
S t u I  S a i l  S e t  I  S p e l  No t l  N spV  X b a l
AGA GCC TGC AGT CTC GAG GCA TGC GGT ACC AAG CTT GGC ACT GGC CGT CGT
A r g  A l a  C y s  S e r  L eu  G lu  A la  C y s G ly  T h r  L y s  L eu  G ly  T h r  G ly  A r g  A r g
P e t l  Xhol SphI Kpnl H in d lll
TTT ACA ACG TCG - 3 '
P h e  T h r  T h r  S e r
F r a m e  s h i f t  i n  p M B P - P a r a l l e 2 :
5 '  -  ACT AGT CGC GGC CGC TTT CGA ATC AGC CTG CAG TCT CGA GGC ATG CGG 
T h r  S e r  A r g  G ly  A r g  P h e  A r g  l i e  S t o p  
S p e l  No tl NspV Xbal P s t l  Xhol SphI Kpnl
TAC CAA GCT TGG CAC TGG CCG TCG TTT TAC AAC GTC G - 3 '
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Fig 3.4 Sequence detail showing the cutting of pA X ll and pMBP-Parallel2 MCS 
and the resulting frame shift in pMBP-parallel2 after the Spa fragment insertion.
Restriction sites are shown in blue and pink. The restriction sites for Spa insertion in 
pMBP-paral!el2 are highlighted with yellow. Red line shows the cutting of Spel which 
caused frame shift. The DNA sequence of pMBP-Parallel2 after the frame shift is 
shown separately and the stop codon highlighted with red.
H in d lll
The Spa gene fragment was amplified using the designed primer and the 
forward universal M13 primer and the resulting fragment was purified on an 
agarose gel (Chapter 2, section 2.2.5.3). The purified gene fragment and the 
pMBP-Parallel2 plasmid were digested with Bamhl\ and Spel and 
appropriate bands purified from an agarose gel (Fig 3.5).
or/EP-Paralel2 digestior product 
1 2
d ges’.ed Spa PCR p'oduct ftoir pAX11
>NA Marker DNA Marker DNA Marker (bp)
Fig 3.5 DNA gel showing the pMBP-Parallel2 double digestion product 
(lanes 1, 2) and double digested Spa PCR product from pA X ll (lanes 3, 
4).
The digestion products of pMBP-Parallel2 and the Spa fragment were 
ligated to form a recombinant plasmid. As both the vector and insert were
digested with the same restriction endonucleases, the cohesive ends were 
joined with DNA ligase. As a back up the Spa fragment was also inserted 
into the blunt vector pT7 blue, this was ligated using T4 DNA ligase in a 
blunt ended cloning protocol (Novagen 70183). Both the recombinant 
plasmids were used to transform XL1 blue cells. White colonies were picked 
and the plasmid isolated with a mini-prep kit. Test digests of these plasmids 
with BamhH and Spel were performed to confirm the insertion of the Spa 
gene. These were run on an agarose gel. If the plasmids contained the 
insert, excision with these enzymes should yield the insert and show a 
fragment of 0.47 kbp (Fig 3.6).
Iigasion contro gstion product BamH\ SpeI test digest
DNA M aw DNA Mar*ef (bp)
Fig 3.6 DNA gel showing insertion of Spa into pMBP-Parallel2 and pT7 
blue vector. Plasmids were test digested with BamHl-Spel to check the insertion 
of Spa (arrow), if present. Lane 1 and 2 -  test digests of pT7 blue plasmids,
Lanes 3-5 -  test digests of pMBP-Parallel2 plasmids. Lane 5 showed a 
successful ligation of pMBP-Parallel2 and Spa gene.
By comparing the band size of the digested MBP plasmid with the control, a 
plasmid containing the insert was identified. This was sequenced to confirm 
that the fragment contained the protein A gene (Fig 3.7).
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pB R 322 ori
5 ' -CAGGGCGCCATGGATCCCCAAGCTTAAAAGATGACCCAAGCCAAAGTGCTAACCTATTGTCAGA 
AGCTAAAAAGTTAAATGAATCTCAAGCACCGAAAGCGGATAACAAATTCAA








IgG  b i n d i n g  r e g i o n  C ( c o m p l e t e )
AATTGGCCAAT TCC CGG GGT ACC GAA TTC ACT AGT CGC GGC CGC TTT CGA A 
S t a r t  o f  MCS Small1 K p n l1 EcoRI1 Spel1,2 No tl2 NspV2
( f r a m e  s h i f t  m u t a t i o n )
AGC CTG CAG TCT CGA GGC ATG CGG TAC CAA GCT T
Xbal2 Pstl Xhol2 SphI2 Kpnl2 H in d i 112
GGCACTGGCCGTCGTTT -  3 '
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Fig 3.7 Map of pMBP-Spa and sequence detail of Spa gene. Sequencing shows a 
successful insertion of Spa gene in the MCS downstream of MBP gene MalE. A half 
of IgG binding region and two complete regions are seen, identified as A, B and C. 
Multiple cloning sites (MCS) downstream of Spa gene are shown in black and pink.
Frame shift mutation is labeled and stop codon highlighted with red. Restriction sites 1 
were from pAXl 1 and 2 from pMBP-Parallel2.
The above figure shows the presence of two and half IgG binding domains. 
These binding regions were identified as A, B and C, the last two and half 
IgG binding regions of the natural Spa gene. The molecular weight of the 
fusion protein was calculated by using the Spa fragment sequence shown in 
Fig 3.7 and the sequence of MalE in pMAL-C2 (New England Biolabs 
website: www.neb.com). The molecular weight was calculated to be 61.07 
kDa.
3.3.2 Expression of Maltose-Binding Protein-Protein A and tests on 
GLUT4 vesicle isolation
E. Coli K12 TB1 cells were transformed with the plasmid pMBP-Spa and the 
fusion protein expressed by induction with IPTG (Chapter 2, section
2.2.5.9). During growth of the cells, glucose in the growth medium was 
necessary to repress the maltose genes on the chromosome of the E. Coli 
host. The cells were sonicated to release the protein. To show that protein 
expression was induced with the IPTG, samples of culture were collected 
during this process and western blotted with rabbit IgG - peroxidase 
conjugate (Fig 3.8 A). The IgG detection of bands in appropriate position (62 
kDa) proved that the Spa portion of the fusion protein was functional. The 
band before IPTG induction was barely visible but after IPTG induction was 
very strong, showing the proper expression of MBP-Spa. In the cell lysate, 
most of the MBP-Spa appeared in the supernatant after centrifugation at 
9000 p for 30 min (Chapter 2, section 2.2.5.10), indicating the fusion protein 
had good cellular solubility. The supernatant of the bacterial lysate was used
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as such for various immuno-precipitation procedures. The initial tests 
showed that after binding the MBP-Spa product to amylose resin, 20 mM 
maltose successfully eluted over 80 % of the total MBP-Spa protein bound 
on the amylose resin in the first 3 fractions (E1-E3). Less than 15 % of 
MBP-Spa was left on the beads (Fig 3.8 B). The bacterial lysate supernatant 
was routinely kept for 6 months stored in aliquots in -80 °C without a drop in 
the binding capacity of the protein.
SN Pellet
B . MS FT WL El E2 E3 E4 E5 beads
MBpspa
Fig 3.8 Western blot with Anti-rabbit IgG showing the characteristics of 
MBP-Spa. (A) Expression of MBP-Spa. Af: cell lysate after IPTG induction. Bf: 
cell lysate before IPTG induction. SN: supernatant from bacterial lysate after 
centrifugation. Pellet: pellet from bacterial lysate after centrifugation. (B) Amylose 
resin binding and maltose elution of MBP-Spa. 1 aliquot (500 pi) of MBP-Spa 
lysate supernatant was used for 0.7 ml amylose resin. MS: MBP-Spa before 
binding. FT: flow through after binding. WL: the last wash of the amylose resin. 
E1-E5: maltose elution 1-5. Beads: protein left on the beads.
The initial test on GLUT4 vesicle isolation was done using 500 pi MBP-Spa, 
0.7 ml amylose resin, and 100 pg anti GLUT4 Ab to immuno-precipitate the 
GLUT4 vesicles from the post density microsome supernatant (pHDM SN) 
from 2 ml of 40 % basal adipocytes (Fig 3.9). MBP-Spa was first bound to 
amylose resin overnight, then incubated for an additional 2 hours with the 
anti GLUT4 Ab. The amylose resin - (MBP-Spa) - anti GLUT4 complex was
92
then incubated with pHDM SN. The MBP-Spa-(anti GLUT4 Ab)-GLUT4 
vesicle complexes were then eluted with 20 mM maltose under gravity. It 
was found that 70 % of GLUT4 from pHDM SN bound to amylose resin, of 
which 60 - 70 % was eluted by maltose. Noticeably the eluted MBP-Spa was 
70 % too. The GLUT4 was mostly concentrated in elution fractions 1 and 2, 
but in some tests it was fractions 2 and 3 that obtained the bulk of the 
GLUT4 vesicles. In the most concentrated fraction (E2 in Fig 3.9), the 
v-SNARE VAMP2 could be detected, which indicated that intact GLUT4 
vesicles were precipitated and these vesicles kept their functional protein for 
membrane fusion. In addition, because VAMP2 is a feature protein for 
GLUT4 storage vesicles (GSV) (Larance et al., 2005), it meant that these 
vesicles belonged to GSV, a population of the intracellular GLUT4 
compartment that is most ready for insulin-stimulated translocation.
rm Hi firm (TV Amvlncp rpcin -L  T TT4 A h A n H n M  QM
MBP-Sp
GLUT
Fig 3.9 Initial test on GLUT4 vesicle isolation with MBP-Spa and amylose resin: 
western blotted with sheep anti C-term GLUT4 Ab and mouse anti VAMP2 Ab.
pHDM: post high density microsome supernatant. FT: the flow through after 
immuno-precipitation. W l: the first wash. E1-E6: 20 mM maltose elution fractions 
1-6. Beads: protein left on the amylose resin after elution.
pHDM FT Wl El E2 E3 E4 E5 E6 Beads
VAMP
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Although intact GLUT4 vesicles were purified in the above test, the 
efficiency was not satisfying. As high as 30 % of the total bound GLUT4 was 
left on the beads after elution. To increase the eluting efficiency, the 
influencing factors were analysed and a few approaches were tried.
As the MBP-Spa used was in cell lysate, which contained a lot of other 
bacterial soluble proteins, those proteins might affect the bindings and bring 
in non-specific interactions. To get rid of some of the impurities, high salt 
was included when MBP-Spa lysate was incubated with amylose resin. 0.5 
M NaCI was added to the protein-resin mixture and after incubation the resin 
was washed with 1 M NaCI. To maximize the elution, maltose 
concentrations were doubled to 40 mM and the resin was incubated with the 
elution buffer for 10 min before collecting the elution fractions. The amylase 
expressed in E. Coli host which stayed in the lysate could degrade the 
amylose on the affinity resin (Riggs, 2000). Degradation of the MBP-Spa 
protein was observed during the isolation procedure too (Fig 3.9 samples 
“FT”, “W1”). To prevent amylose degradation 120 U of a-Amylase inhibitor 
from Triticum aestivum (wheat seed) was added in the procedure. All
together these optimizations were marked as condition© (Fig 3.10). It
showed that about 80 - 85 % of the total bound GLUT4 was eluted in the 1st 
and 2nd fractions.
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Condition©: Amylose resin + MBP-Spa->GLUT4 Ab->pHDM SN
+ -  MBP-Spa 
<«— GLUT4
Fig 3.10 Condition© optimized GLUT4 vesicles isolation western blotted with
sheep anti C-term GLUT4 Ab. pHDM: post high-density microsome supernatant 
before incubated with column. FT: post high-density microsome supernatant after 
incubated with column. E1-E3: 40 mM maltose elution, before El maltose was 
incubated with column for 10 min. Beads: protein left on the resin after elution.
pH DM FT El E2 E3 Beads
In the multi-step immuno-precipitations there are different options for the 
precipitation order. These options sometimes result in different precipitation 
efficiencies. To maximize the precipitation, different orders were tried in this 
assay. As the MBP-Spa was not purified in this assay, there was only 1 
other option to change the precipitation order: react GLUT4 vesicles with 
anti GLUT4 antibody first, then precipitate with MBP-Spa pre-bound to
amylose resin (condition©). Post HDM supernatant was incubated with anti
GLUT4 Ab for more than 2 h and then precipitated with MBP-Spa prebound 
amylose resin. The whole complex was eluted with 40 mM maltose (Fig 
3.11). There was above 80 % of the total bound GLUT4 eluted in the first 
and second fractions.
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Condition®: pHDM SN + anti GLUT4 Ab -> MBP-Spa prebound amylose 
pHDM FT El E2 E3 Beads
MBP-Spa 
<«—GLUT
Fig 3.11 Condition® optimized GLUT4 vesicles isolation western
blotted with sheep anti C-term GLUT4 Ab. pHDM: post high-density 
microsome supernatant before incubated with column. FT: post high-density 
microsome supernatant after incubated with column. E1-E3: 40 mM maltose 
elution, before El maltose was incubated with column for 10 min. Beads:
n ro te in  le f t  on  th e  res in  a f te r  e lu tio n
3.3.3 Cloning of Maltose-Binding Protein-Protein A-Poly His fusion protein
An MBP-Spa-His construct was made to be able to further purify the 
maltose-binding protein. This was mainly aimed to try the different 
precipitation orders, quantify the MBP-Spa, and to find out the optimal 
procedure for GLUT4 vesicle isolation.
The construct was made by tagging the existing MBP-Spa fusion protein 
with a Poly-His tag. It was convenient to clone a Poly-His sequence between 
two restriction enzyme sites in the multiple cloning sites downstream of Spa 
(Fig 3.4). A/ofl and Xhol were selected as cloning sites and the Poly-His 
sequence was designed as an oligonuleotide. As in the original sequence 
between Not\ and Xhol there was a stop codon which would be eliminated 
due to the cloning, it was necessary to include a stop codon at the end of the 
insert. A pair of oligonucleotides was originally designed to include poly-His 
sequence followed by a stop codon and No1\-Xhol restrictions sites as sticky 
ends but this was found to be not successful in the cloning. The 2nd
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approach for the oligonucleotide construct was still to keep the sequence, 
but instead the Xhol site was destroyed by changing the starting “C” to “G” 
(Fig 3.12). The 2nd oligonucleotide would still directly replace the sequence 
in between the No1\-Xho\ in the original plasmid, but after ligation there 
would not be an Xhol site. The designed oligonucleotides are shown in Fig 
3.12.
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O r i g i n a l  o l i g o n u c l e o t i d e :
H i s  f o r :  5 ' -  GGC CGC CAC CAC CAC CAC CAC CAC TGA C - 3 '
Not I P o l y - H i s s t o p  X h o l
H i s  r e v :  5 ' -  TC GAG TCA GTG GTG GTG GTG GTG GTG GTG GC -  3 '
X h o l s t o p P o l y - H i s No tl
2 nd o l i g o n u c l e o t i d e :
H i s  f o r :  5 ' -  GGC CGC CAC CAC CAC CAC CAC CAC TGA G - 3 '
Notl P o l y - H i s s t o p
H i s  r e v :  5 ' -  TC GAC TCA GTG GTG GTG GTG GTG GTG GTG GC -  3 '
s t o p P o l y - H i s W ot I
M u l t i p l e  c l o n i n g  s i t e s :
5 '  -  ACT AGT CGC GGC CGC TTT CGA ATC TAG AGC CTG CAG TCT CGA GGC ATG
T h r  S e r  A r g  G ly  A r g  P h e  A r g  l i e  S t o p
S p e l  N o t l  N spV  X b a l P s t l  X h o l S p h I
CGG TAC CAA GCT TGG CAC TGG CCG TCG TTT TAC AAC GTC G -  3 '
Kpnl H in d lll
Fig 3.12 Sequence detail of the designed His-tag oligonucleotides and the multiple 
cloning sites. Restriction sites Notl and Xhol in designed oligonuleotides and multiple 
cloning sites were shown in blue and green. The corresponding sequence in the multiple 
cloning sites which would be substituted by the oligonucleotide was highlighted with
yellow. Stop codons in both oligonucleotides and multiple cloning sites were labelled in
red. The 2nd oligonuleotide destroyed the Xhol site.
Firstly the attempt of doing Xho\-No1\ double digestion of pMBP-Spa was 
tried but it was not successful (data not shown). Then the double digestion 
was realized through two sequential single digestions. The pMBP-Spa 
plasmid was digested with Xho\ and the linearized DNA was purified on an 
agarose gel. The extracted DNA was then digested with A/ofl and purified to 
obtain a double digestion product, which exposed the A/ofl and Xhol sticky 
ends (Fig 3.13 A, B). The His forward and His reverse oligonuleotides were 
paired to form an insert ready for ligation. The digestion product of 
pMBP-Spa and the insert fragment were ligated in the presence of Xbal 
restriction endonuclease. The Xbal site was between Not\ and Xhol in the 
original vector, so the Xbal enzyme prevented the religation of any
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contaminating insert, if any was present. As a control, the insert was 
replaced by nuclease-free H20 . The ligation products were transformed into 
XL1 blue or TB1 cells and plasmids were purified with mini-prep kit. Test 
digests on these plasmids were carried out with an Xba\ single digest and a 
BamH'\-Spe‘\ double digest (Fig 3.13 C). Xba\ was used to confirm the 
successful insertion of the Poly-His insert. The BamH\-Spe\ double digest 
was to make sure the 0.47 kbp Spa fragment was not affected. The 
plasmids which showed both negative Xba\ cleavage and positive 
BamH\-Spe\ cleavage were sent for sequencing.
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Fig 3.13 DNA gel showing the cloning of pMBP-Spa-His. (A): pMBP-Spa single digested 
with Xhol. Uncut plasmid showed that intact plasmid formed a supercoil (low arrow). Xhol 
single digestion showed linearized plasmid which had a bigger secondary structure (high 
arrow). (B): Xhol single digestion product digested with Notl, to realize the double 
digestion. 1 showed the uncut plasmid was intact and formed a supercoil (low arrow). 2-6 
showed the double digestion product was linearized and had a bigger secondary structure 
(high arrow). (C): mini-prep-purified plasmids tested with Xbal single digest and 
BamHl-Spel double digest. Plasmids 1, 3, 4 showed positive BamHl-Spel double digest, 
resulting a 0.47 kbp Spa fragment (arrow). Plasmids 1, 4 showed a negative Xbal single 
digest.
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The sequencing result clearly showed a successful cloning of Poly-His 
followed by a stop codon downstream of Spa (Fig 3.14). There were 6 
“CAC”s followed by the stop code “TGA”. After “TGA” there was a “G” as 
designed in the oligonuleotide rather than “C” in the original plasmid. This 
single nucleotide destroyed the Xho\ site but did not affect the expression of 
MBP-Spa-His. The molecular weight of the protein did not change.











5 ' -ATTGGCCAAT TCC CGG GGT ACC GAA TTC 
S t a r t  o f  MCS Small Kpnl EcoRl 
ACT AGT CGC GGC CGC CAC CAC CAC CAC CAC CAC 9 K  GTC GAG GCA - 3 '  
Spel Notl P o l y - H i s  s t o p
Fig 3.14 Map and Sequence detail to show the successful cloning of 
pMBP-Spa-His. Poly-His was downstream of Spa gene, starting from Notl 
restriction site in MCS. Stop codon was highlight with red. The nucleotide ‘G ’ 
designed in the oligonuleotide was highlighted with yellow, and it destroyed the 
Xhol site after the stop codon. The sequencing primers used were MalE.
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3.3.4 Expression of Maltose-Binding Protein-Protein A-Poly His fusion 
protein (MBP-Spa-His) and Purification by Ni-NTA His-Bind Resin
The Maltose-Binding Protein-Protein A-Poly His fusion protein construct 
(MBP-Spa-His) was transformed and expressed in the same way as 
MBP-Spa (Chapter 2, section 2.2.5.9). The cell lysate supernatant was 
further purified with Ni-NTA His-Bind Resin (Novagen) (Chapter 2, section
2.2.5.10). The MBP-Spa was used in parallel as a control (Fig 3.15). 
Comparing the bacterial lysate supernatant and pellet from MBP-Spa-His 
with the ones from MBP-Spa, the expression was confirmed to be normal. 
The lysate supernatants were then incubated with Ni-NTA His-Bind Resin. 
To find out the binding capacity of the resin, 50 or 100 pi of 50 pg/ml 
MBP-Spa-His were incubated with constant amount of resin (30 pi) (Fig 
3.15). The Coomassie blue stained gel result confirmed that at least 100 pi 
MBP-Spa-His could bind to 30 pi of beads. As expected, MBP-Spa did not 
bind to the resin at all. This purification was scaled up to produce larger 
amount of protein. The elution was collected and dialysed against column 
buffer to remove the imidazole. The purified protein was concentrated down 
to 1.8 mg/ml and was then ready for further tests.
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MS lysate MSH lysate FT elution
SN P SN P MS MSH1 MSH2 MS MSH1 MSH2
 MBP-Spa or
MBP-Spa-His
Fig 3.15 Protein gei stained with Coomassie blue stain showing the purification of 
MBP-Spa-His with Ni-NTA His-Bind Resin. Both MBP-Spa (MS) and MBP-Spa-His 
(MSH) expression was checked in lysate supernatant (SN) and pellet (P). Supernatant was 
incubated with Ni-NTA His-Bind Resin for 1 h. Flow through (FT) was checked for protein 
left after the binding to the resin. Protein bound on the resin was eluted with 250 mM 
imidazole. 30 pi of resin, 50 pi of MS supernatant, 50 pi (MSH1) or 100 pi (MSH2) of MSH 
supernatant were used for the purification.
3.3.5 Optimization of the GLUT4 vesicle isolation by MBP-Spa-His
As the un-purified MBP-Spa had to be bound to amylose to purify it this 
limited the attempts to optimise the GLUT4 isolation procedure. The purified 
MBP-Spa-His enabled the quantification of the protein and provided more 
options for carrying out the procedure.
To keep it simple, the initial tests were on MBP-Spa-His, anti GLUT4 
antibody only and amylose resin, but GLUT4 isolation was not involved. First 
the purified MBP-Spa-His was pre-mixed with GLUT4 antibody to form a 
complex, and then the complex was incubated with amylose resin. It was 
found that if amylose resin was kept at 0.7 ml and the antibody amount at 
100 pg (667 pmols), then 48 pg MBP-Spa-His (800 pmols) was enough to 
bind all the antibody molecules. The binding capacity of amylose resin 
provided by the manufacturer (New England Biolabs) was 3.0 mg MBP/ml 
bed volume. According to the binding capacity, 0.7 ml resin was in large
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excess over the 48 |jg of MBP-Spa-His. To find the optimal amount of 
amylose resin, a range of the resin amounts were tested. In the tests 
antibody was scaled down to 37 pg and MBP-Spa-His to 18 pg, for the 
purpose of saving antibody. 10 pi, 35 pi, 100 pi and 200 pi of amylose resin 
were tried to bind with MBP-Spa-His-(anti GLUT4 Ab) complex, and the
complex was eluted with 40 mM maltose (condition®, Fig 3.16). This test
showed that 10 pi of amylose resin was able to bind all the complexes. 
However, little was found in the elution. In addition, the small amount of 
resin was hard to manipulate in the experiment procedure. From the sample 
using 35 pi of resin, 55 % of the total bound protein was eluted in the first 
elution and from the samples of 100 and 200 pi resin 80 % was eluted. This 
80 % eluting efficiency was consistent with the MBP-Spa results (section 
3.3.2). When this approach, using 200 pi resin and MBP-Spa-His-GLUT4 Ab 
complex, was used to isolate GLUT4 vesicles from pHDM supernatant
(condition® Fig 3.17), 74 % of the total bound GLUT4 was eluted in the first 
and second elution fractions. It was slightly better than condition® but not 
as good as condition®.
From the above result and the results from section 3.3.2, it was noticeable 
that after elution, there were always some proteins left on the resin, which 
could not be eluted. In other words, these proteins bound to the resin 
irreversibly. In theory, if the eluted proteins rebound to the resin, these 
proteins should be 100 % elutable. So, an idea of purifying the MBP-Spa on 
an amylose resin for a first time and then rebinding the eluted proteins to a 
new resin sample was tried. To rebind protein to new amylose resin, the 
maltose used in the first elution must be removed. Dialysis did not work to 
remove maltose from maltose-binding protein. This is a general 
phenomenon of protein/ligand interactions: after the free ligand is gone, 
ligand that is released from the binding site usually finds another binding site
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before it encounters the dialysis membrane (Silhavy et al., 1975). Maltose 
could be removed by extensive washes. To do the extensive washes the 
protein needs to be bound to a solid matrix. MBP-Spa-His was first bound to 
amylose resin and eluted with maltose. Eluted MBP-Spa-His was rebound to 
Ni-NTA His Bind Resin and extensively washed to remove maltose. The 
protein was eluted from His-Bind Resin with imidazole, dialyzed to get rid of 
the imidazole and rebound to a new lot of amylose resin. The protein did not 
show proper rebinding to the amylose resin (data not shown). It might be 
because the washing was not good enough to remove the maltose. Maltose 
was still bound to MBP-Spa-His to some extent and it interfered with the 
second round of binding.
C o n d itio n (7): M R P-Sna-H is •+■ GT.TJT4Ah am vlose  resin
Complex Beads El E2 E3 E4 E5 E6 









Fig 3.16 Test of the MBP-Spa-His-anti GLUT4 Ab complex test on different 
amounts of amylose resin. 10, 35, 100, 200 pi were the volumes of the resin used. 
Complex was formed by pre-mixing MBP-Spa-His and anti GLUT4 Ab. Complex Bf, 
Af: complex before or after binding with amylose resin. Beads: amylose resin. Beads 
Bf, Af: amylose resin before and after elution. E1-E6: 40 mM maltose elution 1 to 6.
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Condition©: MBP-Spa-His + GLUT4 Ab -> Amylose resin -> pHDM SN
pHDMFT W1 WL El E2 E3 E4 Beads
GLUT4
Fig 3.17 GLUT4 vesicle isolation with MBP-Spa-His-anti GLUT4 Ab 
complex and amylose resin. pHDM: post high-density microsome 
supernatant before incubated with column. FT: post high-density microsome 
supernatant after incubated with column. W l: the first wash. WL: the last 
wash. E1-E4: 40 mM maltose elution, before El maltose was incubated with 
column for 10 min. Beads: protein left on the resin after elution.
3.3.6 GLUT4 vesicles intactness and biological activity
The purified GLUT4 vesicles were expected to be intact and biologically 
active.
To test the intactness and biological activity of the GLUT4 vesicles, an 
acridine orange uptake assay (Warnock et al., 1982) was used but did not 
show successful results. However, the bioactivity was proved in the 
experiments in Chapter 4.
3.4 Discussion and Conclusion
This chapter showed a successful method to immuno-isolate intact 
intracellular vesicles. It was the first time maltose binding protein-protein A 
fusion protein and antibody were used to specifically purify a certain type of 
vesicles from cell fractions. The purified vesicles were proved to be intact.
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GLUT4 vesicles were isolated from other microsomal vesicles with GLUT4 
antibody and maltose-binding protein-protein A fusion protein (MBP-Spa or 
MBP-Spa-His). The 61 kDa fusion protein could be easily expressed in E. 
Coli using a recombinant plasmid containing the maltose-binding protein 
gene MalE, directly followed by two and half IgG binding region of Spa, with 
or without a tag of Poly-His. The expressed protein had good cellular 
solubility. MBP-Spa-His could be easily purified by Ni-NTA His Bind Resin.
MBP tag provides advantages over other tags such as GST, poly-His: 1) It 
does not require additional manipulation such as dialysis of the elution 
product. 2) It does not involve the use of detergents or other denaturing 
agents. These advantages keep the purification procedure easy and mild, 
providing a basis for further experiments carried out on the elution product.
To maximize the GLUT4 vesicle purification efficacy, both MBP-Spa and 
MBP-Spa-His were tested in different conditions. The consensus of the best 
condition was: incubate MBP-Spa with amylose resin in the presence of 
amylase inhibitor and 0.5 M NaCI -> wash the resin with 1 M NaCI then 
normal wash -> incubate GLUT4 Ab with amylose resin -> wash -> incubate 
pHDM supernatant with resin in the presence of amylase inhibitor -> wash 
-> incubate resin with 40 mM maltose for 10 min -> collect the first fraction,
then elute the following fractions by gravity (condition®, Chapter 2, section
2.2.1.5). This procedure was a combination of reduction in non-specific 
binding, inhibition of amylase, and maximization of the elution
MBP’s affinity for amylose resin and maltose depends on hydrogen bonds, 
which in turn are positioned by the three-dimensional structure of the 
protein. The addition of Spa or Spa-His to MBP might have in some way 
changed the fusion protein’s configuration and consequently affected its 
binding property, which may explain the irreversible binding that happened
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in the isolation procedure. Another possibility is that the material that 
remains bound is non-vesicular and more easily trapped in the column 
matrix. Unfortunately the purified MBP-Spa-His did not dramatically improve 
the GLUT4 isolation efficiency, but the construct can be used in the future if 
any experiments need purified MBP-Spa-His particularly.
To conclude, the intact and active GLUT4 vesicles provided by this 
procedure would be useful for studies elucidating the various proteins and 
interactions involved in GLUT4 translocation. This procedure could also be 
flexibly employed in studies about other important intracellular vesicles.
108
Chapter 4 Fusion using plasma membrane 
protein-reconstituted liposomes and immuno-isolated 
GLUT4 vesicles
4.1 Introduction
Insulin action on peripheral tissues including fat, heart and skeletal muscle 
leads to increased translocation of GLUT4-storage vesicles (GSV) from an 
intracellular reservoir compartment to the plasma membrane, which 
ultimately results in exposure of the GLUT4 at the cell surface where it 
facilitates glucose transport. There are two aspects to clarify in this event: 1) 
how is insulin signalling acting on GSV movement towards the plasma 
membrane; 2) how are GSVs fusing with the plasma membrane.
Although the early steps in insulin signalling have been identified and it is 
now well accepted that PI 3-kinase and Akt are involved in this process (Bae 
et al., 2003; Czech and Corvera, 1999; Holman and Kasuga, 1997; Jiang et 
al., 2003), the downstream mediators leading to GLUT4 trafficking have 
been difficult to identify. There are some candidates for insulin regulated Akt 
substrates such as AS160, PIKfyve and synip (section 1.3.3.A) (Berwick et 
al., 2004; Goncharova et al., 2004; Gridley et al., 2005; Sano et al., 2003), 
but studies on how they function on GSV and eventually GSV translocation 
are incomplete. So far, the site of insulin action along the exocytic pathway 
is unknown. Potentially it could involve increased release or budding of 
vesicles from tubulo-vesicular structures (Karylowski et al., 2004; Watson et 
al., 2004a), increased movements of vesicles along microtubules (Bose et 
al., 2002; Semiz et al., 2003), increased transit through cortical actin near 
the cell surface (Chunqiu and Pessin, 2003; Tong et al., 2001) or an 
increased fusion of the vesicles with the plasma membrane.
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Like the various fusion events in organisms, GSV fusion with plasma 
membrane could be a complicated process. It was found that insulin 
increased docking and then fusion of vesicles at the plasma membrane 
(Bose et al., 2004; Bryant et al., 2002; Satoh et al., 1993). But how insulin 
stimulation incorporates other determining factors is under investigation.
Cell free reconstitution of vesicle fusion reactions have many advantages for 
studying cell biology processes, as the separate components on the fusion 
reaction can be separately manipulated and combined. This approach has 
been very powerfully pioneered and applied to the study of intracellular 
vesicles homotypic and heterotypic membrane fusion (Beckers et al., 1989; 
Rothman and Sollner, 1997) but the application to the fusion of intracellular 
vesicles with the limiting plasma membrane has been more difficult to 
achieve (Avery et al., 1999). To further the resolution of the key insulin 
regulated step, an in vitro fusion reaction has been developed in which 
GLUT4 vesicles are immuno-isolated and fused with reconstituted plasma 
membrane in the presence of cell cytoplasm. This delicate system was 
developed by Dr. Francoise Koumanov (University of Bath) and the results 
described in this chapter were in collaboration with her. This assay allowed 
direct analysis of the parameters which functioned in the insulin-stimulated 
fusion.
4.2 In vitro fusion assay design and description
Although membrane fusion can be studied by the lipid mixing approach, it is 
best studied in assays in which vesicle content mixing occurs (Schuette et 
al., 2004; Weber et al., 1998). This is because lipid mixing can occur 
between docked and hemi-fused lipid. Only full fusion results in content 
mixing. To detect content mixing in the fusion reaction, biotin-streptavidin
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technology was employed and TR-FRET was used to detect a fusion 
complex between a FRET pair that was formed in the fusion reaction (Fig 
4.1). Therefore it was necessary to introduce the FRET pair into separate 
vesicles during their preparation. The FRET pair was consisted of 
Biotin-Europium(TMT) (donor) and DyLight647-streptavidin (acceptor) (Fig
4.1 A). When Biotin-Europium(TMT) was excited at 340 nm wavelength, the 
energy transfer from Biotin-Europium(TMT) (donor) to 
DyLight647-streptavidin (acceptor) caused an emission at 670 nm. This 
energy transfer was TR-FRET and it required certain proximity. The 
interaction of biotin and streptavidin provided a proper proximity to allow this 
reaction to proceed. The procedure involved the separate preparation of 
GLUT4 vesicles containing DyLight647-streptavidin, plasma membrane 
liposomes encapsulating Biotin-Europium(TMT), and also cell cytosol from 
rat adipocytes that were either in the basal state or in an insulin-stimulated 
state.
in









♦ Cytosol, ♦ Biocytin, 37 #C
Triton lysis
*  Ex: 340 nm
1
GP15 Biotin Eu(TMT)
Fig 4.1 In vitro fusion of GLUT4 vesicles with reconstituted plasma membrane. A,
In the fusion assay GLUT4 vesicles containing DyLight streptavidin-tagged GLUT4 
were mixed with PM liposomes containing biotinylated Eu(TMT) in the presence of 
cytosol. The transmembrane GLUT4 is shown as the green symbol; the tetrameric 
streptavidin is shown as the multisite red symbol; the Biotin-Eu(TMT) is shown as the 
yellow symbol. To terminate the fusion reaction, TritonX-100 was added. The 
solubilised samples were then analysed for the presence of a 
GLUT4-streptavidin-DyLight647-Biotin-Eu-TMT complex by TR-FRET (with 
excitation at 340 nm and emission at 670 nm). No FRET occurs from the unreacted 
Biotin-Eu(TMT). B, Structures of the GP15 used to biotin tag GLUT4 and the 
Biotin-Eu(TMT) complex that was incorporated into the PM liposomes.
In order to isolate and then harvest GLUT4 vesicles in a functional state, 
Maltose-Binding-Protein/Protein A (MBP-Spa) was expressed and utilised in 
an immuno-precipitation assay (Chapter 3). The maltose elution of vesicles 
would keep the vesicles intact and not damage the vesicle content. To 
encapsulate the DyLight647-streptavidin molecules, GLUT4 was initially 
tagged at the cell surface with the biotin photoaffinity label GP15 (Fig 4.1 B) 
(section 2.2.2) and DyLight647-streptavidin, and then internalized. Post 
HDM supernatant from homogenised cells was then applied directly to an 
amylose resin column to which a MBP-Spa recombinant protein and an
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anti-GLUT4 antibody had been prebound. GLUT4 vesicles were then eluted 
with maltose (Chapter 3 section 3.3.2 and Chapter 2 section 2.2.1.5).
It was found that plasma membrane alone could not be induced to 
encapsulate ligands. Therefore an approach that involved reconstitution of 
plasma membrane in phospholipid liposomes was employed (Kono, 1983; 
Schurmann et al., 1989; Suzuki and Kono, 1980). The 
Biotin-Europium(TMT) ligand (Fig 4.1) was incorporated into the plasma 
membrane liposomes at the reconstitution stage (Chapter 2 section 2.2.6.1). 
Before the fusion assay, the PM liposomes were purified by flotation on 
Histodenz gradients (Weber et al., 1998).
This novel approach to the study of the heterotypic fusion of intracellular 
vesicles with reconstituted plasma membrane is also likely to be a generally 
applicable technique. The cell free approach is particularly powerful in 
studying insulin regulated fusion as separate mixing of vesicles containing 
insulin-activated and non-activated components is feasible. With this 
approach it was attempted to distinguish whether insulin action leads to 
activation of GLUT4 vesicles, activation of components of the cytoplasm 
fraction or activation of components of the plasma membrane fraction.
4.3 Results
4.3.1 Characterizations of the different components of the fusion reaction
To check that the prepared PM liposomes and GLUT4 vesicles indeed 
contained the required proteins that compose those compartments, samples 
through the preparation steps were run on protein electrophoresis and 
different western blots were carried out. It was found that 70 % of the 
GLUT4 from intracellular membrane fractions from rat adipocytes bound to 
the amylose column in the immuno-precipitation, and of this 80 - 85 % could
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be released with maltose using the optimized procedure in Chapter 3 (Fig 
3.10). The vesicles were intact and contained specific v-SNARE protein 
VAMP2 (Fig 3.9). VAMP2 indicated that the population belonged to GSV. To 
answer the question whether GLUT1 was also present in the population of 
immuno-isolated GLUT4 vesicles, the same samples were western blotted 
with anti-GLUT1 antibody but the protein could not be detected in the 
samples containing the immuno-isolated GLUT4 vesicles (Fig 4.2).
pHDM FT Wl El E2 E3 E4 E5 E6 Beads
GLUT1
Fig 4.2 Samples from GLUT4 vesicle isolation with MBP-Spa and 
amylose resin western blotted with mouse anti C-term GLUT1 Ab.
pHDM: post high density microsome supernatant. FT: the flow through 
after immuno-precipitation. W l: the first wash. E1-E6: 40 mM maltose 
elution fractions 1-6. Beads: protein left on the amylose resin after 
elution.
From the test on reconstituted liposomes before and after density-gradient 
spin purification, it was found that 80 % of plasma membrane GLUT4 was 
recovered in the purified liposomes. The t-SNARE proteins were also 
detected, respectively 80 % of syntaxin4 and 60 % of SNAP23 were 
maintained (Fig 4.3). The GLUT4 level in the membranes from insulin 
treated cells was higher than basal but the levels of recovered syntaxin4 and 
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Fig 4.3 Western blots showing important proteins in plasma 
membranes (PM) and PM liposomes. PM from basal (B) and 
insulin treated (Ins) adipose cells were reconstituted into 
phosphatidylcholine liposomes (PM liposomes) and the recoveries of 
GLUT4, and the t-SNAREs Syntaxin4 and SNAP23 were 
determined with rabbit anti GLUT4 Ab, rabbit anti Syntaxin 4 Ab, 
rabbit anti SNAP23 Ab.
4.3.2 Determination of the incorporation extent of the fluorescent probes
For the TR-FRET pair Biotin-Eu(TMT) (donor) and DyLight647-streptavidin 
(acceptor), the preliminary experiments showed that a donor: acceptor ratio 
of 10-15:1 gave the best TR-FRET signal/background (not shown). To track 
and ensure this ratio, the signals for both Biotin-Eu(TMT) (donor) and 
DyLight647-streptavidin (acceptor) were measured and recorded in the 
process of GLUT4 vesicles and PM liposomes preparation in every fusion 
experiment. Tables 4.1 and 4.2 below demonstrate standard measurements 
for PM liposomes and GLUT4 vesicles in one example of fusion assay.
Table 4.1 PM liposomes biotin-Europium(TMT) signal measurement. The signal measured 
in the liposomes preparations was compared with a standard curve of 0 to 10 nM free 
biotin-Eu(TMT). RFU stands for relative fluorescence unit.
sample 10 nM 5 nM 2.5 nM 1 nM 0.5 nM 0.25 nM OnM BasLipo InsLipo
RFU 44911 28691 20085 15755 12639 11993 10258 17365 17319
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Table 4.2 GLUT4 vesicles DyLight647-streptavidin signal measurement. The signal 
measured in the samples at different stages during the GLUT4 vesicles isolation was compared 
with a standard curve of 0 to 1 nM free DyLight647-streptavidin
sample 1 nM 0.5 nM 0.25 nM 0.1 nM 0.05 nM 0.025 nM OnM
RFU 46106 19494 13530 8955 6669 5551 4099
sample pHDM FT Wl W2 W3 W4 W5 W6
RFU 61925 43891 23288 5881 5436 5260 4846 4793
sample El E2 E3 E4 E5 E6
RFU 11028 10249 8014 4787 4670 4219
Through curve fit with linear regression, in this particular experiment the 
donor levels in basal and insulin liposomes were respectively 1.79 nM and 
1.78 nM. The acceptor level in maltose elutions E1 and E2 were 0.18 nM 
and 0.16 nM. Averagely in experiments, the donor levels were 1.5 nM and 
acceptor levels were 0.1 - 0.15 nM. The donor:acceptor ratio was 
approximately 10:1, which was in the suitable range. The concentrations of 
donors in basal and insulin liposomes were similar, which meant the 
contents of the two liposomes were of similar volume. It helped to directly 
compare the basal/insulin conditions in fusion assay.
To investigate whether there was any leakage from the liposomes or 
whether the liposomes were permeable to small molecules, 
BODIPY-FL-avidin was used because its fluorescence increases strongly on 
binding of a biotinylated ligand (Emans et al., 1995). For this 
permeability/leakage test the liposomes were encapsulated with 100 pg/ml 
BODIPY-FL-Neutravidin instead of Biotin-Eu(TMT). The maximum 
fluorescence enhancement was determined with 40 nM 
BODIPY-FL-Neutravidin in the absence of liposomes and using 40 to 200 
nM biocytin. 40 nM BODIPY-FL-Neutravidin loaded liposomes were then 
incubated with 40 to 200 nM biocytin or biotin methyl ester (membrane 
permeable reagent). The BODIPY-FL fluorescence remained low (< 4 % of 
maximum) in the presence of biocytin but increased in the presence of biotin
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methyl ester (57 % of maximum). Lysing the liposomes with 0.2 % 
TritonX-100 prior to the biocytin addition also resulted in BODIPY-FL 
fluorescence enhancement (79 % of maximum). These data confirmed that 
the liposomes were impermeable to biocytin under the conditions used in 
the fusion assay.
4.3.3 Kinetic measurements in the fusion assay
Standard fusion assay was carried out as follows. Basal or Insulin liposomes 
were mixed with basal GLUT4 vesicles in presence of 1 pM biocytin. 
Biocytin was added to prevent potential leakage of GLUT4 vesicles and 
block the outside Dyl_ight647-SA, if any was present. ATP regenerating 
system was mixed and then basal or insulin cytosol was added before or 
after 30 sec pre-incubation in a 37 °C water bath. The samples were then 
incubated for 0, 2, 5, 10 and 30 min at 37 °C. A single representative 
experiment is shown in Fig 4.4. Fluorescence excitation and capture 
parameters were: 30 flashes, a lag time of 50 psec and an integration signal 
capture time of 400 psec. As with all FRET applications there is necessarily 
overlap of the emissions from the donor into the acceptor capture window. A 
670 nm, 10 nm band-width filter was used to capture the acceptor emission 
and minimise emission from the donor. To measure donor emission alone a 
612 nm, 10 nm band-width filter was used. The donor emission in the 
acceptor window is present at time zero of the time course, is the same in 
the absence of membranes, and is relatively constant throughout the time 
course. The averaged time course for fusion (Fig 4.5) was remarkably 
similar to the time course of insulin stimulated glucose transport in intact 
cells (Satoh et al., 1993). The first order rate constant was 14-fold faster 
using plasma membrane liposomes from insulin treated compared with 
basal cells. The rate constant was increased from 0.015 ± 0.005 to 0.213 ± 
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Fig 4.4 Use of time resolved fluorescence energy transfer (TR-FRET) for 
analysis of GLUT4 vesicle fusion (one representative experiment). Fusion 
assay components were prepared as described in text. BB and II means conditions 
in which all components were from basal and insulin treated cells respectively. 
The subtracted zero time values are tabulated below the graph.
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Fig 4.5 Time courses for GLUT4 vesicles and PM liposomes fusion. The
time courses were determined using components from either basal (o) or 
insulin treated ( • )  cells. The curves were derived from fitting a first order rate 
constant from which rate constants were obtained. The rate constant were 
0.015 ± 0.005 and 0.213 ± 0.014 min'1 for basal and insulin samples, 
respectively. Results are the mean and SEM from 5 experiments.
The extent of fusion was determined by comparing the end points of the time 
courses with the total amount of complex and FRET signal that was 
produced when the assay components were treated with detergent in the 
absence of biocytin. Under these conditions all the DyLight647-streptavidin 
bound biotinylated Europium(TMT) as there was no competing ligand and 
no intact membranes to limit their interaction. After 30 min of fusion for the 
insulin samples, and after 60 min of fusion for the basal samples, the FRET 
signals were 95 ±11 % and 77 ± 9 % of the maximum (from 3 separate 
experiments). These end point values were consistent with the estimated 
rate constants and suggest that it was the rate rather than the extent of 
fusion that was stimulated by insulin. Although all the contents of the GLUT4 
vesicles used in the assay participate in fusion, it could not eliminate the 
possibility that the cells contained a population of additional GLUT4 vesicles
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that might behave differently. This was because, although fusion was close 
to 100 % efficient, not all the cell GLUT4 vesicles were recovered using the 
MBP-Spa affinity isolation technique.
As insulin PM and insulin cytosol induced the full fusion, in the following 
results, this sample was regarded as positive control for all the other tested 
conditions. To have convenient and direct comparison, a single 5 min time 
point was used as an index of fusion for different conditions. This time point 
may have led to an underestimation of the magnitude of the insulin response 
as the fusion activity for the insulin treated fractions had reached 60 - 70 % 
of the maximum within this time. Nevertheless, the use of this single time 
point assay allowed direct comparisons between assay conditions.
4.3.4 The fusion assay has necessary components
As mentioned earlier, there were mainly four fractions composing the fusion 
reaction system: basal GLUT4 vesicles, basal/insulin PM liposomes, 
basal/insulin cytosol, and an ATP regenerating system. Among these four, 
basal GLUT4 vesicles and basal/insulin PM liposomes were basic 
constituents to form a fusion assay as they provided the fundamental 
requirements for membrane fusion - the SNARE proteins. In intact cell 
studies it has been determined that the v-SNARE protein VAMP2 and the 
t-SNAREs syntaxin4 and SNAP23 were essential and necessary for GLUT4 
vesicles fusion with plasma membrane (Bryant et al., 2002; Cheatham et al., 
1996; Foran et al., 1999). To understand whether this in vitro system 
showed an equivalent SNARE dependency, fusion assay was carried out 
with GLUT4 vesicles containing cleaved VAMP2 cytosolic domain in 
comparison with normal GLUT4 vesicles. The treatment of the isolated 
GLUT4 vesicles with Botulinum neurotoxin light chain/B protease (BoLC/B) 
prior to fusion resulted in cleavage of the GLUT4 vesicle v-SNARE, VAMP2
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(Fig 4.6 B), and the fusion with this pre-treated GLUT4 vesicles was 
completely blocked (Fig 4.6 A). This confirmed that the in vitro fusion 
process was SNARE dependent.
Much accumulated data on GLUT4 trafficking has implicated the 
involvement of cytoskeletal proteins including microtubules and actin. 
Therefore it was tested whether the fusion step, a partial step in 
translocation, was altered by the actin depolymerising drug, latrunculin B. It 
was found that 250 nM latrunculin B did not inhibit the fusion reaction (Fig 
4.6 C), although this concentration is shown to inhibit GLUT4 translocation 
in cells (Khayat et al., 2000). These data suggest that cytoskeletal 
components and actin are not involved in facilitating fusion and that the 
fusion step in translocation can be separated from the steps in translocation 
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Fig 4.6 GLUT4 vesicle fusion is dependent on SNAREs but not 
cytoskeleton. A, Fusion activity using GLUT4 vesicles with (BoLC/B) and 
without (control) protease pre-treatment was determined. VAMP2-cleaved 
sample showed inhibition. B, GLUT4 vesicles were pretreated with 10 nM 
botulinum light chain/B protease (BoLC/B) for 60 min and cleavage of 
VAMP 2 was determined by western blotting. The control was without 
treatment. C, Fusion activity with and without 250 nM Latrunculin B was 
determined. Latrunculin B sample did not show inhibition.
Although this in vitro system was confirmed to be SNARE-dependent, unlike 
the neuronal SNARE fusion assay described by Weber et ai. (Weber et al., 
1998), SNARE complex alone was not sufficient to support the fusion. In 
other words, basal GLUT4 vesicles and insulin pre-activated PM liposomes 
could not fuse on their own. It was found that cell cytoplasm from 
insulin-treated cells supported fusion in a concentration dependent manner. 
Eventually, if cytoplasm was completely eliminated, fusion would not happen
at all (Fig 4.7). This suggested that factors from cytoplasm were required to 
facilitate and drive fusion and that pre-activated plasma membrane alone 
was insufficient.
Fig 4.7 GLUT4 vesicle fusion is dependent on cytosol. GLUT4 vesicle 
fusion activity was determined using PM liposomes from insulin-treated 
cells. Cytosol was prepared from a concentrated cell suspension (> 70% 
cytocrit) of insulin treated adipose cells. The concentrated cytoplasm was 
diluted by a half and a quarter with a corresponding decrease in fusion 
activity. Data were mean and SEM from 3 experiments in each case, * p < 
0.05 vs control.
In the comparison between pure basal and pure insulin conditions, mixing 
insulin-treated cytoplasm and insulin-treated plasma membrane liposomes 
produced an 8-fold higher rate of fusion than mixing basal cytoplasm and 
basal liposomes at 5 min at 37 °C. Surprisingly it showed that insulin-treated 
plasma membrane liposomes were able to support fusion in the presence of 
basal cytoplasm. By contrast, basal plasma membrane was not able to 
support rapid fusion even in the presence of cytoplasm from insulin-treated 
cells (Fig 4.8), although SNARE proteins were present and cytoplasm 
requirements fulfilled. These data suggested that although factors from
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cytoplasm were required they alone did not provide any regulation of fusion. 
Insulin stimulated plasma membrane components were capable of either 
activating or recruiting factors from the cytoplasm that led to activation of 
fusion.
Fig 4.8 Dependence of fusion activity on insulin-treated plasma 
membrane. GLUT4 vesicle fusion activity was determined using cytosol and 
PM liposomes from either basal (Bas) or insulin-treated cells (Ins). A 7-9 fold 
difference in fusion activity was observed when comparing all basal and all 
insulin components. * p < 0.05 vs Bas cyt, Bas PM. Data are mean and SEM 
from 3 - 1 0  experiments.
4.3.5 Insulin signalling cascade in regulation of fusion
Because plasma membrane from insulin treated cells played the main role 
on driving GLUT4 vesicle fusion, it was wondered in which way this 
component was capable of doing this. The early insulin signalling events 
that led to stimulated glucose transport were understood so far as activation 
of PI 3-kinase (Czech and Con/era, 1999; Hara et al., 1994) and then
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activation of Akt (Foran et al., 1999; Jiang et al., 2003; Murata et al., 2003; 
Whiteman et al., 2002) (Chapter 1, section 1.3.3). To test the function of this 
pathway, blockers for individual steps were used and results were shown as 
following.
PI 3-kinase
To evaluate the role of PI 3-kinase, wortmannin was used as a PI 3-kinase 
inhibitor. When all the components of the fusion assay were pre-treated with 
wortmannin in vitro, fusion was blocked completely at 100 nM and by 
approximately half at 10 nM (Fig 4.9 B). This data was consistent with the 
data from GLUT4 exocytosis and transport assay by Dr. Jing Yang in our 
laboratory (University of Bath) (Fig 4.9 A). GLUT4 exocytosis (Yang et al., 
2002b) was determined by measuring the extent to which internalized 
biotin-tagged GLUT4 re-emerged at the cell surface. Transport activity was 
determined using 3-O-methyl-D-glucose as a tracer (Satoh et al., 1993). The 
dose responses for wortmannin inhibition of GLUT4 exocytosis and glucose 
transport both showed an inhibition with an IC50 of approximately 10 nM (Fig
4.9). The inhibition was also confirmed by a GLUT4 exocytosis western blot 
(Fig 4.9 C top panel). This dose response was markedly well matched by the 
corresponding decrease in phosphoThr308-Akt levels (Fig 4.9 C). The 
wortmannin inhibition data collectively suggested that the fusion rate had the 
same PI 3-kinase dependence as the subsequent steps and therefore rate 
limited these subsequent steps.
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Fig 4.9 PI 3-kinase dependent signalling in regulation of fusion assay and GLUT4 
exocytosis. A, Wortmannin (Wtm) at the indicated concentrations was used to inhibit 
glucose transport activity (• )  and GLUT4 exocytosis (□) and phosphorylation of Akt (o). 
Data were mean and SEM from 3 experiments for transport and exocytosis and mean of 
two experiments for Akt phosphorylation. B, GLUT4 vesicle fusion activity with insulin 
PM liposomes was inhibited by 10 nM and 100 nM wortmannin added to reaction 
components for 10 min at 18 °C and present during the fusion reaction. Data were mean 
and SEM from 3 experiments. C, Top panels were from a representative blot of GLUT4 
exocytosis in basal cells (B) or insulin-treated cells (Ins) in the presence of the indicated 
concentrations of wortmannin. In the absence of wortmannin GLUT4 returned to the 
surface rapidly and was quenched by extracellular avidin (low GLUT4 signal on the blot). 
At high wortmannin concentrations, GLUT4 returned to the surface slowly at a rate 
comparable with that of basal cells. The bottom panels were from a representative blot of 
Akt phosphorylation at threonine308 at the indicated concentrations of wortmannin.
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To examine whether the PI 3-kinase activation was carried through the 
plasma membrane or the cytoplasm or both, the fractions for the fusion 
assay were prepared from wortmannin-treated insulin-stimulated cells (Fig
4.10). When mixed with normal insulin PM liposome and GLUT4 vesicles, 
the cytosol from wortmannin-treated cells did not show inhibition to fusion. 
This might be because the effect of wortmannin was rapidly lost as the 
reagent was inactivated by water and amines over long incubations. In 
addition, this insulin-signalling blocked cytosol showed similar result with 
basal cytosol earlier (Fig 4.8), both of them supported fusion to some extent. 
On the contrary, the plasma membrane fraction from wortmannin-treated 
cells was inactive in the fusion assay. Again, this was consistent with earlier 
observations and interpretations (Fig 4.8), suggesting that the 





Fig 4.10 Fusion with fractions from wortmannin-treated
insulin-stimulated cells. Intact cells were treated with insulin in the absence 
or presence with 100 nM wortmannin and subsequent isolation of separate 
plasma membrane (Ins PM, Wtm PM) and cytosol (Ins cyt, Wtm cyt) 
fractions were used in fusion assay. Then it was determined whether 
inhibitory activity was retained in either the plasma membrane or the cytosol 
fraction. Results were the mean and SEM from 3 experiments.
Akt
In the fractions for fusion assay Akt was detectable in cytoplasm but not 
plasma membrane (Fig 4.11 A, C). Therefore, to establish whether Akt was 
required for the vesicle fusion reaction Akt was removed from the cytoplasm 
by immuno-precipitation (Chapter 2, section 2.2.1.5) (Fig 4.11 A). Depletion 
of Akt1 alone from the cytoplasm fraction reduced fusion activity by 
approximately 50 % while depletion of both Akt1 and Akt2 reduced the 
fusion activity by 80 % (Fig 4.11 B). Although the depletion procedures 
reduced the total amounts of Akt1 and Akt2 to less than 7 % and 3 % of their 
initial levels respectively, there was still some residual fusion noticeable. 
This residual fusion activity may have been due to some low level of 
activated Akt that was already recruited to the plasma membrane, although 
not detectable in western blot (Fig 4.11 C). Alternatively the residual fusion
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activity may have been due to the presence of an Akt isoform that was not 
removed by the depletion protocol. Or this residual fusion showed a 
background reaction under insulin stimulation but not through the PI 
3-kinase pathway. Overall, This inhibition corresponded closely with data 
obtained in intact 3T3-L1 adipocytes using siRNA directed against these two 
Akt isoforms (Jiang et al., 2003).
Knowing that Akt was essential in supporting fusion, it was natural to wonder 
how it has been activated and how the active form acted on GLUT4 fusion. It 
was thought that PI 3-kinase increases the concentration of PI(3,4,5)P3 in 
the membrane and PI(3,4,5)P3 promoted the cell-surface localization of 
PDK1 and Akt (Watson and Pessin, 2006) (section 1.3.3). Then Akt was 
phosphorylated on Thr308 and Ser473 and activated. Under the conditions 
of the fusion reaction (but in the absence of GLUT4 vesicles), the 
recruitment of both Akt1 and Akt2 from cytosol onto liposomes was 
investigated (Fig 4.11 C). It was confirmed that Akt1 and 2 can be recruited 
to the liposomes. The levels of recruitment onto liposomes prepared from 
the insulin-treated samples were significantly higher than from basal 
samples. Similarly when cells were pretreated with the PI 3-kinase inhibitor 
wortmannin before insulin, the levels of Akt subsequently recruited onto 
isolated liposomes were the same as those recruited from the liposomes 
from basal cells. This finding is consistent with the one that liposomes 
prepared from wortmannin and insulin treated cells did not support fusion 
(Fig 4.10).
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Fig 4.11 Requirement of cytoplasmic Akt for GLUT4 vesicle fusion and 
recruitment onto lipsomes. A, Aktl was depleted from cytoplasm of insulin 
stimulated cells using immobilised Aktl antibody clone 5G3 (Cell Signaling 
Technology). No depletion was observed with an irrelevant IgG control. Very little 
depletion of Akt2 occurred using this antibody. Successive use of anti-Aktl antibody 
and anti-Akt2 antibody clone AW114 (Upstate) depleted the cytoplasm of both Aktl 
and Akt2. B, Fusion activity of GLUT4 vesicles with insulin PM liposomes was 
determined using cytoplasm from the IgG control and following Aktl and Akt2 
depletion. Data were mean and SEM from 3 experiments. * p < 0.05 vs. control. C, PM 
liposomes prepared from basal (B) or insulin-treated cells (Ins) or cells treated with 200 
nM wortmannin (Wtm) and then insulin were incubated for 15 min at 37°C in the 
fusion buffer in the absence (right panels) and presence (left panels) of the respective 
cytosol but without the GLUT4 vesicles (which interfere with the detection of the Akt). 
Following the incubations the liposomes were reisolated and separately analyzed for 




Phosphorylation of Thr308 was only found occurring on the Akt that had 
been recruited onto insulin liposomes and this phosphorylation was inhibited 
by in vitro wortmannin treatment (Fig 4.12 A, B). However, the in vitro 
wortmannin treatment would not affect the levels of phosphorylated Akt in 
the plasma membrane liposomes or the cytoplasm individually (Fig 4.12 C). 
The phospho-Akt on the plasma membrane was undetectable and the 
phospho-Akt remained high in the insulin-stimulated cytoplasm as it had 
already been activated. The comparison of with and without in vitro 
wortmannin in the recruitment assay indicated that it was the 
phosphorylation of recruited Akt that was blocked by wortmannin.
Akt was mainly driven onto insulin-activated plasma membrane liposomes 
from insulin activated cytoplasm (Fig 4.12 A, Fig 4.11 C). However, it was 
found that some Akt phosphorylation was still detectable with insulin-treated 
plasma membrane liposomes and basal cytoplasm (Fig 4.12 A, B). This 
suggested that de novo phosphorylation of Akt was occurring under these 
conditions as the basal cytoplasm did not contain any activated Akt. This 
provides an explanation for the in vitro wortmannin sensitivity of the fusion 
reaction (Fig 4.9 B). The Akt was most likely recruited onto the plasma 
membrane from insulin-treated cells because these membranes contain 
phosphatidylinositol-(3,4,5)-triphosphate (PIP3). The continuing PI 3-kinase 
activity would continuously recruit PDK1 which would lead to continuous Akt 
phosphorylation. This essential de novo phosphorylation process may 
explain the observed fusion using samples from insulin-treated plasma 
membrane liposomes and basal cytosol (Fig 4.8). By contrast pre-activated 
and phosphorylated Akt was in abundance in the cytosol from insulin-treated 
cells (Fig 4.12 C) but this was insufficient to drive fusion of GLUT4 vesicles 
with basal plasma membrane liposomes (Fig 4.8). These data suggested
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that the already-phosphorylated Akt in the cytoplasm alone was insufficient 
to drive fusion and it was the Akt recruitment to the plasma membrane and 
the following phosphorylation that facilitated the fusion process.
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Fig 4.12 In vitro wortmannin treatment blocks phosphorylation of Akt recruited 
onto insulin-stimulated PM liposomes. A, The cytosol and PM liposome 
components of the fusion reaction were incubated for 15 min at 37 °C in the fusion 
system but without the GLUT4 vesicles (which interfere with the detection of the 
Akt). The liposome and cytoplasm were then re-isolated and separately analysed for 
the presence of threone308-phosphorylated Akt. Phospho-threonine308 Akt was 
increased in the liposome pellet (comparing the liposome samples from A and B) and 
this was blocked by the wortmannin treatment. B, Quantification of in vitro Akt 
phosphorylation of Akt recruited to PM liposomes in correspondence of the samples 
from A. Data were the mean and SEM from 4 experiments. C, Treatment of separate 
cytosol and PM liposomes from basal (B) and insulin-treated cells (I) with 




This novel assay reconstitutes and directly demonstrates insulin-stimulated 
GLUT4 vesicle fusion with plasma membrane for the first time. The in vitro 
approach provides an excellent evaluation of the roles of different factors in 
the GLUT4 vesicle fusion process. Remarkably the magnitude and time 
course for insulin’s action on glucose transport are fully recapitulated in the 
vesicle fusion reaction. On the contrary, from experiments in vivo and using 
gene-silencing or various inhibitors (Bose et al., 2005; Kanda et al., 2005; 
van Dam et al., 2005) to study the regulation of insulin-stimulated GLUT4 
translocation, it is difficult to dissect the fusion step from insulin signalling. 
The fusion component is hard to interpret because the factors before and 
after fusion could largely influence the appearance of tagged-GLUT4 at the 
cell surface. Using low temperature block on 3T3-L1 adipocytes, van Dam et 
al. implicate two insulin-regulated steps in GLUT4 translocation, the 
Akt-independent redistribution of GLUT4 vesicles towards the cell cortex, 
and the Akt-dependent docking and fusion of GLUT4 vesicles with the PM 
(van Dam et al., 2005). The small interfering RNA-based gene silencing 
used by Bose et al. inhibited insulin-stimulated glucose transport (Bose et 
al., 2005). The gene knock-out technique can also show effectors in this 
process (Kanda et al., 2005). However, all of these techniques are not able 
to separate the process of GLUT4 vesicle fusion with the plasma membrane 
from other translocation steps, nor are they able to study factors involved in 
this particular process. As an improvement, the use of total internal 
reflection fluorescence (TIRF) microscopy (TIRFM) (Lizunov et al., 2005) 
has narrowed down the number of partial reactions involved in the insulin 
stimulated translocation, but the interpretation of these microscopy images 
is ambiguous because the net incorporation of GLUT4 into the plasma 
membrane can be interpreted as indicating an involvement of the 
cytoskeleton, docking and fusion and endocytosis (Lizunov et al., 2005). The
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in vitro assay of the fusion reaction described in this chapter not only allows 
the fusion event to be studied in isolation from any involvement of the 
cytoskeleton or the endocytosis steps, but also allows the dissection of the 
fusion components. Interference protein or inhibitors can be added directly 
to the assay. Selected proteins can also be immuno-depleted from the 
fusion reaction. At present the fusion assay has demonstrated that the 
magnitude and time course of insulin stimulation of fusion is comparable 
with its stimulatory effect on glucose transport in target cells. Furthermore as 
the stimulation of fusion has been shown to be dependent on PI 3-kinase 
and on Akt activities, the study provides a direct identification of the sites of 
action of these signalling intermediates.
Components for fusion assay
The GLUT4 vesicles used in the fusion reaction are labelled and tagged by 
GP15 and streptavidin and then internalized in the absence of insulin. Thus, 
the vesicles obtained in this way represent GLUT4 vesicles in the basal or 
non-stimulated state. The presence of VAMP2 proves the vesicles belong to 
the population of GLUT4 storage vesicles (GSV) and the BoLC/B protease 
cleavage experiments demonstrated that the fusion is SNARE-dependent. 
The GLUT4 vesicle population isolated from rat adipocyte is more 
homogeneous than that from 3T3-L1 cells (Lizunov et al., 2005; Malide et 
al., 1997). In our lab it was found that when using homogenates of rat 
adipose cells only a single population of GLUT4 vesicles can be resolved on 
iodixanol gradients (unpublished data). This population does not contain 
GLUT1 and the levels of GLUT1 in the intracellular compartment of rat 
adipocytes are less than 10 % of the levels of GLUT4 (Holman et al., 
1990a). This situation is different from that found in the 3T3-L1 adipocytes 
system where the ratio of GLUT1:GLUT4 is 1:1 or greater (Calderhead et 
al., 1990; Palfreyman et al., 1992).
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In primary adipocytes, the disperse cytoplasmic GLUT4 vesicles already 
make up a majority of the GLUT4-containing compartments (Lee et al., 1999; 
Malide et al., 2000). But there is thought to be a fraction of peripheral 
GLUT4 vesicles located near the PM, which are suggested to be an initial 
source of GLUT4 that fuses with the PM upon insulin stimulation (Fletcher et 
al., 2000; Semiz et al., 2003). These peripheral vesicles have never been 
directly demonstrated. The GLUT4 vesicles obtained in this assay should be 
mainly cytoplasmic but also contain a certain amount of the peripheral 
vesicles. An attempt to purify the peripheral vesicles was tried by 
re-homogenizing plasma membrane. But these re-purified vesicles failed to 
show fusion competency in fusion assay. The re-purified vesicles might be 
the internalizing vesicles which are still attaching to plasma membrane. As 
they are in the process of leaving the plasma membrane and heading to the 
inside of the cell, they are not likely to be fusable with plasma membrane.
The cytosol appears to be necessary and important in providing 
components that stimulate fusion after their recruitment to the plasma 
membrane. Using immuno-depletion it was found that Akt is required for 
fusion. The Akt isoform specificity for the fusion reaction is similar to that 
revealed using siRNA techniques (Jiang et al., 2003) in that depletion of 
both Aktl and Akt2 is necessary for marked inhibition of translocation (as 
measured in cells) and fusion (as measured in vitro). Our data indicate 
somewhat more dependence on Aktl as depletion of this isoform alone 
reduces fusion by 50 %. This is different from Zhou et a/s finding that Akt2 is 
the key intermediate in insulin acted GLUT4 translocation (Zhou et al.,
2004).
Insulin-activated cytosol alone is insufficient to facilitate fusion with plasma 
membrane liposomes prepared under basal conditions. It reveals that the 
insulin regulated fraction is not the cytosol or the GLUT4 vesicles; instead it
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is the plasma membrane. This conclusion is consistent with several 
additional observations. These observations include that insulin-stimulated 
plasma membrane liposomes can support fusion using cytoplasm from 
basal or wortmannin-treated cells, and insulin-stimulated plasma membrane 
liposomes can recruit and then phosphorylate Akt from the basal, 
signalling-inactive cytoplasm. This cell-free approach has therefore led to a 
focus on the plasma membrane fraction for follow-up studies. Further 
studies will be required to fully identify which components of the plasma 
membrane are pre-activated by insulin treatment of cells. In principle it is 
also possible to immuno-deplete selected proteins from the plasma 
membrane liposomes in the solubilised membrane stage (Chapter 2, section 
2 .2.6.1).
Insulin signalling coupling to fusion
From the fact that the dose response effects of wortmannin on Akt 
phosphorylation, glucose transport activity and GP15 labeled GLUT4 
exocytosis are in close parallel, it is concluded that there is no activation of 
GLUT4 after it is exposed at the cell surface. Therefore it suggests that the 
rate limiting step happens before the exposure of GLUT4 at the surface.
Previous studies have shown that co-sedimentation of GLUT4 vesicles with 
insulin-stimulated plasma membrane is not wortmannin sensitive (Inoue et 
al., 1999). This suggests that after the wortmannin treatment the 
co-sedimented fraction contains docked vesicles and that docking may not 
be wortmannin sensitive. Studies on 3T3-L1 cells (Hausdorff et al., 1999) 
have shown that the incorporation of GLUT4 into the plasma membrane as 
measured in isolated lawns is somewhat less sensitive to PI 3-kinase 
inhibition than the full incorporation of GLUT4 as detected by measurements 
of transport activity. As this lawn procedure measures both docked and 
fused GLUT4 vesicles, one interpretation of these findings is that the
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docking step is less dependent on PI 3-kinase. In addition recent studies in 
3T3-L1 cells have shown that partial inhibition of signalling, either by 
inhibition of PI 3-kinase with LY294002 (Bose et al., 2004) or by inhibition of 
Akt phosphorylation via a low temperature block (van Dam et al., 2005) 
leads to the accumulation of docked vesicles. Collectively these data 
suggest that the wortmannin sensitive step may lie beyond the docking step. 
However, future studies addressing this issue in a cell free system are 
warranted.
Data in this chapter suggests that it is the association of the Akt with the 
liposomes that is the insulin-sensitive step in signalling that leads to the 
activation of fusion. The in vitro wortmannin effect on Akt phosphorylation 
suggests a dynamic and continuous PI 3-kinase and phospho-Akt 
requirement for fusion. An activation of all the fusion components would 
have already occurred in samples in which all components are from 
insulin-stimulated cells. Therefore steps beyond the wortmannin-sensitive PI 
3-kinase step might be expected to no longer require the continuous 
activation of PIP3 production. Our observation that wortmannin still inhibits 
fusion under these conditions suggests that there is turnover of the activated 
and phosphorylated form of Akt. This leads to the conclusion that Akt 
phosphorylation does not lead to a triggering mode of activation of fusion but 
instead a continuous cycling of phosphorylated Akt production is required to 
drive fusion.
Homotypic membrane fusion processes such as endosome/endosome 
fusion reactions are known to be dependent on PI 3-kinases and are 
inhibited by wortmannin. Although somewhat controversial, it seems that 
the PI 3-kinase dependent step in fusion can be bypassed using 
constitutively active Rab isoforms (Jones et al., 1998; Lawe et al., 2001). 
Therefore potential mediators of fusion include the Rab proteins. In this
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context, a common theme in insulin action that appears to be emerging is 
that many Akt substrates are small GTPase GAP proteins (Gridley et al., 
2005; Sano et al., 2003). These substrates include AS160, AS250, 
TSC1/TSC2 etc. In each case phosphorylation via Akt reduces GAP activity 
and therefore leads to activation of the corresponding small G-protein 
activity. It would be of interest to determine whether a protein containing a 
GAP activity is a mediator of membrane fusion of GLUT4 vesicles. A link 
between Rab proteins and fusion may be mediated by Rab effectors that 
combine with the SNARE fusion apparatus and its associated proteins such 
as Munc18c (Bryant et al., 2002; Kanda et al., 2005; Nielsen et al., 2000).
To conclude, in this chapter an in vitro fusion assay to mimic the 
insulin-stimulated GLUT4 vesicle fusion with plasma membrane is 
demonstrated. Crucial factors are studied and this system provides a strong 
tool to reveal the remaining mysteries in this event.
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Chapter 5 Investigation of Ca2+ effects on fusion assay
5.1 Introduction
At the neuronal synapse, Ca2+ triggers neurotransmitter release by synaptic 
vesicle exocytosis. This trigger is with a delay of less than 1 msec, possibly 
less than 100 psec (Sabatini and Regehr, 1996). The speed of Ca2+ action 
suggests that Ca2+ does not induce release by a complex reaction, for 
example by initiating assembly of new SNARE complexes or causing large 
conformational changes. Instead, it is likely that the fusion reaction is largely 
completed before the arrival of trigger Ca2+ (Sudhof, 1995).
Ca2+ triggers neurotransmitter release by binding to Ca2+ sensors that are 
localized at the site of exocytosis and these sensors bind multiple Ca2+ ions. 
In forebrain synapses the Ca2+ sensor is most likely the synaptic vesicle 
protein synaptotagmin (Brose et al., 1992; Perin et al., 1990). 
Synaptotagmin acts on a state of synaptic vesicles in which SNARE 
complexes have fully assembled, suggesting that SNARE complex 
assembly creates a metastable fusion intermediate, perhaps a stalk-like 
state. Ca2+-triggered insertion of the synaptotagmin is sufficient to 
destabilize the intermediate and to trigger fusion pore opening (Jahn et al., 
2003).
In the field of glucose transport and GLUT4 translocation, as early as 1987, 
Draznin et al. found that reduction of intracellular Ca2+ in rat adipocytes 
markedly inhibited insulin-stimulated glucose transport (Draznin et al., 1987). 
They indicated that there must be a minimal concentration of intracellular 
calcium to promote insulin action, but increased levels of intracellular 
calcium may provide a critical signal for attenuation of the insulin action too. 
The optimal effect of insulin was observed at Ca2+ levels between 140 and
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370 nM. This means Ca2+ may play a permissive role in glucose transport, 
or it may actively drive one or more of the steps involved in 
insulin-stimulated GLUT4 trafficking. In the former case there may be no 
change in cytosolic Ca2+ with insulin stimulation. In the latter case insulin 
may increase cytosolic Ca2+ by regulating the activity of a Ca2+ channel. It 
has been proved that insulin treatment of adipocytes does not elevate the 
intracelluar concentration of free Ca2+ (Klip and Ramlal, 1987), which 
indicates that Ca2+ plays a permissive role rather than a driving role. In 
3T3-L1 cells, Whitehead el al. employed the Ca2+-chelating agent 1,2- 
bis(o-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid
tetrakis(acetoxymethyl ester) (BAPTA-AM) and the calmodulin antagonist 
N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide (W13) to investigate 
the role of Ca2+ in insulin-stimulated glucose transport (Whitehead et al., 
2001). BAPTA-AM is a membrane permeable Ca2+ chelator whose 
association and dissociation rates are more than 100-fold higher than 
EGTA. They found BAPTA-AM and calmodulin antagonist W13 reduced 
insulin-stimulated glucose uptake by 95 and 60 % and Akt phosphorylation 
by 75 and 70 %, respectively. GLUT4 translocation was inhibited by 50 % as 
determined by subcellular fractionation analysis and 100 % by antibody 
binding assay. These indicate that Ca27calmodulin is required both for the 
efficient activation of Akt and at a late post-docking stage in GLUT4 vesicle 
fusion. Similarly, another group demonstrated a positive role for intracellular 
Ca2+ in distal insulin signalling events, including initiation/maintenance of Akt 
phosphorylation, insulin-responsive glucose transporter isoform 
translocation, and glucose transport (Worrall and Olefsky, 2002). 
Additionally studies about the effect of Ca2+ influx on insulin-mediated 
glucose uptake in skeletal muscle also indicated that Ca2+ acts late in the 
insulin signalling pathway, for instance, in the GLUT4 translocation to the 
plasma membrane (Lanner et al., 2006).
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Recently it was found that calmodulin binds to AS160 which is an Akt 
substrate protein with a Rab GTPase activating protein domain (Kane and 
Lienhard, 2005). This association was Ca2+ ion dependent. However the 
point mutant of AS160 which did not bind calmodulin did not interfere with 
the capacity of AS160 lacking Akt phosphorylation sites to inhibit GLUT4 
translocation. Consequently calmodulin binding is probably not required for 
the participation of AS160 in insulin-stimulated GLUT4 translocation.
The fusion system designed in Chapter 4 allows us to study the steps of 
GLUT4 vesicle fusion with the plasma membrane. Using this system, it 




As described in Chapter 4, a successful fusion assay was set up using 
insulin PM liposomes and basal GLUT4 vesicles in the presence of insulin 
cytosol and ATP regenerating system. To investigate the involvement of 
Ca2+ in the process of GLUT4 vesicle fusion with plasma membrane, cytosol 
was first pre-incubated with the membrane impermeable Ca2+ chelator 1,2- 
bisJo-aminophenoxyJethane-N.N.N'.N'-tetraacetic acid, sodium (BAPTA) but 
no effect was observed. Ca2+ in the cytosol was also chelated by 1 mM 
EGTA but this slow chelator did not interfere or inhibit fusion (Fig 5.1). This 
observation was consistent with the report by Whitehead etal., in which the 
slow chelator EGTA did not show inhibition on glucose uptake (Whitehead et 
al., 2001). Then cytosol and GLUT4 vesicles were pre-incubated with the 
membrane permeable Ca2+ chelator BAPTA-AM before the fusion assay to 
chelate all the free Ca2+ in the system. 20, 100, 200 pM of BAPTA-AM was 
mixed with cytosol and GLUT4 vesicles respectively and incubated on ice
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for 15 min. The results from the fusion reaction showed that BAPTA-AM 
inhibited fusion activity in a concentration dependent manner (Fig 5.2). In 
this experiment, BAPTA-AM chelated the Ca2+ both outside and inside of 
GLUT4 vesicles. Adding back free Ca2+to fusion system to compensate the 
BAPTA-AM inhibition was not possible because in the presence of 
BATPA-AM, large amounts of Ca2+ were needed to reach the desired 
concentration (nanomolar range). This level of calcium was found to 
interfere with the fluorescence signal.
To determine if the observed inhibition was due to chelating of calcium in the 
cytosol or in the intra-lumenal space of GLUT4 vesicles, only the GLUT4 
vesicles were incubated with BAPTA-AM. Using these pre-treated GLUT4 
vesicles it was observed that fusion was inhibited (Fig 5.3), which suggested 
a role of intra-lumenal vesicular Ca2+ in the fusion process.
Fig 5.1 BAPTA and EGTA do not inhibit fusion activity. BAPTA and EGTA at 
the indicated concentration was added to cytosol. GLUT4 vesicle fusion activity 
was determined using cytosol and PM liposomes from insulin-treated cells. No 
inhibition was observed when comparing control with 200 pM BAPTA or EGTA 
pre-treated sample. Data are mean from two very similar experiments.
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Fig 5.2 BAPTA-AM inhibited fusion activity in a concentration dependent 
manner. BAPTA-AM at the indicated concentration was added to GLUT4 
vesicle and cytosol respectively. GLUT4 vesicle fusion activity was 
determined using cytosol and PM liposomes from insulin-treated cells. A  
3.5-fold difference in fusion activity was observed when comparing control 
with 100 pM BAPTA-AM pre-treated sample; a 6-fold difference was 
observed when comparing with 200 pM BAPTA-AM pre-treated sample. Data 
are mean and SEM from 5 experiments. Comparison control vs different 
BAPTA-AM concentrations * p < 0.05.
Fig 5.3 BAPTA-AM inhibited fusion activity when treated with GLUT4 
vesicles only. GLUT4 vesicles were treated with 200 pM BATPA-AM. GLUT4 
vesicle fusion activity was determined using cytosol and PM liposomes from 
insulin-treated cells. Data are mean from 2 experiments.
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5.2.2 Lack of calcium gradient and calmodulin dependence of fusion
To further investigate the effect of Ca2+ inside the GLUT4 vesicles on fusion, 
GLUT4 vesicles were pre-incubated with 1 pM A23187. A23187 is a Ca2+ 
ionophore which should dissipate an existing Ca2+ gradient between the 
inside and the outside of the vesicles. A23187 did not affect the fusion 
activity (Fig 5.4). This might suggest that the Ca2+ inside of GLUT4 vesicles 
did not act on the fusion but alternative explanations can also be put forward 
(see discussion).
Fig 5.4 A23187 did not affect fusion activity. GLUT4 vesicle fusion 
activity was determined using cytosol and PM liposomes from 
insulin-treated cells. Data are mean from 2 very similar experiments.
To investigate the involvement of calmodulin in the fusion process, W13, a 
calmodulin antagonist, was added to fusion system (Fig 5.5). The result 
showed that W13 did not inhibit fusion activity, which meant calmodulin was 
not involved in the fusion process.
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Fig 5.5 W13 did not affect fusion activity. 100 pM of W13 was
incubated with cytosol before the fusion assay. GLUT4 vesicle fusion 
activity was determined using cytosol and PM liposomes from 
insulin-treated cells. Data are from one experiment.
5.3 Discussion
In the current study the role of Ca2+ in GLUT4 vesicle fusion with plasma 
membrane was investigated by chelating intra-cellular and intra-vesicular 
Ca2+ with a strong chelator BATPA-AM. The results in this chapter showed 
that BAPTA-AM inhibited GLUT4 vesicle fusion with plasma membrane and 
that this effect was due to an action on the GLUT4 vesicles content rather 
than on the cytosol. The inhibition result was consistent with a previous 
report on 3T3-L1 cells which showed BAPTA-AM inhibition on glucose 
transport (Whitehead et al., 2001) but whether this inhibition is because of 
the intra-cellular and intra-vesicular Ca2+ chelation by BAPTA-AM needs to 
be further investigated. This is because BAPTA-AM can also reduce the 
insulin-stimulated phosphorylation of Akt (Whitehead et al., 2001), the 
inhibition shown in this chapter could be at least partly explained by the 
impairment in insulin-signalling.
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The sole treatment of BAPTA-AM on GLUT4 vesicles was performed to 
chelate the intra-vesicular Ca2+ inside the GLUT4 vesicles. Although it 
showed inhibition of the fusion activity the proof was not strong enough to 
guarantee it was only because of the intra-vesicular Ca2+. It was possible 
that excess BAPTA-AM could still be able to chelate the intracellular Ca2+ in 
the cytosol as BAPTA-AM was present during the whole fusion reaction. 
This problem can be resolved if the GLUT4 vesicles are treated with 
BAPTA-AM before isolation.
Addition of Ca2+ ionophore A23187 was another way to study the 
intra-vesicular Ca2+ inside of GLUT4 vesicles. The adjustment of Ca2+ 
concentration between the inside and the outside of GLUT4 vesicles 
through this ionophore did not inhibit fusion activity. This could indicate that 
the BAPTA-AM inhibition was only due to the action on Akt phosphorylation. 
Alternatively, it might also be because the gradient of Ca2+ between the 
inside and the outside of GLUT4 vesicles does not affect the mechanism by 
which Ca2+ triggers fusion. Several studies have shown that Ca2+ is released 
from the lumen of the vesicles during the actual fusion process (Holroyd et 
al., 1999; Peters and Mayer, 1998; Porat and Elazar, 2000; Pryor et al., 
2000), thus promoting fusion. Based on their conclusion, if a burst in the 
release of intra-lumenal vesicular Ca2+ triggers fusion rather than a global 
increase in intracellular Ca2+, it is reasonable that fusion could not be 
inhibited by ionophores because ionophores only equilibrate the ion 
concentration on both sides of a membrane but do not stop the ion 
movement. The equilibrated Ca2+ might still be able to form a burst from one 
side of the membrane to the other side. Additionally, in skeletal muscle it has 
been found that insulin application resulted in a significant increase in Ca2+ 
concentration close to the cell membrane. The insulin concentration 
required for half-maximal increase in this Ca2+ concentration was similar to 
that needed for half-maximal activation of insulin-mediated glucose uptake
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(Bruton et al., 2001; Bruton et al., 1999). Although it was demonstrated that 
the Ca2+ influx was from the extracellular buffer, it suggested that the quick 
movement of Ca2+ ions near membranes was playing an important role in 
insulin-stimulated glucose transport. The near membrane Ca2+ 
concentration can be detected by a membrane-associated Ca2+ indicator 
FFP18 (Bruton et al., 1999; Etter et al., 1994). This indicator could be used 
in the fusion system in the future to monitor the near membrane Ca2+ 
concentration changes during the fusion event. If any near membrane Ca2+ 
is detected, it should be due to the ion movements between the cytosol and 
the GLUT4 vesicles. This is because in the fusion system there is no Ca2+ in 
the buffer.
W13 was shown to impair the phosphorylation of Akt and glucose transport 
(Whitehead et al., 2001), however in my experiments it did not inhibit the 
fusion activity. It is interesting because both W13 and BAPTA-AM can 
decrease the phosphorylation of Akt but BAPTA-AM showed inhibition to 
GLUT4 vesicle fusion with plasma membrane whereas W13 did not. 
BAPTA-AM can chelate free Ca2+ and W13 competes with calmodulin. An 
explanation could be that Ca2+ (but not calmodulin) is required for the 
continuous Akt phosphorylation after all the fractions have been 
fully-stimulated, or merely that the postdocking event requires Ca2+ but not 
calmodulin. The lack of effect of the calmodulin antagonist W13 is also in 
accordance with the studies on AS160 which showed that although an 
interaction between AS160 and calmodulin is possible this interaction did 
not have an effect on AS160 function on GLUT4 trafficking (Kane and 
Lienhard, 2005).
Recently studies in our laboratory demonstrated that the GLUT4 vesicles 
from insulin-stimulated cells also supported fusion (Koumanov and Holman, 
unpublished observations). It provides another route to study the
148
Ca27calmodulin relationship with insulin signalling and GLUT4 vesicle 
fusion. If BAPTA-AM still inhibits fusion with GLUT4 vesicles from 
insulin-stimulated cells it means Ca2+ acts in the postdocking stage, no 
matter whether it affects insulin signalling or not.
To conclude, an inhibition of the fusion with BAPTA-AM was observed. 
However, more experiments will be needed to monitor precisely how this 
effect is exerted.
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Chapter 6 Investigation of V-ATPase effects on the fusion
assay
6.1 Introduction
The vacuolar H+ ATPase (V-ATPase) is an ATP-driven enzyme that 
transforms the energy of ATP hydrolysis to electrochemical potential 
differences of protons across diverse biological membranes via the primary 
active transport of H+. First found in association with endosomal membranes, 
the V-type H+ ATPase is now also found in increasing examples of plasma 
membranes where the proton pump energizes transport across cell 
membranes and entire epithelia. The molecular details reveal up to 14 
protein subunits arranged in a cytoplasmic V1 complex, which mediates the 
hydrolysis of ATP and a membrane-embedded VO complex, which 
translocates H+ across the membrane. It has been shown that the V-ATPase 
acts as a molecular rotor akin to F-type ATPase (Nishi and Forgac, 2002). 
The hydrolysis of ATP turns a rotor consisting largely of one copy of 
subunits D and F of the V1 complex and a ring of six or more copies of 
subunit c of the VO complex. The rotation of the ring is thought to deliver H+ 
from the cytoplasmic to the endosomal or extracellular side of the 
membrane, probably via channels formed by subunit a from the VO complex 
(Fig 6.1). The association/dissociation of V1 and VO complexes is reversible, 
which was recognized as one mechanism of its physiological regulation 
(Beyenbach and Wieczorek, 2006).
Apart from SNARE proteins which are commonly recognized as membrane 
fusion machinery, V-ATPase has also been studied actively in membrane 
fusion, independently of its role in vesicle acidification. The VO complex was 
first implicated in membrane fusion when its subunit c was found to be the
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“mediatophore”, a protein that could produce calcium-dependent release of 
neurotransmitter (Brochier and Morel, 1993). More recently VO subunit was 
reported to associate with target membrane SNAREs and play a role in the 
fusion of yeast vacuoles (Peters et al., 2001), Eventually it has been 
demonstrated that VO functions after trans-SNARE pairing and is coupled to 
the Ca2+-releasing channel (Bayer et al., 2003). Lately Hiesinger et al. 
screened the proteins required for neurotransmission in Drosophila and 
identified the gene vha100, the 110 kDa subunit of V0 (generally referred to 
as subunit a) (Hiesinger et al., 2005). Mutations that resulted in truncated 
vha100 led to a significant decrease in transmission. They also revealed that 
this subunit binds to t-SNAREs, suggesting a model in which SNARE 
proteins guide V0 pores in vesicle and acceptor membranes into apposition, 
thus forming a pore spanning both membranes (Aimers, 2001). A possible 







(from Nishi & Forgac (2002) Nature Rev Mofec Cetl Btot 3. 94-103)
Fig 6.1 Schematic representation of the structure of V-ATPase (Nishi and 
Forgac, 2002). V-ATPase consists of peripheral complex VI and integral 
membrane complex V0. VI is formed by eight different subunits identified with 
capital letters A-H. V0 complex consists of at least three different subunits 
identified with small letter (a,c,d)- Hydrolysis of ATP brings about rotation of the 
VI central shaft together with the c-ring of the V0 complex. Subunit a 
hypothetically provides two H+ from the cytoplasm to the lumen/extracellular 
fluid. The H+ moves via an intermediary H+ binding step to one subunit c 







Fig 6.2 Possible structure of the dimer of V0 that may form a fusion pore 
during vacuole fusion. Two rings of proteolipid, two a subunits and two 
t-SNARE proteins are shown (Aimers, 2001).
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It has been found that exposure of cells to insulin causes an increase in 
intracellular pH in fat (Civelek et al., 1996), 3T3-L1 cells (Klip et al., 1988), 
muscle (Klip et al., 1986), and liver (Peak et al., 1992). The work on rat 
adipocytes (Yang et al., 2002b) and cardiomyocytes (Yang et al., 2002a) 
suggested that insulin-stimulated cytosol alkalinization facilitated the final 
stages of translocation and incorporation of fully functional GLUT4 at the 
surface-limiting membrane. It has been showed the alkalinization effect of 
insulin was blocked by treatment of V-ATPase inhibitor bafilomycin A1 
(Yang et al., 2002a). These studies on a GLUT4-occluded intermediate in 
exocytosis added to the growing evidence for regulation of membrane fusion 
intermediates by electrochemical gradient for H+ (A/;H+) (Peters et al., 
2001; Ungermann et al., 1999).
Using Mass Spectrometry Larance et al. identified proteins present on 
GLUT4 vesicles from 3T3-L1 adipocytes (Larance et al., 2005). Among 
these proteins there is V-ATPase subunit a (110 kDa) from complex V0. 
Based on this fact, an attempt was made towards elucidating the role of 
V-ATPase from GLUT4 vesicles in their fusion with the plasma membrane, 
using the fusion system described in Chapter 4.
6.2 Results
6.2.1 Concanamycin A inhibition
To confirm the presence of V-ATPase on GLUT4 vesicles, concentrated 
GLUT4 vesicle proteins were resolved by SDS-PAGE and western blotted 
with anti goat V-ATPase subunit a antibody. Rat brain lysate and low density 
microsomes were run in parallel as an indication for the exact position of the 
protein band (Fig 6.3). An immunoreactive band at 110 kDa was detected in 
GLUT4 vesicles. In parallel with other controls, it confirmed the presence of 
V-ATPase on GLUT4 vesicles.
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Fig 6.3 Western blots showing V-ATPase subunit a on GLUT4 vesicles.
GLUT4 vesicles immuno-isolated with MBP-Spa and anti-GLUT4 abtibody 
method (Chapter 3) from 2 rats were concentrated to 50 pi by using a 
VIVASpin column. LDM were from rat adipocytes subfractiation. 
V-ATPase subunit a was detected with goat anti-V-ATPase subunit a 
antibody.
To reveal the role of V-ATPase in GLUT4 vesicle fusion with plasma 
membranes, 200 nM concanamycin A was incubated with GLUT4 vesicles 
before the fusion reaction (Fig 6.4). Concanamycin A is an antibiotic which 
binds to the subunit c of the VO complex in V-ATPase (Beyenbach and 
Wieczorek, 2006; Bowman et al., 2004). The concanamycin A pre-treated 
GLUT4 vesicles had a significantly inhibited fusion activity, indicating that 
the V-ATPase is playing a role in the process of fusion.
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Fig 6.4 Concanamycin A inhibits the fusion activity of GLUT4 vesicles.
GLUT4 vesicles were treated with 200 nM concanamycin A . GLUT4 vesicle 
fusion activity was determined using cytosol and PM liposomes from 
insulin-treated cells. A 3.24-fold difference in fusion activity was observed 
when comparing control with 200 nM concanamycin A pre-treated sample. Data 
are mean and SEM from 4 experiments. * p < 0.05 vs Ins cyt, Ins PM.
6.2.2 Investigation of whether the V-ATPase acts on a pH gradient or as 
fusion pore
There are two hypotheses as to how the V-ATPase may act on GLUT4 
vesicle fusion with plasma membrane: 1) the V-ATPase creates the H+ 
gradient between the inside and the outside of GLUT4 vesicles and this H+ 
gradient affects fusion, 2) V0 complex of V-ATPase acts as a fusion pore 
independent of vesicle acidification. If the V-ATPase acidifies the lumen of 
GLUT4 vesicles, the environment outside GLUT4 vesicles would be 
relatively basic. The environment in a normal fusion reaction was pH 7.4. If 
the environment was modified to pH 6.5, the H+ gradient would be reduced. 
When performing the fusion reactions in an environment at pH 6.5, the 
fusion activity was reduced down to 1/3 of the control at pH 7.4 (Fig 6.5).
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Fig 6.5 Low pH (pH 6.5) inhibited fusion activity. GLUT4 vesicle 
fusion activity was determined using cytosol and PM liposomes from 
insulin-treated cells in the environment of pH 6.5 or pH 7.4 (control). A 
3.3-fold difference in fusion activity was observed when comparing 
control with pH 6.5 sample. Data are mean and SEM from 3 
experiments. * p < 0.05 vs Ins cyt, Ins PM.
6.3 Discussion
In this chapter the effect of V-ATPase on GLUT4 vesicle fusion with the 
plasma membrane was studied in two ways: by 1) V-ATPase inhibitor 
concanamycin A treatment of GLUT4 vesicles in order to stop the H+ pump 
activity of V-ATPase, and by 2) perturbation of H+ gradient between inside 
and outside of GLUT4 vesicles.
Concanamycin A treatment showed inhibition of fusion activity and 
suggested a role of V-ATPase in this fusion event. Although concanamycin 
A inhibited GLUT4 vesicle acidification, the mechanism by which the 
V-ATPase was inhibiting the fusion was still not clear. Perturbation of the pH 
gradient by carrying out fusion reaction in a pH 6.5 environment is one way 
to reveal the role of H+ gradient. Fusion activity was blocked in pH 6.5 
medium. An additional useful test would be to study fusion activity in a
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medium buffered at pH 8.0. If fusion activity is stimulated in pH 8.0 
compared with pH 7.4, then this would mean that a H+ gradient is important 
in the fusion reaction. If no stimulation is found when comparing pH 8.0 with 
pH 7.4 then this may mean that the fusion reaction requires an optimal pH 
environment and that a low pH (for example at pH 6.5) is sub-optimal. 
However, even if the fusion was stimulated at pH 8.0, this would not exclude 
the possibility that the VO complex of the V-ATPase might work as a fusion 
pore in the fusion reaction.
A H+ gradient has been suggested to facilitate the translocation of GLUT4 to 
the cell surface and fusion with the plasma membrane (Yang et al., 2002b). 
Several studies suggested the involvement of endosome acidification in 
receptor tail recognition and in control of recycling via interactions with 
internalization motifs (Basu et al., 1981; Reaves and Banting, 1994). In the 
analysis of TfR recycling (Johnson et al., 1993; Presley et al., 1997), it has 
been revealed that reduced endosome acidification results in a reduced rate 
of exit of TfRs from the recycling compartment to the plasma membrane. In 
addition, the distribution of ADP ribosylation factor (ARF) to the cytoplasmic 
face of the trans-Golgi network, where it is required for vesicle coating and 
budding of secretory vesicles, is a pH-dependent process (Zeuzem et al., 
1992). GLUT4 contains targeting motifs at both the N- and C-terminal 
domains. These domains include acidic motifs that may act to fine-tune the 
recognition by adaptor complexes of motifs based on hydrophobic residues, 
phenylalanine at the N-terminus and di-leucine at the C-terminus (Holman 
and Sandoval, 2001; Martinez-Arca et al., 2000; Sandoval et al., 2000; 
Shewan et al., 2000). It seems likely that these acidic domains may be 
recognized by vesicle-coating proteins (Holman and Sandoval, 2001). It is 
hypothesized that the recognition of these domains maybe dependent on pH 
around the GLUT4 vesicles and tubulo-vesicular structures and may 
influence vesicle coating, budding and release steps.
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A more important site for pH regulation of GLUT4 trafficking appears to be at 
the vesicle fusion step at the plasma membrane. Perturbation at this step 
could account for the low transport activity and reduced exposure of GLUT4 
to the impermeant photolabeling reagent but retention of high levels of 
GLUT4 immunocytochemically localized in the vicinity of the plasma 
membrane (Yang et al., 2002b). Analysis of the kinetics of exocytosis has 
revealed that there is an initial rapid burst of exposure of GLUT4 at the cell 
surface, which is then followed by a slower phase. These burst kinetics in 
GLUT4 exocytosis are similar to those reported for other vesicle secretory 
systems (Jahn and Sudhof, 1999; Xu et al., 1999), which indicates that there 
are two vesicle fusion intermediates present in sequence, possibly SNARE 
interaction and another trigger (which could be Ca2+ or a pH gradient for 
example).
Recently more and more studies have revealed the V-ATPase’s role as a 
fusion pore component which is independent of a role in acidification (Bayer 
et al., 2003; Hiesinger et al., 2005; Poea-Guyon et al., 2006). The fact that 
V0 binds to t-SNAREs is consistent with other reports suggesting t-SNARE 
syntaxin is a component of the fusion pore (Han et al., 2004; Han et al.,
2005). The links of the V-ATPase with Ca2+-releasing channel (Bayer et al., 
2003) and with calmodulin (Peters et al., 2001) make its relation to fusion 
even more interesting.
As mentioned earlier, fusion assays in pH 6.5 and pH 8.0 can be considered 
to reveal the pH gradient mechanism. Various proton ionophores, such as 
nigericin, FCCP, can also be implemented to break the pH gradient. In 
addition, if the fusion pore hypothesis is true, it is crucial to prove that the 
loss of V0 complex halts fusion. The failure of V0 complex can be realized 
by immuno-depletion, recombinant protein or antibody interference, and 
other techniques.
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So far there have not been reports on the intra-vesicular pH inside of GLUT4 
vesicles. Using a method similar to that described by Bai et al. (Bai et al.,
2006), VAMP2 could be fused with a pH sensitive marker and this 
recombinant VAMP2 could be transfected into insulin sensitive cells 
containing GLUT4 vesicles. Using microscopy to visualize the pH sensitive 
marker, it should be possible to show a series of changes in the process of 
insulin-stimulated GLUT4 translocation.
In summary in this chapter it has shown that the V-ATPase VO subunit a is 
present in the GLUT4 vesicles and that the use of an inhibitor of the 
V-ATPase decrease significantly the amount of fusion. The change of the 
pH of the incubation medium leads also to a reduction in the fusion process, 
pointing towards an effect of the pH gradient on GLUT4 vesicle fusion with 
the plasma membranes.
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Chapter 7 Liposome fusion using recombinant SNAREs
7.1 Introduction
As discussed in earlier chapters, the incorporation of GLUT4 into the plasma 
membrane of muscle and fat cells is an important biological phenomenon 
involving vesicle-membrane fusion. Insulin signalling results in the 
movement of GLUT4 vesicles towards the plasma membrane and fusion of 
GLUT4 storage vesicles with the plasma membrane. This appears to fail in 
the insulin resistance state, which accompanies several forms of diabetes.
The functional proteins in vesicle/membrane fusion are soluble 
A/-ethylmaleimide sensitive factor attachment protein receptor (SNARE) 
proteins (section 1.4.2). As mentioned earlier, the fusion of transport 
vesicles into acceptor membranes is mediated by a complex of proteins 
known as t-SNAREs and v-SNAREs. T-SNAREs are found on 
target/acceptor membranes and are composed of the syntaxin (Stx) and 
SNAP (soluble A/-ethylmaleimide-sensitive fusion factor attachment protein) 
family of proteins. V-SNAREs are members of the VAMP 
(vesicle-associated membrane protein)/synaptobrevin family and are found 
on vesicle/donor membranes (Bonifacino and Glick, 2004; Hong, 2005) 
(section 1.4.2). The mechanism underlying membrane bilayer fusion 
requires the formation of high-affinity, parallel, four-a-helix bundles 
containing one coiled-coil Stx domain, two coiled-coil SNAP domains, and a 
coiled-coil VAMP domain (Antonin et al., 2002; Sutton et al., 1998). Because 
of the physiological importance of insulin-dependent GLUT4 translocation to 
the cell surface, attempts have been made to characterize the final GLUT4 
vesicle fusion step, drawing from lessons learned from neural synaptic 
transmission, which has been well studied (Table 7.1).
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Table 7.1 Functional SNARE proteins in neuronal transmission and GLUT4 storage 
vesicles (GSV) fusion with the plasma membrane.





As Table 7.1 shows, the functional SNAREs in neuronal transmission are 
VAMP2 (v-SNARE), syntaxinl (t-SNARE) and SNAP25 (t-SNARE) (Leabu, 
2006; Schuette et al., 2004) (section 1.4.3). For the GLUT4 storage vesicles 
(GSV) which fuse with the plasma membrane, the counterparts are VAMP2 
(v-SNARE), syntaxin4 (t-SNARE) and SNAP23 (t-SNARE) (Foster and Klip, 
2000). They have been shown to bind pair-wise in vitro with affinities similar 
to those of the neuronal homologs (Foster et al., 1998). They also form a 
ternary complex in vitro (Rea et al., 1998; Widberg et al., 2003) and are 
present together in 20S SNARE complexes in adipose cells (St-Denis et al., 
1999). Their function and detailed mechanism of action in the fusion is still 
elusive. Generally, it is believed that their interaction occurs as illustrated in 
Fig 7.1. VAMP2 is present in GLUT4 vesicles and participates in the 
formation of a fusion complex with the plasma membrane t-SNAREs, 
syntaxin4 and SNAP23. In this crucial step of fusion, other proteins have 
been reported to play active roles in the fusion complex formation. For 
example, the availability of syntaxin4 might be controlled by Munc18c, which 
has a negative “clamping” effect on syntaxin4 or may induce a 
conformational change in syntaxin4 that renders it available for SNARE 
pairing (Foster and Klip, 2000). Proteins of the Rab family can interact with 
Rab effectors. In neuronal cells, Rab effector such as Rabenosyn5 binds to 
Rab5 and to the syntaxin interacting protein Munc18. The latter interaction 
then regulates the SNARE pairing (Schimmoller et al., 1998). In
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insulin-sensitive tissues, Rab4 has been implicated in GLUT4 vesicles 











Fig 7.1 SNARE protein interaction in regulation of GLUT4 vesicle fusion with the plasma 
membrane.
7.2 Principle and the design of the SNARE-dependent fusion assay
The idea of the work described in this chapter is inspired by the milestone 
work in the field of membrane fusion by Weber et al (Weber et al., 1998). 
They expressed the recombinant v- and t-SNAREs, reconstituted the 
SNARE proteins into artificial liposomes, and allowed these liposomes to 
fuse with assistance of SNARE proteins in an absolutely cell-free 
environment. The success of this system provides evidence that SNARE 
proteins constitute the minimal machinery for membrane fusion. The basis 
of this assay is lipid mixing with fluorescence dequenching (Struck et al., 
1981): when liposomes fuse, the distance between fluorescence quenching 
pairs increases, the quenching decreases and fluorescence signal
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increases. As mentioned in Chapter 1 (section 1.4.4), lipid mixing could 
produce a pseudo signal at a hemi-fusion stage. To avoid this, the assay 
described in this chapter is instead a content mixing assay and based on the 
formation of the fluorescent Eu(DPA)33' chelation complex. Eu3+ and 
dipicolinic acid (DPA) are encapsulated in two sets of liposomes of interest, 
namely t-SNARE and v-SNARE liposomes. When these liposomes fuse 
under certain conditions, Eu3+ and DPA form Eu(DPA)33‘ chelation complex. 
The fluorescence intensity of Eu on its own is very low, but when the 
complex is excited at a wavelength close to the absorption maximum of 
DPA, the fluorescence is enhanced 104-fold because of an internal energy 
transfer from the ligand to the metal ion. Fusion of the liposomes would then 
register as an increase of the fluorescence intensity due to the formation of 
the Eu(DPA)33’ complex (Fig 7.2).
Intensity fluorwceof 
Eu-DPA complex
Excitation wavelength: 340mn 
Emission wavelength: 612nm
Fig 7.2 Content mixing with Eu/DPA probes. See
text for details.
For practical applicability of this assay, several conditions have to be met. 
First, both EuCI3 and DPA have to be able to be encapsulated within 
phospholipid vesicles without affecting the structure of the bilayer; their rates
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of leakage from the vesicles should be low. Second, the formation of the 
Eu/DPA complex should be fast enough to permit kinetic analysis of vesicle 
fusion. Third, in order to eliminate the possibility that mere leakage of vesicle 
contents would result in fluorescence development, the composition of the 
external medium has to be such that formation of the complex outside the 
vesicles is effectively prevented.
7.3 Results
7.3.1 Fusion of plain liposomes induced by PEG
To determine if DPA and Eu3+ are a good pair to measure the extent of 
liposome fusion, experiments were first performed with plain liposomes 
containing either DPA or Eu3+, namely PD and PE liposomes. To induce the 
fusion of the plain liposomes, the fusogenic reagent polyethelene glycol 
(PEG) was used at concentrations of 1 to 4 % (w/v). As shown in Fig 7.3, 4 
% PEG induced a quicker increase in the detected fluorescent signal. The 
relative fluorescent unit was normalized relative to the maximum signal 
obtained after detergent addition which was set as 100 % fluorescence. This 
result demonstrated that the content mixing method is occurring and allows 
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Fig 7.3 PEG induced plain liposomes fusion. 5 pi of Eu encapsulated plain 
liposomes (PE) were mixed with 5 pi of DPA encapsulated plain liposomes (PD), 
in the presence purified PEG. Fluorescence was expressed as a percentage of the 
signal obtained after addition of 0.1 % TritonX-100 (considered as 100 %). PEG 
was added at 0 sec.
7.3.2 Reconstitution of t- and v-SNAREs into liposomes
Recombinant t- and v-SNAREs were expressed, purified and reconstituted 
into liposomes (sections 2.2.5, 2.2.6). The last step in the reconstitution of 
the SNARE proteins into the liposomes is the separation of the liposomes 
from the crude material on an Optiprep gradient (Chapter 2, section 2.2.6.2). 
After the end of the centrifugation, different layers were collected from the 
top to the bottom of the tube (Fig 7.4). Sample of these layers were 
analysed by western blotting to detect the SNARE protein distribution across 
the gradient. The t-SNAREs syntaxin4, SNAP23 and v-SNARE VAMP2 
were mainly present in the top layers (labelled 1 and 2 in Fig 7.5). In all the 
subsequent experiments, Eu3+ encapsulated t-SNARE liposomes (TE) and 
DPA encapsulated v-SNARE liposomes (VD) were harvested from layers 1 
and 2 (1 ml in total). There was also a tiny amount of sytaxin4 present in the 
layer 3 (Fig 7.5).
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Fig 7.4 Representation of the layers distribution in an Optiprep 
gradient. 10 fractions were collected from the top to the bottom of the 
gradient (0.5 ml from each layer)








Fig 7.5 Reconstitution of t- and v-SNAREs into liposomes and their 
analysis by western blotting. Rabbit anti Syntaxin4 antibody showed a 
syntaxin 4 band at 34 kDa. Rabbit anti GST antibody showed a SNAP23-GST 
band at 50 kDa. Rabbit anti VAMP2 antibody showed a VAMP2 band at 13 
kDa.
7.3.3 Orientation of t- and v-SNAREs in liposomes
To test the SNARE orientation when incorporated in the liposomes, 
t-SNARE or v-SNARE liposomes were treated with trypsin in the absence or
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presence of detergent (Fig 7.6). The t-SNAREs (syntaxin4, SNAP23) in TE 
liposomes were completely digested by 1 mg/ml trypsin with or without 
detergent. The complete digestion was most likely due to the trypsin amount 
being present in large excess. The v-SNARE (VAMP2) in VD liposomes was 
digested incompletely in the absence of detergent but completely with 
detergent. For VAMP2, Botulinum neurotoxin light chain/B protease 
(BoLC/B) cleavage experiments were carried out to test whether VAMP2 






Fig 7.6 A test of the orientation of t- and v-SNAREs in liposomes by 
trypsin digestion. All liposomes were incubated at 37 °C for 30 min. 
Trypsin was present at 1 mg/ml and TritonX-100 was present at 0.2 % 
(w/v) as final concentrations.
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Fig 7.7 Analysis of VAMP cleavage by Botulinum neurotoxin light 
chain/B protease (BoNT/B). A, Western blot for VAMP2 in VD 
liposomes after treatment with a range of BoNT/B LC. B, Densitometry 
results were obtained from quantification of the western blot signals. 
Values were expressed as Integrated Optical Density (IOD) values.
Increasing amounts of the v-SNARE VAMP2 present in VD vesicles were 
cleaved by BoNT/B LC as the enzyme concentration was increased. The 
band intensities were quantified as IOD values. These reached a plateau of 
digestion at 100 nM enzyme treatment (Fig 7.7 B). Even in presence of 
detergent some of the VAMP2 protein remained uncleaved. The 
quantification result indicates that 65.7 % of the VAMP2 is inserted in the 
right orientation in the liposomes (cytoplasmic-side out). However, the 
quantification of trypsin digestion of VAMP2 (Fig 7.6) showed that 92 % was 
digested. This higher percentage may be due to the over digestion of some 
internally orientated VAMP2 by trypsin at high concentration (1 mg/ml).
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7.3.4 Quantifications of t- and v-SNAREs in liposomes




Fig 7.8 Quantification of t- and v-SNAREs in liposomes. The indicated 
liposome samples were 10 pi each. The amounts of recombinant protein 
standard sample were 108, 109, 1010molecules/pl, with 10 pi of each added 
to the gel. Standards: GST-syntaxin4 (56 kDa), NucA-SNAP23 (43 kDa), 
NucA-VAMP (33 kDa). This result shown was from two very similar 
experiments.
To estimate the amount of each one of the SNARE protein in the liposomes, 
a sample of TE or VD liposomes was analysed by western blot alongside 
known amount of the respective recombinant protein (Fig 7.8). The amount 
of t-SNARE syntaxin4 reconstituted was approximately 108 molecules/pl TE 
liposomes; SNAP23 reconstituted was approximately 108 molecules/pl TE 
liposomes. The amount of v-SNARE VAMP2 reconstituted was 108 - 109 
molecules/pl VD liposomes.
7.3.5 SNARE-reconstituted liposome fusion is induced by Ca2+ and 
cytoplasm
When normalization of the fluorescence signal was carried out for the 
experiments in which PEG-induced fusion was studied, 0.1 % TritonX-100 
(w/v) was used to gain the maximum 100 % fluorescence value. In the
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SNARE fusion assay, octyl-glucoside, TritonX-100, Tween20, C12E9, sodium 
cholate, n-Dodecyl-maltoside were tried in an attempt to obtain a maximum 
100 % fluorescence value. However, none of these reagents produced a 
fluorescence increase. Instead, the fluorescence even decreased in some of 
the cases. This decrease may occur if, in the presence of the IC buffer and 
cytoplasm, the Eu3+ is quenched by the EGTA in the IC buffer. However, in 
the presence of surrounding dialysis buffer, the decrease could not be 
explained in this way. Instead it is suggested that perhaps there is a 
quenching effect of the detergent more directly on the fluorescence of the 
probe. Because the SNARE vesicle fusion was mainly carried out in the 
presence of surrounding IC/cytoplasm which contains EGTA, the
highest/plateau fluorescence signal after the Ca2+inducing was set as 100
0//o.
When TE and VD liposomes or the plain liposomes were mixed in 1:1 ratio 
in presence of IC buffer only, the fluorescence went slowly down (Fig 7.9), 
indicating no fusion was induced and a slow leakage of fluorescent material 
was occurring. The addition of Ca2+to these liposomes did not modify the 
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Fig 7.9 Liposome fusion in the presence of IC buffer alone. 50 pi of Eu
containing liposomes (PE, TE) were mixed with 50 pi of DPA containing 
liposomes (PD, VD) in the presence of 25 pi IC buffer. 3.5 pi of 200 mM CaCl2 
was added at the indicated 15 min time point to achieve a free Ca2+ final 
concentration of 100 pM for the induction. The fluorescent intensity is expressed 
as Relative Fluorescent Units (RFU). The result shown was from two very 
similar experiments.
In the presence of cytoplasm the fluorescence remained constantly flat. 
Basal and insulin stimulated cytoplasm affected the fluorescent signal in the 
same way (Fig 7.10).
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Fig 7.10 Liposome fusion in the presence of cytoplasm. 50 pi of Eu
liposomes (PE, TE) were mixed with 50 pi of DPA liposomes (PD, VD) in 
the presence of 25 pi of cytoplasm from basal (B) or insulin stimulated (I) 
cells (2.3 mg/ml). The fluorescent intensity is expressed as Relative 
Fluorescent Units (RFU).
Fig 7.11 shows the time course of the fusion with Eu3+ and DPA liposomes 
after Ca2+ was added. A single representative experiment is also shown in 
Fig 7.12 in Ca2+ added samples. After the addition of CaCI2 to the liposome 
suspension in cytoplasm and from time zero, the Europium fluorescence 
intensity increased gradually until a maximum was reached. This was 
followed by a plateau. These results indicate that when Ca2+ and cytoplasm 
are surrounding the liposomes, they induce a mixing of liposome contents. 
For SNARE liposome fusion in the presence of Ca2+, the ti/2was 15.12 min. 
For plain liposomes, it was 40.97 min.
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Fig 7.11 Ca2+and cytosol induced fusion. 50 pi of Eu liposomes were mixed 
with 50 pi of DPA liposomes in the presence of 25 pi of cytosol (2.3 mg/ml) from 
rat adipocytes. Normalization of fluorescence changes was carried out as follows. 
Fluorescence was plotted from time point 0 at which Ca2+ was added. 3.5 pi of 
200 mM Ca2+ stock was added to achieve free Ca2+of 100 pM. For SNARE 
liposomes, the lowest signal before Ca2+ was added was F0. The highest signal 
after Ca2+ was added was F10o- The Fluorescence level = (F-F0) / (F 10o-F0). For 
plain vesicles, the lowest signal before Ca2+ was added was F ’o- The Fluorescence 
level = (F ’ -F ’o) /  (Fioo-F0). The results were mean ± SEM (n=3).
7.3.6 The effect of different divalent cations effect on 
SNARE-reconstituted liposome fusion
To determine whether the Ca2+ effect observed was specific, another 
divalent cation Mg2+ at the same concentration was used in parallel and in 
the same assay. As Fig 7.12 shows, no fusion was induced by Mg2+, 
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Fig 7.12 The effect of different divalent cations on fusion. 50 pi of Eu
liposomes were mixed with 50 pi of DPA liposomes in the presence of 25 pi 
cytoplasm (2.3 mg/ml) from basal cells (B). The arrow points to the time of Ca2+ 
or Mg2+ addition. The fluorescent intensity is expressed as Relative Fluorescent 
Units fRFUl
7.3.7 Analysis of fusion following BoNT/B cleavage of SNAREs
To study whether the Ca2+ and cytoplasm induced fusion is 
SNARE-dependent, BoNT/B cleaved VD liposomes were compared with the 
normal VD liposomes. As Figure 7.13 shows that, BoNT/B cleaved 
liposomes, inactivated BoNT/B liposomes (control), and normal VD 
liposomes produced the same pattern of fluorescence change in the fusion 


















Fig 7.13 Analysis of whether fusion in BoNT/B LC cleaved-liposomes 
is inhibited. 50 pi of Eu3+ liposomes were mixed with 50 pi of DPA 
liposomes (preincubated with 100 nM (labeled as “toxin 100 nM”), 400 
nM BoNT/B (“toxin 400 nM”), inactivated BoNT/B (“intoxin”) at 37°C 
for 1 h) in the presence of 25 pi of cytoplasm from insulin stimulated cells 
(I) (2.3 mg/ml). The arrow points to the time of Ca2+ addition. The 
fluorescent intensity is expressed as Relative Fluorescent Units (RFU).
7.4 Discussion
The main objective of the work in this chapter was to set up an in vitro 
system to study the fusion that is solely dependent on the SNARE proteins 
that are present in the system that mediates fusion of GLUT4-containing 
vesicles with plasma membranes from insulin responsive tissue.
Previous work by Weber et al (Weber et al., 1998) has described the 
successful reconstitution of the neuronal SNAREs in liposomes and their 
use in an in vitro system based on the detection of lipid mixing. The 
fluorescent probe pair they used was NBD and Rhodamine. The probes 
were inserted in the phospholipid bilayers. When the two fluorescent probes 
were in close proximity and in the same liposome, the fluorescence was 
quenched and no signal was detected. When the fusion occurred, the 
distance between the two probes was increased and a fluorescent
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dequenching occurred, which was detected as the signal of fusion. As 
described earlier, the drawback of this method is in the hemi-fusion step, in 
which the probe can go through the “bridge” between liposomes (section 
1.4.4). In this case, the distance of the two probes can be enhanced, but 
fusion is not complete and the content of the two liposomes do not mix. 
Recently, Vicogne et al set up a very similar system using SNARE protein 
pairs involved in insulin-stimulated GLUT4 vesicles fusion with plasma 
membrane (Vicogne et al., 2006). In their report, they described a method to 
improve the lipid mixing assay. With sodium dithionite in the environment 
buffer, the outer membrane half-bilayer signal was reduced and a 
fluorescent signal from only the inner membrane lipids was recorded. In this 
way the pseudo signal from the hemi-fusion is eliminated as the inner lipids 
of the bilayers only mix if a full fusion has occurred.
In comparison, the content mixing method which has been used in this 
chapter (Fig 7.2) has its advantages. It directly gets rid of the hemi-fusion 
signal to make the fusion detection more convincing. The Eu3+/DPA 
fluorescence enhancement is a novel assay compared to Tb3+/DPA assay, 
which has been used in various investigations previously (Chien et al., 1994; 
Glaser and Gross, 1994; Wilschut et al., 1980; Wilschut and 
Papahadjopoulos, 1979).
The phospholipid liposome preparation involved a detergent dialysis method 
and for the most part it followed the method described by Weber et al. 
(Weber et al., 1998) apart from that the lipid solution was diluted two times 
for the purpose of forming the liposome and encapsulating the Eu3+ or DPA. 
After this the detergent was dialysed out and liposomes were collected after 
a gradient spin. The whole preparation was first carried out in sodium 
phosphate buffer pH 7.4 but it was found that Eu3+ precipitated with
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phosphate (data not shown). Then the buffer was modified to HEPES/NaCI 
pH 7.4.
Comparing the Vicogne et al. and Weber et al.*s systems, another major 
difference appears to be related to the recombinant t-SNARE protein used.
In their systems, t-SNAREs were co-expressed and tagged with either GST 
(Weber et al., 1998) or poly-His (Vicogne et al., 2006) to further purify the 
proteins. In Weber’s system the respective plasmids pTW19 for syntaxinIA 
and pGEX-mSNARE25B for GST-SNAP25 were co-transformed. The 
cytoplasmic t-SNARE complex was purified through glutathione agarose 
beads. In Vicogne’s system syntaxin4 and SNAP23 cDNAs were cloned into 
the dual protein expression vector pET-duet. In the vector the syntaxin4 
coding sequence was cloned in-frame with the N-terminal 6His-tag of the 
first multicloning site, and the SNAP23 coding sequence was in-frame with 
the second multicloning site. The t-SNARE complex was purified with 
Ni-NTA His-Bind Resin. These purifications used in the above two systems 
enabled the t-SNARE quantification before reconstitution. The quantification 
was used to adjust and monitor the amount of protein incorporated in 
liposomes.
In the method used in this chapter, although SNAP23 was tagged with GST, 
the attempt to purify the t-SNARE complex through glutathione agarose 
beads was unsuccessful (Ribe, 2005). In the studies of the former PhD 
student David Ribe, syntaxin4 was observed to stick to the glutathione 
agarose beads and could not be eluted together with SNAP23 (Ribe, 2005). 
The main problems lie in the following two aspects. Firstly, the pGEX vector 
used in t-SNARE co-expression described in this chapter was not designed 
for protein dual-expression. The system used may potentially cause 
problems in protein expression and folding. Secondly, t-SNAREs were 
sequestered in inclusion bodies, and then the inclusion body proteins were
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denatured and buffer-exchanged to remove the denaturing reagent 
guanidine. Under these conditions the proteins were expected to renature 
but this may not occur efficiently. All these steps may have affected the 
biological properties of the protein and resulted to the unsuccessful GST 
purification. The t-SNARE liposomes were therefore reconstituted from the 
inclusion body protein solution instead of from purified t-SNARE complex 
(section 2.2.6.2). Because of the transmembrane characteristics of 
syntaxin4 and the interaction between syntaxin4 and SNAP23, the 
t-SNAREs were expected to form a complex and insert properly into the 
liposome membranes in the liposome reconstitution step. In the following 
gradient spin step (section 2.2.6.2), the reconstituted liposomes were 
expected to separate from other contamination proteins that were present in 
the inclusion body protein solution. Hence, using this method, the amount of 
t-SNARE protein involved in reconstitution could not be monitored and 
adjusted, leaving more variability from experiment to experiment. Although 
from the western blot analysis, the t-SNARE proteins after reconstitution 
appeared to be largely purified as we expected, the un-ideal conditions 
involved could affect the liposome quality to variable extents: the 
denaturing-renaturing step could influence the protein stability; the 
contaminating proteins could affect the efficiency and quality of 
reconstitution.
The content mixing experiments described in this chapter showed that the 
simple mixing of the two sets of liposomes does not induce fusion, which is 
contrary to what is observed both with the neuronal SNAREs (Weber et al., 
1998) and GLUT4 fusion SNAREs (Vicogne et al., 2006). Consistency with 
the findings in Chapters 4 and 5, results described in this chapter suggest 
that Ca2+ and additional elements contained in the cytoplasm are needed. 
Although attempts to demonstrate SNARE-specific fusion failed, Ca2+ did 
induce the fusion to different extents depending on whether SNARE
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liposomes or plain liposomes were used. This finding somewhat implies that 
the Ca2+effect was not dependent on lipid alone. Also the difference of Ca2+ 
and Mg2+ effects on fusion further confirmed that the fusion induced by Ca2+ 
and cytosol described in this chapter was not simply a non-specific divalent 
cation effect on lipids. However, in other studies Mg2+ could produce positive 
effects for neuronal SNAREs fusion (Fix et al., 2004).
Vicogne et al proposed and proved that fusogenic reagents phosphatidic 
acid (PA) and phosphatidylinositol-4,5-bisphosphate (PIP2) promoted the 
formation of membrane layer curvature, so as to form hemi-fusion status 
and eventually full fusion (Vicogne et al., 2006). Through kinetic studies they 
proved the hemi-fusion step is the rate-limiting factor for the in vitro 
membrane fusion. This conclusion adds new insights into the properties 
required for SNARE-mediated membrane fusion. It will also be interesting to 
test this idea in the fusion system described in Chapter 4.
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Chapter 8 Final conclusion and discussion
8.1 Conclusion
This thesis demonstrated two in vitro fusion systems and investigated the 
mechanisms involved in insulin-stimulated GLUT4 translocation in rat 
adipocytes with these two systems.
The first system is composed of reconstituted rat adipocytes plasma 
membrane liposomes, immuno-isolated GLUT4 vesicles from rat 
adipocytes, rat adipocytes cytosol and an ATP-regenerating system. 
Fractions from basal or insulin pre-treated rat adipocytes enable testing of 
different conditions of interest. Reagents like inhibitors can be added to the 
system.
The construct of MBP-Spa described in Chapter 3 enabled the generation of 
an important fraction in the fusion system - biologically active GLUT4 
vesicles. In detail, MBP-Spa bound to amylose resin, then bound to 
C-terminal GLUT4 antibodies and the antibodies immunologically isolated 
GLUT4 vesicles from rat adipocytes subfractionation. The formed complex 
was then eluted by maltose. The presence of VAMP2 confirmed that this 
population of isolated GLUT4 vesicles should be categorized to GLUT4 
storage vesicles, which are the most competent intracellular GLUT4 
compartments for insulin-stimulated GLUT4 translocation (Larance et al.,
2005).
As described in Chapter 4, the system successfully showed different extents 
of fusion when comparing between basal and insulin-stimulated conditions. 
With detailed time course curves for both of the conditions, the kinetics were 
observed to be markedly similar to those of glucose transport recorded in
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real cells. This suggested that fusion is the rate-limiting step in 
insulin-stimulated glucose uptake. The SNARE protein VAMP2 and cytosol 
were found to be necessary in the fusion event, while cell skeleton was not 
necessary. Insulin plasma membrane was demonstrated to be the crucial 
component in supporting fusion. The effect of the insulin signalling cascade 
on fusion reaction was studied. Inhibition of PI 3-kinase and Akt activities 
eliminated fusion. Akt was found to be recruited to the insulin plasma 
membrane and phosphorylated there. The recruitment and phosphorylation 
promoted fusion.
Preliminarily the studies of Ca2+ and V-ATPase effects and requirements in 
this fusion system have been described in Chapters 5 and 6. Addition of the 
membrane-permeable strong Ca2+ chelator BAPTA-AM and the V-ATPase 
inhibitor concanamycin A produced inhibition of fusion. However, the studies 
were insufficiently complete to show a clear picture on their mechanisms of 
inhibition.
The second system, which is described in Chapter 7, is liposome fusion 
using reconstituted SNARE proteins. Components of the SNARE system 
were reconstituted in vitro but experiments on fusion failed to provide 
evidence for SNARE-specificity. Nevertheless, the requirements for cytosol 
and Ca2+ in this fusion did show consistency with the first system, the fusion 
of GLUT4 vesicles and PM liposomes.
8.2 Discussion
In this thesis the factors that influence insulin-stimulated GLUT4 vesicle 
fusion with plasma membrane are studied with in vitro fusion systems. 
These factors ranged from the members of insulin signalling cascade to final 
membrane fusion facilitators.
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Several studies have suggested that under conditions in which insulin action 
is perturbed, some GLUT4 vesicles are released from the intracellular 
reserve compartment and accumulate under the plasma membrane but do 
not fuse with it. These studies include the use of a low temperature block 
(Satoh et al., 1993; van Dam et al., 2005), the use of insulin 
counter-regulatory treatments with isoproterenol and cytosol acidification 
(Vannucci et al., 1992; Yang et al., 2002b; Yang et al., 2002a), and inhibition 
or loss of function of the SNARE-regulatory protein Munc18c (Kanda et al., 
2005; Thurmond and Pessin, 2000). One interpretation of these findings is 
that insulin action on a separate release or transit step involving the 
cytoskeleton may account for accumulation of non-fused GLUT4 vesicles 
(Baumann et al., 2000; Kanda et al., 2005; Thurmond and Pessin, 2000; van 
Dam et al., 2005). However, cytoskeleton components are not directly 
involved in fusion as no Latrunculin B effect is found using the system 
described in Chapter 4.
As the available GLUT4 for glucose transport is directly derived from the 
fusion step, a low basal rate of fusion will rate limit and determine the overall 
rate of the GLUT4 translocation process. It has been found that the full 
cellular insulin response on glucose transport is recapitulated in the 
magnitude, time course and PI 3-kinase dependence of the fusion step. This 
leads to the hypothesis that insulin regulation of fusion is not only limiting the 
appearance of GLUT4 at the surface but is indirectly and consequentially 
influencing the extent to which the internal reserves are emptied, and the 
extent to which vesicles are associated with the cytoskeleton. This indirect 
effect could occur if there is queuing for fusion and transit along 
microtubules. The extent and location of queuing could then be dependent 
on the extent of release of GLUT4 at the fusion site. Instead of having a 
regulating role, the cytoskeletal proteins may have a permissive role in 
allowing and facilitating access of GLUT4 vesicles to the plasma membrane
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fusion apparatus (Bose et al., 2004). Perturbation of cytoskeletal proteins 
including microtubules and actin may block the insulin response in intact 
cells since the translocation-facilitating function of these proteins would be 
blocked. Such a queuing mechanism would be consistent with the 
observation that low concentrations of insulin lead to partial release of 
GLUT4 to the cell surface (Govers et al., 2004).
Despite advances in the understanding of GLUT4 intracellular trafficking and 
strong evidence of PI 3-kinase and Akt being crucial regulators of 
insulin-induced GLUT4 vesicle fusion with plasma membrane, the specific 
input of Akt signalling to GLUT4 trafficking is still not known. The Akt 
substrate AS160, as a Rab GTPase-activating protein (GAP), has been 
found to be required for basal GLUT4 intracellular retention as well as for 
insulin-induced GLUT4 redistribution to the PM (Sano et al., 2003; Zeigerer 
et al., 2004). Knockdown of AS160 has resulted in an increase in basal 
GLUT4 exocytosis (Eguez et al., 2005). However, the range of Akt substrate 
involvement in insulin-stimulated GLUT4 translocation is not limited to 
AS160. It has been shown that inhibition of Akt in AS 160-knockdown 
adipocytes can still impair insulin-stimulated GLUT4 exocytosis by two-fold, 
suggesting that Akt substrates other than AS160 are involved in insulin 
regulation of GLUT4 exocytosis (Gonzalez et al., 2006). Moreover, it is 
suggested that signalling pathways other than Akt contribute to the full effect 
of insulin on GLUT4 redistribution to the plasma membrane (Gonzalez et al.,
2006). The observation that insulin promotes an acceleration of GLUT4 
exocytosis in Akt1/2 inhibitor (Akti-1/2)-treated AS 160-knockdown 
adipocytes also provides additional evidence for non-Akt-mediated 
regulation of GLUT4 exocytosis (Gonzalez et al., 2006).
Although the candidates that bridge the insulin signalling cascade and 
SNARE mediated GLUT4 vesicle fusion with plasma membrane remain
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mysterious, the SNARE mediated membrane fusion has been studied 
extensively. In terms of the kinetics of fusion, in the artificial fusion assays to 
mimic the synaptic vesicle fusion event, when VAMP is reconstituted in 
liposomes and t-SNARE in a planar lipid bilayer, the kinetics are similar to 
those occurring in vivo (Fix et al., 2004). When both sets of SNAREs are in 
liposomes, the reaction is slower (Parlati et al., 1999). Therefore the 
geometries of the lipid bilayers affect the kinetics of reconstituted fusion. In 
the system described in Chapter 4, although the size of the plasma 
membrane liposomes used was remarkably smaller than living cells (data 
not shown), the kinetics of the fusion is close to the kinetics of 
insulin-stimulated glucose uptake in vivo. This suggests that the system 
described in Chapter 4 reconstitutes well the real event in cells. In the fusion 
assay using recombinant t- and v-SNAREs the kinetics are expected to be 
slower than the real event.
Some reports questioned the requirement for SNAP25 in SNARE-mediated 
membrane fusion. Reconstituted VAMP2 liposomes and synaptic vesicles 
are able to fuse with planar lipid bilayers containing only syntaxinl (Bowen 
et al., 2004; Woodbury and Rognlien, 2000). SNAP25-knockdown mice 
show normal vesicle docking and fusion, with stimulus-dependent 
neurotransmitter release abolished (Woodbury and Rognlien, 2000). It is 
suggested that SNAP25 and its homologues are more involved in regulating 
fusion rather than directly participating in catalyzing fusion. SNAP25 and 
SNAP23 are shown to control the different conditions of granule release by 
forming docking complexes at different Ca2+ thresholds (Chieregatti et al., 
2004).
Connecting with the regulation to SNARE-mediated membrane fusion, the 
effects and functions of the Ca2+ chelation and the V-ATPase inhibition of 
insulin-stimulated GLUT4 vesicle fusion with plasma membrane have also
184
been intriguing. Ca2+ might work as a trigger to break the balance in a “stalk” 
stage in hemi-fusion and to assist the completion of the fusion. It may also 
affect Akt signalling in the first place (Whitehead et al., 2001). H+ gradient 
generated by V-ATPase can be another trigger for fusion that may assist the 
SNARE interaction. V-ATPase itself may also work for the formation of a 
fusion pore.
The cell biology of insulin-stimulated GLUT4 trafficking is complex. Many 
issues and controversies have yet to be solved. The identification of fusion 
as the key regulated step in the overall translocation process should 
facilitate further focus on this topic. Innovative approaches have identified 
much of the machinery of membrane fusion (Bryant et al., 2002). Further 
application of such approaches to the problem of insulin regulation of cell 
glucose metabolism would be expected to be a fruitful avenue of further 
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Table 1 Compositions of the buffers used in the general experiments
Name of buffer Composition
Phosphate Buffered Saline 
(PBS)
Tris Buffered Saline (TBS) 
Tris Buffered Saline -  
Tween 20 (TBS-T)
Column Buffer for Amylose 
Resin
154 mM NaCI, 12.5 mM Na2HP04 .12H20 , pH 7.2
10 mM Tris, pH 7.4,154 mM NaCI
10 mM Tris, pH 7.4,154 mM NaCI, 0.1 % (v/v) Tween-20
20 mM HEPES pH 7.4, 150 mM NaCI
High salt column buffer 1 
High salt column buffer 2
20 mM HEPES pH 7.4, 500 mM NaCI 
20 mM HEPES pH 7.4,1 M NaCI
Ni-NTAWash Buffer 300 mM NaCI, 50 mM sodium phosphate buffer, 20 mM imidazole, pH 8.0
Ni-NTA Elute Buffer
SDS Sample Buffer 
Resolving Gel Buffer
300 mM NaCI, 50 mM sodium phosphate buffer, 250 mM 
imidazole, pH 8.0
Protein samples were solubilised in 2 % (w/v) SDS, 62.5 
mM Tris HCI pH 6 .8 , 0.01 % (w/v) bromophenol blue, 
and 10 % (v/v) glycerol. The reducing agent was 20 mM 
Dithiothreitol (DTT) unless otherwise stated 
1.5 M Tris HCI, 0.4 % (w/v) SDS, pH 8.8
Stacking Gel Buffer 0.5 M Tris HCI, 0.4 % (w/v) SDS, pH 6.1
Electrophoresis Running 
Buffer 25 mM Tris HCI, pH 6.3, 0.1 % (w/v) SDS, 0.2 M Glycine
T ransfer Buffer 39 mM Glycine, 48 mM Tris, 0.0375 % SDS (w/v), 20 % methanol (v/v), pH 8.8 without adjusting
NUPAGE LDS Sample 
Buffer
Protein samples were solubilised in 2 % (w/v) LDS,
1.705 % (w/v) Tris Base, 1.665 % (w/v) Tris HCI, 0.015 
% (w/v) EDTA, 0.01875 % (w/v) Serva Blue G250, 
0.00625 % (w/v) Phenol Red and 10 % (v/v) glycerol, pH 
8.5 without adjusting. The reducing agent was 20 mM 
Dithiothreitol (DTT) unless otherwise stated
NUPAGE MOPS SDS 
Running Buffer
50 mM MOPS, 50 mM Tris Base, 3.465 mM SDS, 1.025 
mM EDTA, pH 7.7 without adjusting
NUPAGE MES SDS 
Running Buffer
50 mM MES, 50 mM Tris Base, 3.465 mM SDS, 1.025 
mM EDTA, pH 7.3 without adjusting
NUPAGE Transfer Buffer 25 mM Bicine, 25 mM Bis-Tris, 1.025 mM EDTA, pH 7.2
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without adjusting
Ponceau S Stain 0.1 % (w/v) Ponceau S, 3 % (w/v) trichloroacetic acid
Stripping Buffer 100 mM P-Mercaptoethanol, 2 % SDS, 62.5 mM Tris HCI, pH 6.7
BCA Reagent B 4 % (w/v) CuS04.5H20
Luria Broth (LB) 1 % (w/v) Bacto™ Tryptone, 0.5 % (w/v) Bacto™ YeastExtract, 0.5 % NaCI, pH 7.5, autoclaved
1 % (w/v) Bacto™ Tryptone, 0.5 % (w/v) Bacto™ Yeast
Agar Plates Extract, 0.5 % NaCI, 1.5 % (w/v) Agar, pH 7.5, 
autoclaved
Tris-acetate EDTA (TAE) 40 mM Tris-acetate, pH 8 ,1 mM EDTAbuffer
30 mM potassium acetate, 10 mM CaCI2, 50 mM MnCI2,
TFB1 medium 100 mM RbCI, 15 % (v/v) glycerol, pH 5.8 with 1 M acetic
------------------------------------------ acid, 0.2 pm filter-sterilized
10 mM MOPS or PIPES, 75 mM CaCI2, 10 mM RbCI, 15
TFB2 medium % (v/v) glycerol, pH 6.5 with 1 M KOH, 0.2 pm 
filter-sterilized
IB Wash Buffer for 50 mM Tris HCI pH 7.5,1 mM EDTA, 1 % (w/v)
recombinant t-SNAREs octyl-B-D-glucoside
Solubilisation buffer for 6 M guanidine HCI, 10 mM DTT, 1 % (w/v)
recombinant t-SNAREs octyl-B-D-glucoside
2) Rat adipocytes buffers
Table 2 Composition of buffers in rat adipocytes experiments
Name of buffer Composition
Krebs-Ringer-HEPES 
(KRH) for Adipocytes
140 mM NaCI, 4.7 mM KCI, 2.5 mM CaCI2, 1.25 mM 
MgS04, 0.2 mM NaH2P04, 10 mM HEPES, pH 7.4
HEPES-EGTA-Sucrose 
I (HESI) 250 mM Sucrose, 0.5 mM EGTA, 20 mM HEPES, pH 7.0
HESI Sucrose Cushion 1.12 M Sucrose, 1 mM EDTA, 20 mM HEPES, pH 7.0
Adipocyte Digestion 
Buffer
3.5 % (w/v) BSA in KRH supplemented with 5 mM glucose 
and 500 pg/ml Collagenase type 1 from Clostridium 
histolyticum
Adipocyte Lysis Buffer 2 % (w/v) Nonaethylene glycol monododecyl ether (Thesit) (C30H62O10), PBS
Intracellular Buffer (IC 
buffer)
20 mM HEPES pH 7.4,140 mM K-glutamate, 5 mM NaCI, 1 
mM EGTA
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3) Fusion assay buffers
Table 3 Composition of buffers in plasma membrane liposomes and GLUT4 vesicles
fusion assay
Name of buffer Composition
Reconstitution Buffer 
(RB)
25 mM HEPES pH 7.4,100 mM KCI, 10 % (w/v) glycerol or 
ddH20 , 1 mM DTT
RB for pH fusion assay 
(low HEPES)
1C buffer for pH fusion 
assay (high HEPES)
5 mM HEPES pH 7.4,100 mM KCI, 10 % (w/v) glycerol or 
ddH20 , 1 mM DTT
50 mM HEPES pH 7.4 or pH 6 or pH 8.3, 140 mM 
K-glutamate, 5 mM NaCI, 1 mM EGTA
Table 4 Composition of buffers in SNARE protein reconstituted liposomes fusion assay
Name of buffer Composition
Reconstitution Buffer for 
SNARE fusion assay 
(sRB)




25 mM HEPES pH 7.4, 100 mM NaCI, 15 mM EuCI3) 150 




25 mM HEPES pH 7.4, 100 mM NaCI, 150 mM 
2,6-pyridinedicaroxylic Acid (dipicolinic Acid, DPA) 
25 mM HEPES pH 7.4,100 mM NaCI, 1 mM DTT
4) Compositions for resolving and stacking gels
Table 5 Quantities of stock solutions required for 2 mini-gels (Bio-Rad).
Stock Solutions Resolving gel Stacking gel10% 15% 6%
Acylamide stock solution (ml) 5 7.5 3.4
Resovling gel buffer (ml) 5 5 -
Stacking gel buffer (ml) - - 5
Double-distilled water (ml) 5 2.5 7.5
Ammonium persulphate (pi) 100 100 100
TEMED (pi) 8 8 20
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